Personale

Recapiti

Orario di ricevimento

Italiano

Biografia

Curriculum

Note

Pubblicazioni

Insegnamenti

English

Biography

Curriculum

Note

Icro MEATTINI

Ruolo attuale:: Professore Associato
SSD:: MEDS-22/A - Diagnostica per immagini e radioterapia
Afferenza organizzativa:: Dipartimento di Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'

Recapiti

	0552751280
	icro.meattini(AT)unifi.it

Ulteriori Recapiti

	SODc Radioterapia Oncologica AOU Careggi
	+39 055 7947264
	icro.meattini(AT)unifi.it

Icro MEATTINI

Biografia

Personal

I have worked as Clinical and Radiation Oncologist since 2011 at the Radiation Oncology Unit of the Oncology Department at the Florence University Hospital (Florence, Italy). I am responsible for the outpatient clinics and clinical trials Units, and leader of the clinical oncology group of the breast cancer multidisciplinary team/Breast Unit. In 2018, I became associate professor at the Department of Clinical and Experimental Biomedical Sciences “Mario Serio” of the University of Florence (Florence, Italy).

I consider myself to be a passionate oncologist taking care of my patients in a holistic fashion, and integrating my clinical, empathic, and academic skills. I am married to a medical physicist active in the field of automated planning in radiation therapy and breast cancer. Outside of work, I am father of a wonderful daughter and I adore spending quality time with my family, traveling, playing tennis, and discovering cultures.

Background

I am an active member of ESTRO, European Organisation for Research and Treatment of Cancer – EORTC, European Society of Medical Oncology – ESMO, and the Italian Association of Radiotherapy and Clinical Oncology – AIRO. I am a member of the steering committee of the EORTC Breast Cancer Group and Radiation Oncology Scientific Council and a former Chair of the AIRO Breast Cancer Group, and founder of the Clinical Oncology Breast Cancer Group – COBCG cooperative network. In addition, I am a Core Group member of the ESTRO Guidelines Committee Sub-Group on Breast (former ACROP) and a Faculty member of the ESTRO teachers’ courses and of the College of the European School of Oncology – ESO.

My main fields of interest are breast cancer, multimodal treatments, oligometastatic disease, health-related quality of life, prevention of cardiac toxicity, hypofractionation, partial breast irradiation, clinical trials research. I am an author of over 220 peer-reviewed international papers and principal investigator of several phase 2-3 trials. My research focusses on de-escalation and optimisation of treatments, to tailor oncological approaches to improve cancer outcomes and health-related quality of life for patients (for example, I am principal investigator of phase 3 trials: EUROPA, SAFE, and Florence-APBI-IMRT).

I promote the international and national networking among professionals in a multidisciplinary fashion and facilitate connections between new generations of oncologists. I am a faculty teacher for ESTRO courses, namely the accelerated partial breast irradiation. Through ESTRO, I have highlighted the crucial importance of mentorship. I collaborate with surgical and medical oncologists, promoting mentorship teaching at preceptorship through the European Society of Surgical Oncology – ESSO and ESMO and I support social media activities with ESO.

I am involved in development of guidelines and recommendations within ESTRO, through the ESTRO Guidelines Committee, and contributed to DIBH, re-irradiation, oligometastatic definition and OligoCARE projects (ESTRO-EORTC joint initiative), and RT-drug combination guidelines in breast cancer.

I am involved in several initiatives promoting implementation of technological advances in radiation therapy to limit toxic effects of treatments and to increase the effectiveness of therapy. An example is minimising cardiac toxicity by using modern RT techniques and evaluating pharmacological prevention of subclinical heart damage in patients also receiving systemic therapy for breast cancer. As a clinical oncologist, I am fully involved in integrating RT and modern drugs, and I lead an international multidisciplinary expert panel to develop guidelines on concomitant treatment for breast cancer.

Lastly and importantly, I endeavour to promote and enhance equity, diversity, and inclusion in oncology, by limiting ethnic and gender inequality in science and facilitating equity of access to optimal treatments for all patients.

Experience

2018 – Associate Professor of Radiation Oncology at Department of Experimental and Clinical Biomedical Sciences “M. Serio” – University of Florence, Florence, Italy & Consultant Clinical Oncologist at AOU Careggi Hospital, Florence, Italy.

2018 – 2024 National Scientific Qualification I-level as Full Professor for Radiation Oncology (Scientific Disciplinary Sector SSD MED/36).

2011 – 2018 Consultant Clinical/Radiation Oncologist at Radiation Oncology Unit, Oncology Department. AOU Careggi Hospital, University of Florence, Florence, Italy.

2010 – 2011 Post-training Research Fellowship at Radiation Oncology Unit, Oncology Department. AOU Careggi Hospital, University of Florence, Florence, Italy.

Education and Qualifications

2017 – 2019 EORTC Early Career Investigators (ECI) Leadership Program for the management of Clinical Research in Oncology. Brussels, Belgium.

2016 – 2018 Master’s degree in Oncologic Drugs and Radiotherapy. University of Brescia, Brescia, Italy

2005 – 2009 Resident in Training, MD Program, University of Florence, Florence, Italy.

2008 – 2009 Resident in Training Fellowship, Royal Marsden Hospital, London, UK.

2005 – 2006 Postgraduate Fellow in Risk-assessment in Radiotherapy. European project LSHC-CT-2004-503564 of Sixth Program MAESTRO – Advanced Methods and Equipment for Simulation and Treatment in Oncology Radiology. Department of Clinical Physiopathology, University of Florence, Florence, Italy.

1999 – 2005 MD degree, University of Florence, Florence, Italy

H-index: 27, Publications: original peer-reviewed: 221 (available at https://pubmed.ncbi.nlm.nih.gov/?term=Meattini+I&sort=date&size=200), Book Editor: 1, Book Chapter Contributor: 5.

Icro MEATTINI

Curriculum

ESPERIENZA LAVORATIVA

2024 – presente
Responsabile, Breast Unit, Azienda Ospedaliero-Universitaria Careggi (AOUC), Ospedale Universitario di Firenze, Firenze, Italia
Coordinatore, Breast Cancer Multi-Disciplinary Team (MDT), AOUC, Ospedale Universitario di Firenze, Firenze, Italia
2018 – presente
Professore Associato di Radioterapia Oncologica, Dipartimento di Scienze Biomediche Sperimentali e Cliniche “M. Serio” – Università di Firenze, Firenze, Italia
Consulente, Oncologo Radioterapista e Clinico, Unità di Radioterapia Oncologica, AOUC, Ospedale Universitario di Firenze, Firenze, Italia
Coordinatore, Breast Cancer MDT per Radioterapia Oncologica (2012 – presente)
Responsabile, Unità di Ricerca Clinica, Dipartimento di Radioterapia Oncologica (2017 – presente)
2018 – 2029
Abilitazione Scientifica Nazionale di I livello, Professore Ordinario in Radioterapia Oncologica (Settore Scientifico-Disciplinare [SSD] MED/36)
2011 – 2018
Dirigente Medico di I livello, Oncologo Radioterapista/Clinico
AOUC, Ospedale Universitario di Firenze, Firenze, Italia
Unità di Radioterapia Oncologica, Dipartimento di Oncologia
2010 – 2011
Assegnista di Ricerca su “Valutazione della predisposizione genetica alla tossicità da radiazioni indotta” presso l’Unità di Radioterapia Oncologica, Dipartimento di Oncologia, AOUC, Ospedale Universitario di Firenze, Università di Firenze, Firenze, Italia

ISTRUZIONE E FORMAZIONE
- 2017 – 2019
  European Organisation for Research and Treatment of Cancer (EORTC)
  Early Career Investigators (ECI) Leadership Program per la gestione della ricerca clinica in oncologia
- 2016 – 2018
  Università di Brescia, Brescia, Italia
  Master di II livello in “Farmaci Oncologici e Radioterapia”.
  Tesi di Master: “Ipofrazionamento nelle pazienti giovani affette da carcinoma mammario”.
  Relatore: Prof. Stefano M. Magrini
- 2005 – 2009
  Università di Firenze, Firenze, Italia
  Scuola di Specializzazione in Radioterapia Oncologica.
  Tesi di Specializzazione: “Carcinoma mammario in pazienti trattati per Linfoma di Hodgkin: esperienza dell’Università di Firenze”.
  Relatore: Prof. Giampaolo Biti.
  Votazione: 70/70 e Lode
- 2008 – 2009
  Royal Marsden Hospital, Londra, Regno Unito
  Fellowship presso il Royal Marsden Hospital, Londra (UK).
  Supervisore: Prof. Michael Brada
- 2005 – 2006
  Università di Firenze, Firenze, Italia
  Research fellow presso il Dipartimento di Fisiopatologia Clinica
  Argomento di ricerca: “Valutazione del rischio in Radioterapia”.
  [Progetto europeo LSHC-CT-2004-503564 del 6º programma MAESTRO (Advanced Methods and Equipment for Simulation and Treatment in Oncology Radiology)]
- 1999 – 2005
  Università di Firenze, Firenze, Italia
  Laurea in Medicina e Chirurgia.
  Tesi di Laurea: “Carcinoma prostatico localizzato trattato con Radioterapia a Intensità Modulata (IMRT)”.
  Relatore: Prof. Giampaolo Biti.
  Votazione: 110/110 e Lode
- 1994 – 1999
  Liceo Scientifico “N. Rodolico”, Firenze, Italia
  Diploma di Maturità Scientifica.
  Votazione: 100/100
  
  COMPETENZE PERSONALI
  - LINGUA MADRE
    Italiano
  - LINGUE STRANIERE
    Inglese
    - Comprensione: Lettura C1 | Ascolto C1
    - Espressione Orale: Interazione C1 | Produzione C1
    - Scrittura: C1
    Spagnolo
    - Comprensione: Lettura B2 | Ascolto B2
    - Espressione Orale: Interazione B2 | Produzione B2
    - Scrittura: B2

Autore di oltre 300 pubblicazioni scientifiche sottoposte a peer-review in riviste internazionali, consultabili al seguente link:
https://www.ncbi.nlm.nih.gov/pubmed/?term=meattini+i

h-index: 36 (21 marzo 2025)
306 documenti, 6361 citazioni da 5283 documenti
Consultabili al seguente link:
https://www.scopus.com/authid/detail.uri?authorId=23027824500

ORGANIZZAZIONE E PARTECIPAZIONE COME RELATORE A CONGRESSI SCIENTIFICI NAZIONALI E INTERNAZIONALI

Membro del Comitato Organizzatore Locale del XVII Congresso Nazionale dell’Associazione Italiana di Radioterapia Oncologica (AIRO), 2007, Firenze, Italia.
Relatore invitato, XXII Congresso Nazionale AIRO. Roma. Argomento: “Radioterapia dopo terapia sistemica neoadiuvante: irradiare le stazioni linfonodali? contro”. 17-20/11/2012.
Relatore invitato. Workshop “Advanced Breast Cancer: Evidence and Future Perspectives”. Montecatini Terme, Italia. 24/05/2013.
Relatore invitato al 17° ECCO - 38° ESMO - 32° ESTRO (European Cancer Congress: Reinforcing Multidisciplinary). Amsterdam, Paesi Bassi.
- Relatore nella Roundtable Session “How to Improve Career Opportunities for Young Oncologists Across Europe”. 27/09/2013-01/10/2013.
Relatore invitato. XXIII Congresso Nazionale AIRO. Taormina, Italia. “Tossicità in associazione con terapie sistemiche”. 26-29/10/2013.
Presentazione (“Report”). ESTRO 33, Vienna, Austria. Comunicazione orale selezionata nella sessione “Clinical”. Argomento: “Carcinoma mammario. Tossicità dell’APBI con IMRT versus irradiazione dell’intera mammella: follow-up a 3 anni di uno studio randomizzato di Fase III” (primo autore e relatore: I. Meattini). 4-8/04/2014.
Relatore invitato. Workshop “Aggressive disease and indolent disease in advanced stage breast cancer”. Pontedera, Italia. 19/06/2014.
Relatore invitato. Workshop “Metastatic breast cancer therapy: role of anthracyclines”, Pisa, Italia. 08/10/2014.
Relatore invitato. Workshop “Building the best therapeutic program for the BC+ HR+/HER2- patient”, Montecatini, Italia. 31/10/2014.
Relatore invitato. XXIV Congresso Nazionale AIRO. Padova, Italia. “Wide Angle in Oncological Radiotherapy 2014”. 9-11/11/2014.
Relatore invitato. “Consensus on the new indication in the eribulin as second line therapy”, Reggio Emilia, Italia. 03/03/2015.
Presentazione (“Report”). 3° ESTRO Forum, Barcellona, Spagna. Presentazione come “poster discussion” nella sessione “Clinical”. “APBI versus whole breast irradiation in women age 70 years or older: a subgroup analysis of a phase 3 randomized trial” (primo autore e relatore: I. Meattini). 24-28/04/2015.
Relatore alla Consensus Conference “dalla pratica del follow-up alla cultura del survivorship care”, organizzata da AIOM (Associazione Italiana di Oncologia Medica). Roma, 10-11/09/2015.
Relatore invitato. XXV Congresso Nazionale AIRO. Rimini, Italia. Simposio “Ricostruzione mammaria e implicazioni radioterapiche”. 7-10/11/2015.
Relatore invitato. V AIRO ZOOM Journal Club 2015, Bologna, Italia. 19/02/2016.
Relatore invitato. Workshop “HER2 determination: amplification methods”. AOUC Firenze, Italia. 26/02/2016.
Relatore invitato. Workshop “La Breast Unit come modello di cura per la medicina di genere nella AOU Careggi”, AOUC Firenze, Italia. 08/03/2016.
Relatore invitato. “HER2 positive breast carcinoma: Highlights and perspectives”. AOU Careggi Firenze, Italia. 13/04/2016.
Relatore invitato. “We Breast”. Workshop “Trattamento del carcinoma mammario HR+/HER2- in pazienti in postmenopausa: dalla letteratura alla pratica clinica. Chemioterapia e ormonoterapia”. Prato, Italia. 14/06/2016.
Relatore invitato. Advisory Board “Trattamento delle pazienti con carcinoma mammario metastatico HR+ HER2- con Everolimus plus Exemestane: condivisione di aspetti clinico-pratici per ottimizzare la gestione e il trattamento”. Antignano (Livorno), Italia. 27/06/2016.
Relatore invitato. “Sustainability forum and opportunities in the health sector”. Tavola rotonda “Le nuove frontiere in oncologia”. Stazione Leopolda, Firenze, Italia. 23/09/2016.
Relatore invitato. Workshop “Il Governo dell’Innovazione Farmaceutica: Modelli di Gestione Sostenibile di Farmaci Oncologici Innovativi e ad Alto Costo”. Istituto Toscano Tumori, Firenze, Italia. 27/09/2016.
Commissione Scientifica del XXVII e XXVIII Congresso Nazionale AIRO (Associazione Italiana di Radioterapia Oncologica). Rimini, Italia 2017-2018.
Relatore invitato. XXVI Congresso AIRO. Simposio: “Farmaci innovativi nel carcinoma mammario”. Rimini, Italia. 30/09/2016 - 02/10/2016.
Relatore invitato. Conferenza “Terapia primaria del carcinoma mammario”. I martedì oncologici AIOM Toscana. Pisa, Italia. 04/10/2016.
Relatore invitato. Seminario di diagnostica senologica con presentazione interattiva. Argomento: “La ripresa di malattia: diagnosi e significato biologico. Utilità e limiti del follow-up”. Firenze, Italia. 17-20/10/2016.
Relatore invitato. Sessione itinerante AIRO “Consensus per l’irradiazione delle stazioni linfonodali mammarie”, Ospedale dell’Angelo di Venezia Mestre, Italia. 21/10/2016.
Relatore invitato. Brescia Meetings in Radiation Oncology. “Progetti di Ricerca Internazionali in Cardio-Oncologia: focus sul carcinoma mammario”. Brescia, Italia. 17-18/11/2016.
Presentazione (“Report”). ECCO 2017. Amsterdam, Paesi Bassi. Proffered Paper Session: “Breast Cancer”. Presentazione orale: “IMRT-Florence phase 3 trial: analisi della qualità di vita correlata alla salute nell’Accelerated Partial Breast Irradiation”. 29/01/2017.
Relatore invitato. “Advanced Breast Cancer HR+: HER2- vs HER2+. Open questions. BreastINg Work: aBC HR+/HER2- an evolving panorama”. Camogli, Italia 31/03/2017 - 01/04/2017.
Relatore invitato. ESTRO 36, Vienna, Austria. Argomento: “Lecture on External beam partial irradiation”. 5-9/05/2017.
Relatore invitato. “Gestione della paziente con carcinoma mammario metastatico”. Pisa, Italia, 11/05/2017.
Consensus conference. Argomento: “Carcinoma in situ della mammella”. Catania, Italia. 18-20/05/2017.
Relatore invitato. “Corso di aggiornamento in Cardio-Oncologia”. Pietrasanta, Italia. 15/09/2017.
Relatore invitato. “Carcinoma mammario metastatico con recettori ormonali positivi. Quale entità clinica?”. Bergamo, Italia. 22-23/09/2017.
Relatore invitato. European Society for Radiation Oncology (ESTRO) ed European Organization for the Research and Treatment of Cancer (EORTC). Annual Meeting Korean Society for Radiation Oncology (KOSRO). Seoul, Corea. 13/10/2017.
Membro dell’Executive Committee del IX Congresso di Senologia (AIS). Firenze, Italia. 8-10/11/2017.
Relatore invitato. “Highlights in Radiotherapy. Quali novità dai Congressi Internazionali 2017?” Centro di Ricerca Radiologica “Il Cardello”. Roma, Italia. 25/01/2018.
Membro dell’Executive Committee ed Expert Board del “2nd Think Tank meeting on research challenges in breast cancer”, con endorsement ESTRO, Assisi, Italia 1-3/03/2018.
Local Organizer dello Spring Meeting del Radiation Oncology Group (ROG) dell’EORTC (European Organization for Cancer Research and Treatment). Firenze, Italia 11-13/03/2018.
Relatore invitato. Panel of Experts. 11th European Breast Cancer Conference (EBCC). Sessione “Multidisciplinary Team in the Real World: Young HER2 Negative Patients with Breast Cancer”. Barcellona (Spagna). 21-23/03/2018.
ESTRO Conference 37, Barcellona (Spagna). Comunicazione Orale selezionata: “DCIS trattato con chirurgia conservativa e radioterapia: un’esperienza multicentrica nazionale”. 20-24/04/2018.
Relatore invitato. Meeting “I se ed i ma del trattamento del carcinoma mammario metastatico ER+/HER2-“. Ferrara, 11-12 maggio 2018.
Relatore invitato. Brescia Meetings in Radiation Oncology “Immunity, drugs, radiation: from biology to contemporary clinical oncology”. Brescia, 20-21 settembre 2018.
Coordinatore Advisory Board. Corso ECM “Help Desk in aBC. Condividere l’esperienza clinica”. Firenze, 5 ottobre 2018.
Advisory Board. “Breast Cancer Expert Meeting”. Pisa, 13 novembre 2018.
Relatore invitato. Annual Meeting Swedish Breast Medical Oncologist, Brostonkologisk Forening (BOF). Hesselby Slott, Vallingby, Stoccolma (Svezia). 23-25 gennaio 2019.
Panel of Experts. “Breast Surgery Toolbox – Hirslanden Klinik St. Anna Brustzentrum (rappresentante ESTRO). ‘A consensus and toolbox to improve breast conservation rates and to guide axillary management after preoperative systemic therapy (PST)’”. Lucerna (Svizzera). 8 febbraio 2019.
Relatore invitato. Meeting “Focus sulla chirurgia oncologica e ricostruttiva della mammella”. Pisa, 11-12 aprile 2019.
Relatore invitato. ESTRO 38 Annual Meeting. “SP-0463 Towards less radiotherapy in breast cancer treatment”. Milano, 27-30 aprile 2019.
Executive Committee e Relatore invitato. XI Edizione del Convegno “Attualità in Senologia (AIS)”. Firenze, 6-8 novembre 2019.
Relatore invitato. VIII Breast Surgery Workshop. “Ductal carcinoma in situ of the breast”. Aarhus, 21-23 maggio 2019.
Panel of Experts. III Skagen meeting. Skagen, 4-6 giugno 2019.
Advisory Board. “HR+ 2020, Il carcinoma mammario avanzato in alta risoluzione”. Firenze, 21 giugno 2019.
Relatore invitato. 29° Corso Residenziale “Modern Radiotherapy, time issues and new drugs”. Roma, 21-23 ottobre 2019.
Relatore invitato. XXI Congresso della Società Brasiliana di Radioterapia. Rio de Janeiro (Brasile), 23-27 ottobre 2019.
Relatore invitato. ESMO Breast Cancer Virtual Meeting. “Is cardiac damage still relevant? And how can be avoided?”. Virtuale, 23-24 maggio 2020.
Relatore invitato. 12th European Breast Cancer Conference (EBCC-12) (virtual). “European Society for Radiotherapy & Oncology (ESTRO) - State of the Art in Radiation Oncology 2020. The best treatment in breast cancer radiotherapy 3D vs. IMRT”. Virtuale, 2-3 ottobre 2020.
Relatore invitato. Breast Turkish International Meeting Breastambul (hybrid/virtual). Istanbul, virtuale, 17-18 ottobre 2020.
Relatore invitato. ESTRO40 Annual Meeting (virtual). 28 nov – 1 dic 2020.
Relatore invitato. World Congress of Brachytherapy 2020 (virtual). Dibattito: “Partial Breast Irradiation with 1-3 fractions”. Virtuale, 6-8 maggio 2021.
Relatore invitato. Highlights St. Gallen Breast Cancer Conference 2021. Webinar, 28 maggio 2021.
Relatore invitato. MORE TIME MORE LIFE. “Advanced Breast Cancer HR+ HER2-, dagli studi alla pratica clinica: gli inibitori CDK4/6 sono davvero tutti uguali?”. Webinar, 2 luglio 2021.
Relatore invitato. Senoforum Accademia di Senologia Umberto Veronesi. 15-16 luglio 2021.
Relatore invitato. ESTRO41 Annual Meeting. Sessione: “New endpoints for early breast cancer - Less is more?”. Titolo presentazione: “Health-related quality of life - Primary or surrogate endpoint?”. Madrid, 27-31 agosto 2021.
Docente e Relatore. ESMO Virtual Preceptorship on Cancer Care in Elderly Patients. “Radiotherapy in older patients”. 2-3 settembre 2021.
Faculty. Focus Group CNAO: “Patologie mammarie”. Webinar, 21 settembre 2021.
Relatore invitato. Webinar ECM FAD “Il meraviglioso mondo dei PARP inibitori: dalla biologia molecolare alla pratica clinica”. Webinar, 23 settembre 2021.
Faculty member e Relatore invitato. Breastics24h Breast Oncoplastic. Oncoplastic Multidisciplinary Board Meeting. Webinar, 25 settembre 2021.
Relatore invitato e Faculty. ESSO Advanced Course on Breast Cancer Surgery. Live Virtual Course, 24 novembre 2021.
Panel of Experts. Assisi ATTM. Assisi, 21-23 febbraio 2022.
Relatore invitato e Faculty. ESTRO APBI multidisciplinary Course. Virtuale, 28-30 marzo 2022.
Relatore invitato e Chair di sessione. “Omission of radiation therapy”. GBCC Annual Meeting. Seoul, Corea, aprile 2022.
Relatore invitato, Chair e “selected proffered paper”. ESTRO42 Annual Meeting. Copenaghen, 6-10 maggio 2022.
Faculty e Relatore invitato. 2° Congresso Rete Senologica Toscana. Cortona, 13-14 maggio 2022.
Relatore invitato e Faculty. ESMO Preceptorship programme on breast cancer. Live Virtual Course, 14-15 giugno 2022.
Panel of Experts. IV Skagen meeting. Skagen, 21-23 giugno 2022.
Faculty e Relatore invitato. 13th European Breast Cancer Conference (EBCC). Barcellona, Spagna, 16-18 novembre 2022.
Faculty e Relatore invitato. 18° St. Gallen International Breast Cancer Conference (SGBCC). Vienna, Austria, 15-18 marzo 2023.
Relatore invitato. ESTRO 2023 Clinical Pre-meeting palliative care course. Vienna, Austria, 12 maggio 2023.
Relatore invitato. ESTRO 2023 Annual Meeting. Vienna, Austria, 12-16 maggio 2023.
Faculty. ESSO Advanced Course on Breast Cancer Surgery. Madrid (SP), 28-30 settembre 2023.
Relatore invitato. 42° Congresso European Society of Surgical Oncology. Firenze, Italia, 25-27 ottobre 2023.
Faculty. ESMO Preceptorship on Breast Cancer. Lugano, Svizzera, 6-7 ottobre 2023.
Relatore invitato. XXXIII Congresso Nazionale AIRO. Rimini, Italia, 27-29 ottobre 2023.
Relatore invitato. Programma Educazionale al 2023 San Antonio Breast Cancer Symposium. San Antonio, Texas (USA), 4-9 dicembre 2023.
Relatore invitato, Chair. 14° European Breast Cancer Conference (EBCC). Milano, Italia, 20-22 marzo 2024.
Relatore invitato. ESMO Breast Cancer 2024. Berlino, Germania, 15-17 maggio 2024.
Faculty. 24° Workshop on Methods in Clinical Cancer Research (MCCR). Sint Michielsgestel, Paesi Bassi, 15-21 giugno 2024.
Relatore invitato. 17th Annual Meeting of the Korean Society of Medical Oncology & 2024 International Conference (KSMO 2024). Seoul, Corea del Sud, 26-27 settembre 2024.
Relatore invitato e Faculty. Breastambul Conference 2024. Istanbul, Turchia, 10-12 ottobre 2024.
Relatore invitato. San Antonio Breast Cancer Symposium 2024. San Antonio, Texas (USA), 9-12 dicembre 2024.
Relatore invitato. Breast Cancer at the Limits meeting. Londra, Regno Unito, 10 gennaio 2025.
Relatore invitato, Chair & Faculty roles. 2025 ESTRO Annual meeting. Vienna, Austria, 2-5 maggio 2025.
Relatore invitato. ESMO Breast Cancer 2025. Monaco di Baviera, Germania, 15-17 maggio 2025.
Relatore invitato. Educational Session. 2025 ASCO Annual meeting. Chicago, USA, 30 maggio – 3 giugno 2025.
Relatore invitato. San Antonio Breast Cancer Symposium 2025. San Antonio, Texas (USA), 9-12 dicembre 2025.

GESTIONE, ORGANIZZAZIONE E PARTECIPAZIONE NELLE ATTIVITÀ DI GRUPPI DI RICERCA NAZIONALI E INTERNAZIONALI

Co-Chair della Sezione Interregionale Tosco-Umbra dell’Associazione Italiana di Radioterapia Oncologica (GTUOR). Biennio 2013-2015.
Co-Chair del Gruppo di Studio per il Carcinoma Mammario dell’Associazione Italiana di Radioterapia Oncologica (AIRO). Biennio 2014-2016.
Radiation Oncology Group (ROG) e Breast Cancer Group (BCG) dell’European Organization for Cancer Research and Treatment (EORTC). 2014-oggi.
Co-Chair del Breast Working Party (BWP) del ROG dell’EORTC. 2013-2018.
Selezionato per il programma di Early Career Investigator (ECI) promosso dall’EORTC. 2017-2019.
European Organization for Research and Treatment of Cancer (EORTC) - Radiation Oncology Group (ROG) - Disease Oriented Groups Junior Representative (jRDR) per il Carcinoma Mammario. Marzo 2018-2020.
Socio Fondatore e Chair del Gruppo Multicentrico Nazionale/Internazionale “Clinical Oncology Breast Cancer Group (COBCG)”. Marzo 2018-presente.
Membro del Collegio Italiano dei Senologi (2016-2020).
Membro di AIRO (Associazione Italiana di Radioterapia e Oncologia Clinica) dal 2006 a oggi.
Membro di AIRB (Associazione Italiana di Radiobiologia).
Membro di ESTRO (European Society for Radiation Oncology) dal 2012.
Membro di EORTC (European Organization for Research and Treatment of Cancer) dal 2014.
Writing Committee per le “Linee Guida Italiane AIRO” sul Carcinoma Mammario. 2017-2018.
Reviewer Committee per le “Linee Guida Italiane AIRO” sul Carcinoma Mammario. 2019-2020.
Reviewer Committee per le “Linee Guida Italiane sul Carcinoma Mammario” AIOM (Associazione Italiana di Oncologia Medica). 2018-2020.
Executive Committee del Convegno Biennale “Attualità in Senologia”. Firenze. 2019 e 2021.
Scientific Committee di SenoNetwork. 2020-2022.
Scientific Committee del Convegno Nazionale AIRO. 2016-2022.
Chair del Gruppo di Studio sul Carcinoma Mammario di AIRO. 2020-2022.
Board Member del Radiation Oncology Scientific Council (ROSC) EORTC. 2020-presente.
Membro di ESTRO SAG (Scientific Advisory Group) per la Radioterapia Clinica. ESTRO Meeting 2020 (virtuale), Meeting 2021 (Madrid) e Meeting 2022 (Copenaghen).
Membro del Board ESTRO-ACROP guidelines focus group sul carcinoma mammario. 2022-presente.
Scientific Committee della Regione Toscana – Rete Senologica Toscana per la gestione dell’ascella. 2021-2022.
Faculty member del College della European School of Oncology (ESO). 2022-presente.
Membro del Task force “Accelerated Partial Breast Irradiation (APBI) Replacement: An ASTRO Evidence-Based Clinical Practice Guideline”. Marzo 2022.
Faculty member della 13° European Breast Cancer Conference (EBCC). Barcellona, Spagna, 16-18 novembre 2022.
Faculty member della 18° St. Gallen International Breast Cancer Conference (SGBCC). Vienna, Austria, 15-18 marzo 2023.
Faculty member della 13° European Breast Cancer Conference (EBCC). Milano, Italia, marzo 2024.
Membro del Clinical Board ESTRO. 2023–2026.
Membro dell’ESTRO Educational Committee (EDC). 2023–presente.
Chair dell’ESTRO-Industry task force. 2024–presente.
Chair dell’ESTRO Clinical Radiotherapy Scientific Advisory Group (SAG). ESTRO Meeting 2025 (Vienna, Austria).
Organising Committee del 15° EBCC. Barcellona, Spagna, marzo 2026.
- Co-Principal Investigator: APBI-IMRT-Florence (NCT02104895) phase III trial. Studio randomizzato su Accelerated Partial Breast Irradiation con Radioterapia a Intensità Modulata (IMRT) vs. Whole Breast Irradiation (WBI). Ente: Università di Firenze, Italia.
- Sub-Investigator: PERTAIN Trial (Hoffmann-La Roche). Studio sull’uso di Pertuzumab in combinazione con Trastuzumab + inibitore dell’aromatasi in pazienti con carcinoma mammario metastatico HR+, HER2+. NCT01491737.
- Sub-Investigator: SAFE HER trial (Hoffmann-La Roche). Studio di sicurezza e tollerabilità di Herceptin (Trastuzumab) sottocute assistito e auto-somministrato in pazienti con carcinoma mammario HER2+ in stadio iniziale (SafeHer). NCT01566721.
- Sub-Investigator: BELLE3 trial (Novartis), fase III, randomizzato, in doppio cieco e controllato con placebo su BKM120 in combinazione con fulvestrant in pazienti in postmenopausa con carcinoma mammario localmente avanzato o metastatico HR+ e HER2- in progressione dopo inibitore di mTOR.
- Sub-Investigator: SAFE phase III trial (NCT02236806). Ruolo di ACE-inibitori e Beta-bloccanti nella prevenzione della cardiotossicità in pazienti con carcinoma mammario trattate con antracicline (neo)adiuvanti e/o trastuzumab: studio randomizzato, controllato con placebo, a 4 bracci. Università di Firenze, Italia.
- Sub-Investigator: GIM13 AMBRA (Oncotech Consortium). Studio di coorte longitudinale sulle scelte terapeutiche del carcinoma mammario metastatico HER2- nella pratica clinica italiana.
- Sub-Investigator: GIM10 CONSENT (IRCCS AOU San Martino-IST). Studio clinico di fase III sul confronto tra somministrazione concomitante e sequenziale di CT e AI come terapia adiuvante in pazienti in postmenopausa con carcinoma mammario ormono-sensibile.
- Sub-Investigator: SANDPIPER Trial (Hoffmann-La Roche). Studio di fase III su Taselisib + Fulvestrant vs Placebo + Fulvestrant in pazienti con carcinoma mammario avanzato o metastatico che abbiano recidivato o progredito durante o dopo terapia con inibitore dell’aromatasi. NCT02340221.
- Sub-Investigator: BONADIUV phase II trial (NCT02616744). Studio di fase II, in singolo cieco, randomizzato e controllato con placebo, per valutare l’impatto del trattamento con bifosfonati orali sulla densità minerale ossea in donne in terapia adiuvante con inibitori dell’aromatasi. Università di Firenze, Italia.
- Sub-Investigator: GIM16 FEVEX (Consorzio Oncotech). Studio di fase III sul carcinoma mammario localmente avanzato (LABC) o metastatico (MBC) HR+ e HER2- in donne in postmenopausa precedentemente trattate con inibitori non steroidei dell’aromatasi (NSAI).
- Sub-Investigator: SINODAR ONE trial (Humanitas Research Foundation - Rozzano, Milano). Confronto tra asportazione e conservazione dei linfonodi ascellari in pazienti con carcinoma mammario T1-T2 e metastasi nel linfonodo sentinella.
- Sub-Investigator: PAINTER trial (Medical Oncology of the Fatebenefratelli Hospital). Studio “Polymorphism And INcidence of Toxicity in ERibulin Treatment”. NCT02864030.
- Co-Investigator: LUCY Study (Lynparza Breast Cancer Real-World Utility, Clinical Effectiveness and Safety Study), fase IIIb, in aperto, multicentrico, su Olaparib in monoterapia nel trattamento del carcinoma mammario metastatico HER2- con mutazioni germinali BRCA1/2. Eudract Code: 2017-001054-34.
- Co-Investigator: Patients With Her2-Positive Unresectable Locally Advanced Or Metastatic Breast Cancer (F. Hoffmann-La Roche Ltd). Protocol Number MO39146.
- Co-Investigator: Studio di fase III, randomizzato, in doppio cieco, controllato con placebo, multicentrico sull’efficacia e sicurezza di Atezolizumab in combinazione con chemioterapia in pazienti con carcinoma mammario triplo negativo (localmente avanzato non resecabile o metastatico) con recidiva precoce (F. Hoffmann-La Roche Ltd). Protocol Number MO39193. Eudract Number 2016-005119-42.
- Co-Investigator: Studio di fase III, multicentrico, randomizzato, in doppio cieco, controllato con placebo su Atezolizumab (anticorpo anti-PD-L1) in combinazione con Paclitaxel vs Placebo + Paclitaxel in pazienti con carcinoma mammario triplo negativo localmente avanzato o metastatico, precedentemente non trattate (F. Hoffmann-La Roche Ltd). Protocol Number MO39196 Eudract Number 2016-004024-29.
- Co-Investigator: Palbociclib Collaborative Adjuvant Study (PALLAS): studio di fase III randomizzato su Palbociclib in combinazione con la terapia endocrina adiuvante standard vs la sola terapia endocrina in carcinoma mammario HR+ / HER2- in stadio iniziale. Alliance Foundation Trials, LLC. NCT02513394.
- Co-Investigator: Studio non interventistico per caratterizzare i pattern di trattamento e gli esiti nel mondo reale di donne con carcinoma mammario HR+, HER2- in fase avanzata o metastatica in Italia (Pfizer). Protocol Number A5481031.
- Co-Investigator: Compleement-1: “Studio di fase IIIb, in aperto, multicentrico, per valutare sicurezza ed efficacia di ribociclib (LEE011) in combinazione con letrozolo nel trattamento di uomini e donne in pre/postmenopausa con carcinoma mammario HR+ / HER2- avanzato, mai trattati con terapia ormonale per malattia avanzata”. Eudract Code: 2016-003467-19.
- Principal Investigator: Studio di fase III (EUROPA trial). “ExclUsive endocRine therapy Or Partial breast irradiation for women aged ≥70 years with luminal A-like early stage breast cancer (EUROPA): uno studio randomizzato di fase 3 di non-inferiorità”. ClinicalTrial.gov Identifier NCT04134598. Ente: Università di Firenze.
  
  Membro dell’ESTRO Clinical Radiotherapy SAG. ESTRO Meeting 2026 (Stoccolma, Svezia).
  
  RESPONSABILITÀ E COORDINAMENTO DEI LAVORI SCIENTIFICI E DELLA RICERCA
RESPONSABILITÀ SCIENTIFICA DI PROGETTI NAZIONALI E INTERNAZIONALI
- Assegno di Ricerca professionale presso il Dipartimento di Fisiopatologia Clinica dell’Università di Firenze, Italia. Argomento: “Valutazione del rischio in Radioterapia”. Progetto Europeo n. LSHC-CT-2004-503564 - VI Programma MAESTRO (Methods and Advanced Equipment for Simulation and Treatment in Radio Oncology). 01/10/2005 - 01/03/2006.
- Borsa di Ricerca dal titolo “Valutazione della predisposizione genetica alla tossicità da radiazioni indotta” (DAI Oncologia, SODC Radioterapia) presso il Dipartimento di Fisiopatologia Clinica dell’Università di Firenze, Italia. (Contributo regionale alla ricerca sanitaria 2009). 01/07/2010 - 30/07/2011.
  
  PARTECIPAZIONE IN COMITATI EDITORIALI DI RIVISTE E SERIE EDITORIALI
  - Cancer and Clinical Oncology (ISSN: 1927-4858, Print; ISSN: 1927-4866, Online)
  - Case Reports in Pathology (ISSN: 2090-6781)
  - Translational Cancer Research (TCR) (ISSN cartaceo: 2218-676X; ISSN online: 2219-6803)
  - Subject Editor (Radiation Therapy) per Critical Review in Oncology/Hematology (ISSN 1040-8428), 2022-2024.
  - Editorial Board, Radiotherapy and Oncology (ISSN 0167-8140), 2025-presente.
  - Editorial Board, European Journal of Surgical Oncology (EJSO), 2025-presente.
    
    REVISORE PER RIVISTE SCIENTIFICHE
    - Cancer and Clinical Oncology (ISSN: 1927-4858, Print; ISSN: 1927-4866, Online)
    - Case Reports in Pathology (ISSN: 2090-6781)
    - BMC Cancer (ISSN: 1471-2407)
    - Onkologie (ISSN: 1423-0240)
    - Radiologia Medica (ISSN: 1826-6983)
    - Tumor Biology (ISSN: 1010-4283)
    - Clinical Breast Cancer (ISSN: 1526-8209)
    - Urologic Oncology (ISSN: 1078-1439)
    - The Breast (ISSN: 0960-9776)
    - Future Oncology (ISSN: 1479-6694)
    - Radiotherapy and Oncology (ISSN 0167-8140)
    - Critical Review in Oncology/Hematology (ISSN 1040-8428)
    - The Lancet Oncology (ISSN 1470-2045)
    - JAMA Oncology (ISSN 2374-2437, ISSN 2374-2445)
      
      Attività clinica, diagnostica, terapeutica e di follow-up; partecipazione a MDT (team multidisciplinari), terapie concomitanti (radioterapia, chemioterapia, terapie a bersaglio molecolare), cure di supporto e palliative.
    - - Responsabile della Breast Unit presso l’AOUC Florence University Hospital e Coordinatore del Breast Cancer MDT.
      - Attività di Day-Hospital: chemioterapie e terapie molecolari in setting primario, adiuvante e metastatico; terapie di supporto; gestione dei controlli durante il trattamento; partecipazione a trial clinici interni, nazionali e internazionali (sponsor e accademici).
      - Attività nell’unità di pianificazione radioterapica: gestione delle consulenze su inizio terapia e tolleranza; utilizzo di acceleratori lineari, tomoterapia, GammaKnife, CyberKnife; uso di sistemi di pianificazione dei trattamenti (contouring e planning di radioterapia standard, conformazionale, stereotassica, IMRT, VMAT, con software XiO, Odyssey, Pinnacle, Monaco).
      - Medicina Radiologica, Tecniche di Imaging e Radioterapia (2018-2020)
        
        DIAGNOSTIC IMAGING TECHNIQUES II [B019930, B024640, B029359]
        
        GENERAL RADIOLOGY DIAGNOSTIC TECHNIQUES - SENOLOGY AND INTERVENTIONAL RADIOLOGY [B029341]
        
        Assistenza Sanitaria (2020-2021)
        
        PREVENTIVE SCIENCES [B020074, B030150]
        
        Ostetricia (2021-presente)
        
        HEALTH AND SAFETY PROMOTION [B030999]
        
        Infermieristica (2018-presente)
        
        DIAGNOSTIC AND THERAPEUTIC PROCESSES [B030242]
        
        Medicina e Chirurgia (2018-presente)
        
        DIAGNOSTIC IMAGING (INTEGRATED COURSE) [0090435]
        
        Conoscenza di sistemi di “record and verify”; uso di sistemi PACS per la gestione delle immagini; uso di sistemi di verifica del posizionamento del paziente e dispositivi di immobilizzazione.
        
        Journal of Clinical Oncology (ISSN 0732-183X, ISSN 1527-7755)
        
        INCARICHI IN CORSI UNIVERSITARI E ISTITUTI DI RICERCA
        
        Fellowship presso l’Unità di Radioterapia Oncologica del Royal Marsden Hospital, Londra (UK), supervisore Prof. Michael Brada (01/10/2008 - 31/03/2009).
        
        Attività clinica presso il “Royal Marsden Hospital” (RMH), Londra (UK) e attività di ricerca presso il The Institute of Cancer Research (ICR), Londra, Sutton (UK).
        
        Collaborazione clinica nei centri RMH Chelsea e Sutton, specializzati in tumori polmonari e cerebrali (Prof. Michael Brada), patologie ematologiche (Prof. Alan Horwich) e partecipazione ai Multi-Disciplinary Team (MDT) di carcinoma polmonare (RMH Sutton) e cerebrale (St. George Hospital, Wimbledon, Londra).
        
        Didattica frontale e tutorato studenti nei Corsi di Laurea Magistrale, presso la Facoltà di Medicina e Chirurgia e nel Corso di Laurea Triennale in Tecniche di Radiologia Medica.
        
        Didattica frontale e mentoring nella Scuola di Specializzazione in Radioterapia Oncologica (AOUC Firenze).
        
        Co-relatore di tesi (Relatore Prof. Lorenzo Livi) per il Corso di Laurea in Medicina e Chirurgia, Università di Firenze, Italia.
        
        Docente locale per l’“Advanced Course on Multidisciplinary Breast Cancer Treatment” della European Society of Radiotherapy Oncology (ESTRO), ESTRO Teaching Course on the Multidisciplinary Management of Breast Cancer 2015, ESTRO School of Radiation Oncology.
        
        Docente dell’ESTRO Teaching Course on Accelerated Partial Breast Irradiation. 2020-presente.
        
        Docente (Faculty) del Master di II livello “Farmaci Oncologici e Radioterapia” presso l’Università di Brescia, Brescia, Italia. 2023-presente.
        
        CORSI ACCADEMICI PRESSO L’UNIVERSITÀ DI FIRENZE:
        
        ATTIVITÀ CLINICA
        
        Principali responsabilità assistenziali (Unità di Radioterapia Oncologica – AOUC Firenze, Prof. Lorenzo Livi):
        
        Tutte le informazioni fornite in questo curriculum vitae sono accurate e veritiere. Autorizzo il trattamento dei miei dati personali in conformità al Regolamento (UE) 2016/679 sulla protezione dei dati personali (GDPR). Qualsiasi uso o divulgazione non autorizzati di queste informazioni è vietato. Dichiaro di essere consapevole che i dati personali forniti saranno trattati con la massima riservatezza e utilizzati esclusivamente per le finalità correlate all’attuale processo di selezione.
        
        Firenze, Italia
        21/03/2025
        
        Prof. Icro Meattini

Icro MEATTINI

Pubblicazioni

Legenda

Contributo su rivista |

Articolo su libro |

Libro |

Contributo in atti di convegno (proceeding) |

Brevetto |

Curatela | Altro

Altro |

Tesi di Dottorato

Meattini, Icro; Coles, Charlotte E; Tramm, Trine; Borghesi, Simona; Krug, David; Montero, Angel; Nardone, Valerio; Salvestrini, Viola; Valzano, Marianna; Valentini, Vincenzo; Aristei, Cynthia; Poortmans, Philip (2025). Biomarker-Directed Radiotherapy in Breast Cancer: A Narrative Review. JAMA ONCOLOGY, pp. 0-0, ISSN:2374-2437 DOI

Lastraioli, Elena; Iorio, Jessica; Piazza, Francesco; Capitani, Chiara; Santillo, Michele; Duranti, Claudia; Bianchi, Simonetta; Meattini, Icro; Fraser, Scott P.; Djamgoz, Mustafa B. A.; Becchetti, Andrea; Arcangeli, Annarosa (2025). Clinical relevance of macromolecular complexes involving integrins, potassium and sodium ion channels and the sodium/proton antiporter in human breast cancer. CANCER CELL INTERNATIONAL, vol. 25, pp. 0-0, ISSN:1475-2867 DOI Accesso ONLINE all'editore

Meattini, Icro; Kunkler, Ian H (2024). Omission of radiation therapy after breast conserving surgery for older women at low-risk of local recurrence: One option among many. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, vol. 50, pp. 0-0, ISSN:0748-7983 DOI

Marrazzo, Livia; Meattini, Icro; Becherini, Carlotta; Salvestrini, Viola; Visani, Luca; Barletta, Giuseppe; Saieva, Calogero; Del Bene, Maria Riccarda; Pilato, Giuseppe; Desideri, Isacco; Arilli, Chiara; Paoletti, Lisa; Russo, Serenella; Scoccianti, Silvia; Martella, Francesca; Francolini, Giulio; Simontacchi, Gabriele; Nori Cucchiari, Jacopo; Pellegrini, Roberto; Livi, Lorenzo; Pallotta, Stefania (2024). Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trial. LA RADIOLOGIA MEDICA, pp. 0-0, ISSN:1826-6983 DOI

Zampieri, Mattia; Schoonvelde, Stephan A C; Vinci, Michele; Meattini, Icro; Visani, Luca; Fornaro, Alessandra; Coppini, Raffaele; Romei, Andrea; Marchi, Alberto; Morelli, Ilaria; van Slegtenhorst, Marjon A; Palinkas, Eszter Dalma; Livi, Lorenzo; Michels, Michelle; Olivotto, Iacopo (2024). Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy. MAYO CLINIC PROCEEDING, vol. 99, pp. 218-228, ISSN:2542-4548 DOI

Lambertini, Matteo; Blondeaux, Eva; Agostinetto, Elisa; Hamy, Anne-Sophie; Kim, Hee Jeong; Di Meglio, Antonio; Bernstein Molho, Rinat; Hilbers, Florentine; Pogoda, Katarzyna; Carrasco, Estela; Punie, Kevin; Bajpai, Jyoti; Ignatiadis, Michail; Moore, Halle C F; Phillips, Kelly-Anne; Toss, Angela; Rousset-Jablonski, Christine; Peccatori, Fedro A; Renaud, Tiphaine; Ferrari, Alberta; Paluch-Shimon, Shani; Fruscio, Robert; Cui, Wanda; Wong, Stephanie M; Vernieri, Claudio; Ruddy, Kathryn J; Dieci, Maria Vittoria; Matikas, Alexios; Rozenblit, Mariya; Villarreal-Garza, Cynthia; De Marchis, Laura; Del Mastro, Lucia; Puglisi, Fabio; Del Pilar Estevez-Diz, Maria; Rodriguez-Wallberg, Kenny A; Mrinakova, Bela; Meister, Sarah; Livraghi, Luca; Clatot, Florian; Yerushalmi, Rinat; De Angelis, Carmine; Sánchez-Bayona, Rodrigo; Meattini, Icro; Cichowska-Cwalinska, Natalia; Berlière, Martine; Salama, Mahmoud; De Giorgi, Ugo; Sonnenblick, Amir; Chiodi, Camila; Lee, Young-Jin; Maria, Camille; Azim, Hatem A; Boni, Luca; Partridge, Ann H (2024). Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study. JAMA, vol. 331, pp. 49-59, ISSN:0098-7484 DOI

Lastrucci, Andrea; Marrazzo, Livia; Meattini, Icro; Simontacchi, Gabriele; Wandael, Yannick; Talamonti, Cinzia; Pallotta, Stefania; Ricci, Renzo; Livi, Lorenzo (2024). Advancing patient setup: A comprehensive scoping review of tattoo-less techniques in radiation therapy. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 204, pp. 0-0, ISSN:1040-8428 DOI

Lorito, Nicla; Subbiani, Angela; Smiriglia, Alfredo; Bacci, Marina; Bonechi, Francesca; Tronci, Laura; Romano, Elisabetta; Corrado, Alessia; Longo, Dario Livio; Iozzo, Marta; Ippolito, Luigi; Comito, Giuseppina; Giannoni, Elisa; Meattini, Icro; Avgustinova, Alexandra; Chiarugi, Paola; Bachi, Angela; Morandi, Andrea (2024). FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer. EMBO MOLECULAR MEDICINE, pp. 0-0, ISSN:1757-4684 DOI

Bacci, Marina; Lorito, Nicla; Smiriglia, Alfredo; Subbiani, Angela; Bonechi, Francesca; Comito, Giuseppina; Morriset, Ludivine; El Botty, Rania; Benelli, Matteo; López-Velazco, Joanna I; Caffarel, Maria M; Urruticoechea, Ander; Sflomos, George; Malorni, Luca; Corsini, Michela; Ippolito, Luigi; Giannoni, Elisa; Meattini, Icro; Matafora, Vittoria; Havas, Kristina; Bachi, Angela; Chiarugi, Paola; Marangoni, Elisabetta; Morandi, Andrea (2024). Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer. SCIENCE TRANSLATIONAL MEDICINE, vol. 16, pp. 0-0, ISSN:1946-6242 DOI

Krasniqi E.; Filomeno L.; Arcuri T.; Di Lisa F.S.; Astone A.; Cutigni C.; Foglietta J.; Nunzi M.; Rossi R.; Minelli M.; Meattini I.; Visani L.; Scialino J.; Livi L.; Moscetti L.; Marchetti P.; Botticelli A.; Paris I.; Pavese F.; D'Angelo T.; Sini V.; Stani S.; Valerio M.R.; Grassadonia A.; Tinari N.; Mazzotta M.; Vergati M.; D'Auria G.; Gamucci T.; D'Onofrio L.; Gasparro S.; Roselli A.; Fulvi A.; Ferretti G.; Torchia A.; Giordano M.; Greco F.; Pantano F.; Tonini G.; Fabbri A.; Bria E.; Garufi G.; Fiorio E.; Raffaele M.; Pistelli M.; Berardi R.; Saltarelli R.; Kayal R.; Ferranti F.R.; Cannita K.; Irelli A.; D'Ostilio N.; De Rossi C.; Palumbo R.; Cariello A.; Sanguineti G.; Calabro F.; Pizzuti L.; Barba M.; Botti C.; Pelle F.; Cappelli S.; Cavicchi F.; Puccica I.; Villanucci A.; Sperduti I.; Ciliberto G.; Vici P. (2024). Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study. CANCERS, vol. 16, pp. 0-0, ISSN:2072-6694 DOI

Schonecker S.; Angelini L.; Gaasch A.; Zinn A.; Konnerth D.; Heinz C.; Xiong Y.; Unger K.; Landry G.; Meattini I.; Braun M.; Polcher M.; Harbeck N.; Wurstlein R.; Niyazi M.; Belka C.; Pazos M.; Corradini S. (2024). Surface-based deep inspiration breath-hold radiotherapy in left-sided breast cancer: final results from the SAVE-HEART study. ESMO OPEN, vol. 9, pp. 0-0, ISSN:2059-7029 DOI

Meattini, Icro; De Santis, Maria Carmen; Visani, Luca; Scorsetti, Marta; Fozza, Alessandra; Meduri, Bruno; De Rose, Fiorenza; Bonzano, Elisabetta; Prisco, Agnese; Masiello, Valeria; La Rocca, Eliana; Spoto, Ruggero; Becherini, Carlotta; Blandino, Gladys; Moscetti, Luca; Colciago, Riccardo Ray; Audisio, Riccardo A; Brain, Etienne; Caini, Saverio; Hamaker, Marije; Kaidar-Person, Orit; Lambertini, Matteo; Marrazzo, Livia; Saieva, Calogero; Spanic, Tanja; Strnad, Vratislav; Wheelwright, Sally; Poortmans, Philip M P; Livi, Lorenzo (2024). Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial. THE LANCET ONCOLOGY, pp. 0-0, ISSN:1470-2045 DOI

Ignatiadis M.; Poulakaki F.; Spanic T.; Brain E.; Lacombe D.; Sonke G.S.; Vincent-Salomon A.; Van Duijnhoven F.; Meattini I.; Kaidar-Person O.; Aftimos P.; Lecouvet F.; Cardoso F.; Retel V.P.; Cameron D. (2024). EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe. EUROPEAN JOURNAL OF CANCER, vol. 207, pp. 0-0, ISSN:0959-8049 DOI

Kirby, A M; Guckenberger, M; Slotman, B J; Clark, C H; Eriksen, J G; van der Heide, U; De Ioanna, S; Gasparotto, C; Cortese, A J; Meattini, I (2024). European Society of Radiotherapy and Oncology (ESTRO) strategy 2024-2026: Growth and diversification in a rapidly changing world. RADIOTHERAPY AND ONCOLOGY, vol. 196, pp. 0-0, ISSN:0167-8140 DOI

Ghilli, Matteo; Becherini, Carlotta; Meattini, Icro; Angiolini, Catia; Bengala, Carmelo; Marconi, Aroldo; Galli, Lorenzo; Angiolucci, Giovanni; Coltelli, Luigi; Borghesi, Simona; Lastrucci, Luciana; Manca, Gianpiero; Bianchi, Simonetta; Doria, Morena; Casella, Donato; Marotti, Lorenza; Amunni, Gianni; Roncella, Manuela (2024). Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network. LA RADIOLOGIA MEDICA, vol. 129, pp. 0-0, ISSN:1826-6983 DOI

Bernini, Marco; Gigliucci, Giacomo; Cassetti, Dario; Tommasi, Cinzia; Gaggelli, Ilaria; Arlia, Lorenzo; Becherini, Carlotta; Salvestrini, Viola; Visani, Luca; Nori Cucchiari, Jacopo; De Benedetto, Diego; Di Naro, Federica; Bicchierai, Giulia; Bellini, Chiara; Bianchi, Simonetta; Orzalesi, Lorenzo; Livi, Lorenzo; Meattini, Icro (2024). Pre-pectoral breast reconstruction with tissue expander entirely covered by acellular dermal matrix: feasibility, safety and histological features resulting from the first 64 procedures. GLAND SURGERY, vol. 13, pp. 0-0, ISSN:2227-684X DOI

Loibl, S; André, F; Bachelot, T; Barrios, C H; Bergh, J; Burstein, H J; Cardoso, M J; Carey, L A; Dawood, S; Del Mastro, L; Denkert, C; Fallenberg, E M; Francis, P A; Gamal-Eldin, H; Gelmon, K; Geyer, C E; Gnant, M; Guarneri, V; Gupta, S; Kim, S B; Krug, D; Martin, M; Meattini, I; Morrow, M; Janni, W; Paluch-Shimon, S; Partridge, A; Poortmans, P; Pusztai, L; Regan, M M; Sparano, J; Spanic, T; Swain, S; Tjulandin, S; Toi, M; Trapani, D; Tutt, A; Xu, B; Curigliano, G; Harbeck, N (2024). Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ANNALS OF ONCOLOGY, vol. 35, pp. 0-0, ISSN:1569-8041 DOI

Chun S.-J.; Kim K.; Kim Y.B.; Paek S.H.; Lee K.-H.; Song J.-H.; Jang W.I.; Kim T.H.; Salvestrini V.; Meattini I.; Livi L.; Shin K.H. (2024). Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery. RADIOTHERAPY AND ONCOLOGY, vol. 199, pp. 0-0, ISSN:0167-8140 DOI

Salvestrini, Viola; Valzano, Marianna; Meattini, Icro; Becherini, Carlotta; Visani, Luca; Francolini, Giulio; Morelli, Ilaria; Bertini, Niccolò; Orzalesi, Lorenzo; Bernini, Marco; Bianchi, Simonetta; Simontacchi, Gabriele; Livi, Lorenzo; Desideri, Isacco (2024). Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques. LA RADIOLOGIA MEDICA, vol. 129, pp. 0-0, ISSN:1826-6983 DOI

Francolini, Giulio; Ghoshal, Arunangshu; Caini, Saverio; Piazzini, Tessa; Becherini, Carlotta; Detti, Beatrice; Di Cataldo, Vanessa; Valzano, Marianna; Visani, Luca; Salvestrini, Viola; Olmetto, Emanuela; Desideri, Isacco; Meattini, Icro; Livi, Lorenzo (2024). Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis. RADIOTHERAPY AND ONCOLOGY, vol. 190, pp. 0-0, ISSN:0167-8140 DOI

Meattini, Icro; Marta, Gustavo Nader; Carroll, Susan; Rivera, Sofia; Lamoury, Gillian; De Felice, Francesca; Lambertini, Matteo; Livi, Lorenzo; Kaidar-Person, Orit; Poortmans, Philip (2024). Omission of radiation therapy after breast-conserving surgery for biologically favourable tumours in younger patients: The wrong answer to the right question. RADIOTHERAPY AND ONCOLOGY, vol. 190, pp. 0-0, ISSN:0167-8140 DOI

Karihtala P.; Schiza A.; Fountzilas E.; Geisler J.; Meattini I.; Risi E.; Biganzoli L.; Valachis A. (2024). Clinical trials in older patients with cancer – typical challenges, possible solutions, and a paradigm of study design in breast cancer. ACTA ONCOLOGICA, vol. 63, pp. 441-447, ISSN:0284-186X DOI

Rakha, Emad A; Quinn, Cecily; Masannat, Yazan A; Lee, Andrew H. S.; Tan, Puay Hoon; Karakatsanis, Andreas; Matrai, Zoltan Tamas; Al Shaibani, Salman Husain M; Gehani, Salahddin A; Shaaban, Abeer; Khout, Hazem; Chagla, Leena; Cserni, Gábor; Varga, Zsuzsanna; Yong, Wong Fuh; Meattini, Icro; Kulka, Janina; Yang, Wentao; Tse, Gary M; Pinder, Sarah E; Fox, Stephen; Dixon, J Michael (2024). Revisiting surgical margins for invasive breast cancer patients treated with breast conservation therapy - Evidence for adopting a 1 mm negative width. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, vol. 50, pp. 0-0, ISSN:0748-7983 DOI

Gori, Stefania; De Rose, Fiorenza; Ferro, Antonella; Fabi, Alessandra; Angiolini, Catia; Azzarello, Giuseppe; Cancian, Maurizio; Cinquini, Michela; Arecco, Luca; Aristei, Cynthia; Bernardi, Daniela; Biganzoli, Laura; Cariello, Anna; Cortesi, Laura; Cretella, Elisabetta; Criscitiello, Carmen; De Giorgi, Ugo; Carmen De Santis, Maria; Deledda, Giuseppe; Dessena, Massimo; Donati, Sara; Dri, Arianna; Ferretti, Gianluigi; Foglietta, Jennifer; Franceschini, Davide; Franco, Pierfrancesco; Schirone, Alessio; Generali, Daniele; Gianni, Lorenzo; Giordani, Stefano; Grandi, Giovanni; Cristina Leonardi, Maria; Magno, Stefano; Malorni, Luca; Mantoan, Carlotta; Martorana, Federica; Meattini, Icro; Meduri, Bruno; Merlini, Laura; Miglietta, Federica; Modena, Alessandra; Nicolis, Fabrizio; Palumbo, Isabella; Panizza, Pietro; Angela Rovera, Francesca; Salvini, Piermario; Santoro, Armando; Taffurelli, Mario; Toss, Angela; Tralongo, Paolo; Turazza, Monica; Valerio, Matteo; Verzè, Matteo; Vici, Patrizia; Zamagni, Claudio; Curigliano, Giuseppe; Pappagallo, Giovanni; Zambelli, Alberto (2024). Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project. CANCER TREATMENT REVIEWS, vol. 131, pp. 0-0, ISSN:0305-7372 DOI

Shaitelman, Simona F; Anderson, Bethany M; Arthur, Douglas W; Bazan, Jose G; Bellon, Jennifer R; Bradfield, Lisa; Coles, Charlotte E; Gerber, Naamit K; Kathpal, Madeera; Kim, Leonard; Laronga, Christine; Meattini, Icro; Nichols, Elizabeth M; Pierce, Lori J; Poppe, Matthew M; Spears, Patricia A; Vinayak, Shaveta; Whelan, Timothy; Lyons, Janice A (2024). Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline. PRACTICAL RADIATION ONCOLOGY, vol. 14, pp. 0-0, ISSN:1879-8500 DOI

Valachis, Antonis; Biganzoli, Laura; Christopoulou, Athina; Fjermeros, Kamilla; Fountzila, Elena; Geisler, Jürgen; Gomez-Bravo, Raquel; Karihtala, Peeter; Kosmidis, Paris; Koutras, Angelos; Linardou, Helena; Lindman, Henrik; Martínez-Ballestero, Iván; Rodríguez, Anna Belén; Meattini, Icro; Munoz-Mateu, Montserrat; Othman, Mukhrizah; Psyrri, Amanda; Risi, Emanuela; Schiza, Aglaia; Spathas, Nikolaos; Utriainen, Meri; Visani, Luca; Ballesteros, Soledad; Basdekis, Ioannis; Hay, Susanne Dieroff; Fotis, Theo; Fricker, Samuel; Graaf, Gimon de; Jenset, Marit; Kanters, Tim; Lampropoulos, Kostas; Markou, Christiana; Mastoraki, Kalliopi; Nanou, Christina; Reales Aviles, José Manuel; Santaholma, Marianne; Kosmidis, Thanos (2024). Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients. FUTURE ONCOLOGY, pp. 0-0, ISSN:1479-6694 DOI

Kaidar-Person, O; Ratosa, I; Franco, P; Masiello, V; Marazzi, F; Pedretti, S; Ciabattoni, A; Leonardi, M C; Tramm, T; Coles, C E; Meattini, I; Arenas, M; Offersen, B V; Boersma, L J; Valentini, V; Dodwell, D; Poortmans, P; Aristei, C (2024). The Assisi think tank focus review on postoperative radiation for lobular breast cancer. RADIOTHERAPY AND ONCOLOGY, vol. 201, pp. 0-0, ISSN:0167-8140 DOI

Lee, Shing Fung; Kennedy, Samantha K F; Caini, Saverio; Wong, Henry C Y; Yip, Pui Lam; Poortmans, Philip M; Meattini, Icro; Kaidar-Person, Orit; Recht, Abram; Hijal, Tarek; Torres, Mylin A; Cao, Jeffrey Q; Corbin, Kimberly S; Choi, J Isabelle; Koh, Wee Yao; Kwan, Jennifer Y Y; Karam, Irene; Chan, Adrian W; Chow, Edward; Marta, Gustavo N (2024). Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis. BMJ, vol. 386, pp. 0-0, ISSN:1756-1833 DOI

Colciago, Riccardo Ray; Lancellotta, Valentina; Santis, Maria Carmen De; Bonzano, Elisabetta; Rose, Fiorenza De; Rocca, Eliana La; Meduri, Bruno; Pasinetti, Nadia; Prisco, Agnese; Gennari, Alessandra; Tramm, Trine; Cosimo, Serena Di; Harbeck, Nadia; Curigliano, Giuseppe; Poortmans, Philip; Meattini, Icro; Franco, Pierfrancesco (2024). The role of radiation therapy in the multidisciplinary management of male breast cancer: a systematic review and meta-analysis. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, pp. 0-0, ISSN:1040-8428 DOI

López-Fernández, Teresa; Marco, Irene; Aznar, Marianne C; Barac, Ana; Bergler-Klein, Jutta; Meattini, Icro; Scott, Jessica M; Cardinale, Daniela; Dent, Susan (2024). Breast cancer and cardiovascular health. EUROPEAN HEART JOURNAL, pp. 0-0, ISSN:0195-668X DOI

Bardia, Aditya; Jhaveri, Komal; Im, Seock-Ah; Pernas, Sonia; De Laurentiis, Michelino; Wang, Shusen; Martínez Jañez, Noelia; Borges, Giuliano; Cescon, David W; Hattori, Masaya; Lu, Yen-Shen; Hamilton, Erika; Zhang, Qingyuan; Tsurutani, Junji; Kalinsky, Kevin; Rubini Liedke, Pedro Emanuel; Xu, Lu; Fairhurst, Rick M; Khan, Sabrina; Denduluri, Neelima; Rugo, Hope S; Xu, Binghe; Pistilli, Barbara; Meattini, Icro (2024). Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01. JOURNAL OF CLINICAL ONCOLOGY, pp. 0-0, ISSN:1527-7755 DOI

Bernini, Marco; Spolveri, Federico; Tofani, Lorenzo; De Benedetto, Diego; Bicchierai, Giulia; Bellini, Chiara; Morrone, Doralba; Nori Cucchiari, Jacopo; Bianchi, Simonetta; Livi, Lorenzo; Orzalesi, Lorenzo; Meattini, Icro (2024). B3 Breast Lesions: Positive Predictive Value and Follow-Up on a Large Single-Institution Series. JOURNAL OF SURGICAL RESEARCH, vol. 299, pp. 0-0, ISSN:1095-8673 DOI

Meattini, Icro; Becherini, Carlotta; Caini, Saverio; Coles, Charlotte E; Cortes, Javier; Curigliano, Giuseppe; de Azambuja, Evandro; Isacke, Clare M; Harbeck, Nadia; Kaidar-Person, Orit; Marangoni, Elisabetta; Offersen, Birgitte V; Rugo, Hope S; Salvestrini, Viola; Visani, Luca; Morandi, Andrea; Lambertini, Matteo; Poortmans, Philip; Livi, Lorenzo (2024). International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations. THE LANCET ONCOLOGY, vol. 25, pp. 0-0, ISSN:1474-5488 DOI

Francolini, Giulio; Banini, Marco; Di Cataldo, Vanessa; Detti, Beatrice; Caini, Saverio; Loi, Mauro; Simontacchi, Gabriele; Desideri, Isacco; Greto, Daniela; Valzano, Marianna; Roghi, Manuele; Serni, Sergio; Vaggelli, Luca; Salvestrini, Viola; Visani, Luca; Becherini, Carlotta; Olmetto, Emanuela; Franzese, Ciro; Baldaccini, Davide; Scorsetti, Marta; Sollini, Martina; Chiti, Arturo; Meattini, Icro; Valicenti, Richard K; Livi, Lorenzo (2023). PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study. THE PROSTATE, vol. 83, pp. 1201-1206, ISSN:0270-4137 DOI

Becherini, Carlotta; Visani, Luca; Caini, Saverio; Bhattacharya, Indrani S; Kirby, Anna M; Nader Marta, Gustavo; Morgan, Gilberto; Salvestrini, Viola; Coles, Charlotte E; Cortes, Javier; Curigliano, Giuseppe; de Azambuja, Evandro; Harbeck, Nadia; Isacke, Clare M; Kaidar-Person, Orit; Marangoni, Elisabetta; Offersen, Birgitte; Rugo, Hope S; Morandi, Andrea; Lambertini, Matteo; Poortmans, Philip; Livi, Lorenzo; Meattini, Icro (2023). Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis. CANCER TREATMENT REVIEWS, vol. 119, pp. 0-0, ISSN:0305-7372 DOI

Kaidar-Person, Orit; Meattini, Icro; Boersma, Liesbeth J; Becherini, Carlotta; Cortes, Javier; Curigliano, Giuseppe; de Azambuja, Evandro; Harbeck, Nadia; Rugo, Hope S; Del Mastro, Lucia; Gennari, Alessandra; Isacke, Clare M; Vestmø Maraldo, Maja; Marangoni, Elisabetta; Nader Marta, Gustavo; Mjaaland, Ingvil; Salvestrini, Viola; Spanic, Tanja; Visani, Luca; Morandi, Andrea; Lambertini, Matteo; Livi, Lorenzo; Coles, Charlotte E; Poortmans, Philip; Offersen, Birgitte V (2023). Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO). RADIOTHERAPY AND ONCOLOGY, pp. 0-0, ISSN:0167-8140 DOI

Meattini, Icro; Kim, Kyubo; Livi, Lorenzo (2023). Accelerated Partial Breast Irradiation: Florence Phase 3 Trial Experience and Future Perspectives. AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS, vol. 46, pp. 10-15, ISSN:0277-3732 DOI

Franco, Pierfrancesco; De Felice, Francesca; Jagsi, Reshma; Nader Marta, Gustavo; Kaidar-Person, Orit; Gabrys, Dorota; Kim, Kyubo; Ramiah, Duvern; Meattini, Icro; Poortmans, Philip (2023). Breast cancer radiation therapy: A bibliometric analysis of the scientific literature. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, vol. 39, pp. 0-0, ISSN:2405-6308 DOI

Shaitelman, Simona F; Anderson, Bethany M; Arthur, Douglas W; Bazan, Jose G; Bellon, Jennifer R; Bradfield, Lisa; Coles, Charlotte E; Gerber, Naamit K; Kathpal, Madeera; Kim, Leonard; Laronga, Christine; Meattini, Icro; Nichols, Elizabeth M; Pierce, Lori J; Poppe, Matthew M; Spears, Patricia A; Vinayak, Shaveta; Whelan, Timothy; Lyons, Janice A (2023). Publisher's Note to Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline (Pract Radiat Oncol. 2024;14:xxx-xxx. Epub ahead of print November 14, 2023.). PRACTICAL RADIATION ONCOLOGY, vol. 14, pp. 0-0, ISSN:1879-8500 DOI

Leonardi M.C.; Pepa M.; Zaffaroni M.; Vincini M.G.; Luraschi R.; Vigorito S.; Morra A.; Dicuonzo S.; Mazzola G.C.; Gerardi M.A.; Zerella M.A.; Cante D.; Petrucci E.; Borzi G.; Marrocco M.; Chieregato M.; Iadanza L.; Lobefalo F.; Valenti M.; Cavallo A.; Russo S.; Guernieri M.; Malatesta T.; Meaglia I.; Liotta M.; Palumbo I.; Marcantonini M.; Mezzenga E.; Falivene S.; Arrichiello C.; Barbero M.P.; Ivaldi G.B.; Catalano G.; Vidali C.; Giannitto C.; Ciabattoni A.; Meattini I.; Aristei C.; Orecchia R.; Cattani F.; Jereczek-Fossa B.A. (2023). Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional study. TUMORI, pp. 0-0, ISSN:0300-8916 DOI

De Rose F.; Colciago R.R.; Lucidi S.; La Rocca E.; Prisco A.; Bonzano E.; Meduri B.; De Santis M.C.; Dicuonzo S.; Pasinetti N.; Palumbo I.; Meattini I.; Franco P. (2023). Axillary Management in Breast Cancer Patients Undergoing Upfront Surgery: Results from a Nationwide Survey on Behalf of the Clinical Oncology Breast Cancer Group (COBCG) and the Breast Cancer Study Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). CURRENT ONCOLOGY, vol. 30, pp. 7489-7498, ISSN:1718-7729 DOI

Giordano G.; Griguolo G.; Landriscina M.; Meattini I.; Carbone F.; Leone A.; Del Re M.; Fogli S.; Danesi R.; Colamaria A.; Dieci M.V. (2023). Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 192, pp. 0-0, ISSN:1040-8428 DOI

Sars, Carl; Sackey, Helena; Frisell, Jan; Dickman, Paul W; Karlsson, Fredrik; Kindts, Isabelle; Marta, Gustavo Nader; Freitas-Junior, Ruffo; Tvedskov, Tove Filtenborg; Kassem, Loay; Ali, Ahmed S; Ihalainen, Hanna; Neron, Mathias; Kontos, Michalis; Kaidar-Person, Orit; Meattini, Icro; Francken, Anne Brecht; van Duijnhoven, Frederieke; Moberg, Ingvild Ona; Marinko, Tanja; Kollar, Attila; Ahmed, Mahbubl; Remoundos, Dennis; Banks, Jenny; Jagsi, Reshma; Dossett, Lesly A; Lindqvist, Ebba K (2023). Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists. BREAST CANCER RESEARCH AND TREATMENT, vol. 199, pp. 0-0, ISSN:1573-7217 DOI

Pasquier, David; Bidaut, Luc; Oprea-Lager, Daniela Elena; deSouza, Nandita M; Krug, David; Collette, Laurence; Kunz, Wolfgang; Belkacemi, Yazid; Bau, Maria Grazia; Caramella, Caroline; De Geus-Oei, Lioe-Fee; De Caluwé, Alex; Deroose, Christophe; Gheysens, Olivier; Herrmann, Ken; Kindts, Isabelle; Kontos, Michalis; Kümmel, Sherko; Linderholm, Barbro; Lopci, Egesta; Meattini, Icro; Smeets, Ann; Kaidar-Person, Orit; Poortmans, Philip; Tsoutsou, Pelagia; Hajjaji, Nawale; Russell, Nicola; Senkus, Elżbieta; Talbot, Jean-Noël; Umutlu, Lale; Vandecaveye, Vincent; Verhoeff, Joost J C; van Oordt, Willemien Menke-van der Houven; Zacho, Helle D; Cardoso, Fatima; Fournier, Laure; Van Duijnhoven, Frederieke; Lecouvet, Frédéric E (2023). Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups. THE LANCET ONCOLOGY, vol. 24, pp. 0-0, ISSN:1474-5488 DOI

Oladeru, Oluwadamilola T; Dunn, Samantha A; Li, Jian; Coles, Charlotte E; Yamauchi, Chikako; Chang, Jee Suk; Cheng, Skye Hung-Chun; Kaidar-Person, Orit; Meattini, Icro; Ramiah, Duvern; Kirby, Anna; Hijal, Tarek; Marta, Gustavo Nader; Poortmans, Philip; Isern-Verdum, Josep; Zissiadis, Yvonne; Offersen, Birgitte Vrou; Refaat, Tamer; Elsayad, Khaled; Hijazi, Hussam; Dengina, Natalia; Belkacemi, Yazid; Luo, Feng Deng; Lu, Shun; Griffin, Colleen; Collins, Maya; Ryan, Phoebe; Larios, Dalia; Warren, Laura E; Punglia, Rinaa S; Wong, Julia S; Spiegel, Daphna Y; Jagsi, Reshma; Taghian, Alphonse; Bellon, Jennifer R; Ho, Alice Y (2023). Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic. JCO GLOBAL ONCOLOGY, vol. 9, pp. 0-0, ISSN:2687-8941 DOI

Nardone, Valerio; Meirson, Tomer; De Felice, Francesca; Meattini, Icro (2023). Genomic Profiling: Can We Rely on Retrospective Analysis to Drive Changes in Clinical Practice?. JOURNAL OF CLINICAL ONCOLOGY, vol. 41, pp. 0-0, ISSN:1527-7755 DOI

Meattini, Icro; de Oliveira Franco, Rejane; Salvestrini, Viola; Hijal, Tarek (2023). Partial Breast Irradiation. BREAST, vol. 69, pp. 0-0, ISSN:1532-3080 DOI

Meattini, Icro; Coles, Charlotte E (2023). Accumulating long-term evidence for partial breast irradiation. THE LANCET ONCOLOGY, vol. 24, pp. 0-0, ISSN:1474-5488 DOI

Masi, Laura; Doro, Raffaela; Di Cataldo, Vanessa; Francolini, Giulio; Zani, Margherita; Visani, Luca; Meattini, Icro; Livi, Lorenzo (2023). Preoperative single fraction breast radiotherapy: Intra-fraction geometric uncertainties and dosimetric implications. PHYSICA MEDICA, vol. 112, pp. 0-0, ISSN:1724-191X DOI

Kastora, Stavroula Lila; Holmquist, Alexander; Valachis, Antonios; Rocco, Nicola; Meattini, Icro; Somaiah, Navita; Peled, Anne; Chatterjee, Abhishek; Catanuto, Giuseppe; Tasoulis, Marios Konstantinos; Nava, Maurizio Bruno; Poortmans, Philip; Pusic, Andrea; Masannat, Yazan; Karakatsanis, Andreas (2023). Outcomes of Different Quality of Life Assessment Modalities After Breast Cancer Therapy: A Network Meta-analysis. JAMA NETWORK OPEN, vol. 6, pp. 0-0, ISSN:2574-3805 DOI

Kaidar-Person, Orit; Pfob, André; Gentilini, Oreste Davide; Borisch, Bettina; Bosch, Ana; Cardoso, Maria João; Curigliano, Giuseppe; De Boniface, Jana; Denkert, Carsten; Hauser, Nik; Heil, Jörg; Knauer, Michael; Kühn, Thorsten; Lee, Han-Byoel; Loibl, Sibylle; Mannhart, Meinrad; Meattini, Icro; Montagna, Giacomo; Pinker, Katja; Poulakaki, Fiorita; Rubio, Isabel T; Sager, Patrizia; Steyerova, Petra; Tausch, Christoph; Tramm, Trine; Vrancken Peeters, Marie-Jeanne; Wyld, Lynda; Yu, Jong Han; Weber, Walter Paul; Poortmans, Philip; Dubsky, Peter (2023). The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus. ECLINICALMEDICINE, vol. 61, pp. 0-0, ISSN:2589-5370 DOI

Garreffa, Emanuele; Meattini, Icro; Coles, Charlotte E; Agrawal, Amit (2023). Use of tumour bed boost radiotherapy in volume replacement oncoplastic breast surgery: A systematic review. CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, vol. 186, pp. 0-0, ISSN:1879-0461 DOI

Francolini, Giulio; Garlatti, Pietro; Di Cataldo, Vanessa; Triggiani, Luca; Simoni, Nicola; Detti, Beatrice; Lorenzetti, Victoria; Colombo, Federico; Morelli, Vittorio; Ganovelli, Michele; Caprara, Luisa; Orsatti, Carolina; Burchini, Luca; Frosini, Giulio; Bertini, Niccolò; Loi, Mauro; Simontacchi, Gabriele; Greto, Daniela; Desideri, Isacco; Meattini, Icro; Livi, Lorenzo (2023). Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysis. LA RADIOLOGIA MEDICA, vol. 128, pp. 0-0, ISSN:1826-6983 DOI

Banini, Marco; Visani, Luca; Livi, Lorenzo; Meattini, Icro (2023). De-escalating postoperative radiation therapy after primary systemic therapy in cT1-2N1 breast cancer: lesson from the RAPCHEM/BOOG 2010-03 trial. ANNALS OF TRANSLATIONAL MEDICINE, vol. 11, pp. 366-366, ISSN:2305-5839 DOI

Francolini, Giulio; Gaetano Allegra, Andrea; Detti, Beatrice; Di Cataldo, Vanessa; Caini, Saverio; Bruni, Alessio; Ingrosso, Gianluca; D'Angelillo, Rolando Maria; Alitto, Anna Rita; Augugliaro, Matteo; Triggiani, Luca; Parisi, Silvana; Facchini, Gaetano; Banini, Marco; Simontacchi, Gabriele; Desideri, Isacco; Meattini, Icro; Valicenti, Richard K; Livi, Lorenzo (2023). Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO). JOURNAL OF CLINICAL ONCOLOGY, pp. 0-0, ISSN:0732-183X DOI

Willmann J.; Appelt L.; Balermpas P.; Baumert G.; de Ruysscher D.; Hoyer M.; Hurkmans C.; Kaidar-Person O.; Meattini I.; Niyazi M.; Poortmans P.; Reynaert N.; Tandini-Lang S.; van der Linden Y.; Nieder C.; Andratschke N. (2023). Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform. RADIOTHERAPY AND ONCOLOGY, vol. 189, pp. 0-0, ISSN:0167-8140 DOI

Curigliano G.; Burstein H.J.; Gnant M.; Loibl S.; Cameron D.; Regan M.M.; Denkert C.; Poortmans P.; Weber W.P.; Thurlimann B.; Aebi S.; Al-Foheidi M.; Andre F.; Anikusko M.; Badwe R.; Barrio A.V.; Barrios C.; Bergh J.; Bonnefoi H.; Bretel Morales D.; Brucker S.; Caldas C.; Cardoso F.; Cardoso M.J.; Carey L.; Chia S.; Coles C.; Cortes J.; de Boniface J.; Delaloge S.; DeMichele A.; Fastner G.; Fitzal F.; Francis P.; Gamal H.; Gentilini O.; Gradishar W.; Gulluoglu B.; Harbeck N.; Heil J.; Huang C.-S.H.; Huober J.; Jiang Z.; Kaidar-Person O.; Kok M.; Lee E.-S.; Loi S.; Martin M.; Meattini I.; Morrow M.; Partridge A.; Penault-Llorca F.; Piccart M.; Pierce L.; Regan M.; Reis-Filho J.; Rubio I.; Rugo H.; Rutgers E.; Saura C.; Senkus E.; Shao Z.; Singer C.; Spanic T.; Thuerlimann B.; Toi M.; Tolaney S.; Turner N.; Tutt A.; Vrancken Peeters M.-J.; Watanabe T.; Weber W.; Wildiers H.; Xu B. (2023). Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023. ANNALS OF ONCOLOGY, pp. 0-0, ISSN:0923-7534 DOI

Morelli I.; Becherini C.; Banini M.; Valzano M.; Bertini N.; Loi M.; Francolini G.; Meattini I.; Salvestrini V.; Bonomo P.; Livi L.; Desideri I. (2023). Radiomic Analysis for Human Papillomavirus Assessment in Oropharyngeal Carcinoma: Lessons and Pitfalls for the Next Future. APPLIED SCIENCES, vol. 13, pp. 0-0, ISSN:2076-3417 DOI

Francolini, Giulio; Ganovelli, Michele; Di Cataldo, Vanessa; Detti, Beatrice; Caini, Saverio; Loi, Mauro; Simontacchi, Gabriele; Desideri, Isacco; Greto, Daniela; Valzano, Marianna; Serni, Sergio; Vaggelli, Luca; Salvestrini, Viola; Visani, Luca; Becherini, Carlotta; Olmetto, Emanuela; Franzese, Ciro; Baldaccini, Davide; Scorsetti, Marta; Sollini, Martina; Chiti, Arturo; Meattini, Icro; Valicenti, Richard K; Livi, Lorenzo (2023). Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results. CLINICAL & EXPERIMENTAL METASTASIS, vol. 40, pp. 0-0, ISSN:0262-0898 DOI

Francolini, Giulio; Carnevale, Maria Grazia; Di Cataldo, Vanessa; Loi, Mauro; Detti, Beatrice; Orsatti, Carolina; Caprara, Luisa; Bertini, Niccolò; Lorenzetti, Victoria; Olmetto, Emanuela; Becherini, Carlotta; Visani, Luca; Salvestrini, Viola; Simontacchi, Gabriele; Greto, Daniela; Bonomo, Pierluigi; Doro, Raffaela; Masi, Laura; Desideri, Isacco; Meattini, Icro; Serni, Sergio; Livi, Lorenzo (2023). Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort. LA RADIOLOGIA MEDICA, pp. 0-0, ISSN:1826-6983 DOI

Kaidar-Person, Orit; Tramm, Trine; Kuehn, Thorsten; Gentilini, Oreste; Prat, Aleix; Montay-Gruel, Pierre; Meattini, Icro; Poortmans, Philip (2023). Optimising of axillary therapy in breast cancer: lessons from the past to plan for a better future. LA RADIOLOGIA MEDICA, pp. 0-0, ISSN:1826-6983 DOI

Marrazzo, Livia; Meattini, Icro; Simontacchi, Gabriele; Livi, Lorenzo; Pallotta, Stefania (2023). Updates on the APBI-IMRT-Florence Trial (NCT02104895) Technique: From the Intensity Modulated Radiation Therapy Trial to the Volumetric Modulated Arc Therapy Clinical Practice. PRACTICAL RADIATION ONCOLOGY, vol. 13, pp. e28-e34, ISSN:1879-8500 DOI

Livia Marrazzo, Laura Redapi, Roberto Pellegrini, Peter Voet, Icro Meattini, Chiara Arilli, Silvia Calusi, Marta Casati, Deborah Chilà, Antonella Compagnucci, Cinzia Talamonti, Margherita Zani, Lorenzo Livi, Stefania Pallotta (2023). Fully automated volumetric modulated arc therapy technique for radiation therapy of locally advanced breast cancer. RADIATION ONCOLOGY, pp. 0-0, ISSN:1748-717X DOI

Salvestrini, Viola; Kim, Kyubo; Caini, Saverio; Alkner, Sara; Ekholm, Maria; Skyttä, Tanja; Becherini, Carlotta; Coles, Charlotte E; Kaidar-Person, Orit; Offersen, Birgitte; de Azambuja, Evandro; Visani, Luca; Cortes, Javier; Harbeck, Nadia; Rugo, Hope S; Isacke, Clare M; Marangoni, Elisabetta; Morandi, Andrea; Lambertini, Matteo; Poortmans, Philip; Livi, Lorenzo; Meattini, Icro (2023). Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis. RADIOTHERAPY AND ONCOLOGY, vol. 186, pp. 0-0, ISSN:0167-8140 DOI

Salvestrini V.; Becherini C.; Visani L.; Desideri I.; Morelli I.; Scoccimarro E.; Cerbai C.; Bonaparte I.; Bertini N.; Bettazzi B.; Scotti V.; Bernini M.; Orzalesi L.; Nori J.; Bianchi S.; Francolini G.; Meattini I.; Livi L. (2023). Hypofractionated Postmastectomy Radiotherapy (HF-PMRT): What did We Learn from COVID-19 Era?. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, vol. 50, pp. 0-0, ISSN:0390-6663 DOI

Coltelli L.; Allegrini G.; Orlandi P.; Finale C.; Fontana A.; Masini L.C.; Scalese M.; Arrighi G.; Barletta M.T.; De Maio E.; Banchi M.; Fini E.; Guidi P.; Frenzilli G.; Donati S.; Giovannelli S.; Tanganelli L.; Salvadori B.; Livi L.; Meattini I.; Pazzagli I.; Di Lieto M.; Pistelli M.; Casadei V.; Ferro A.; Cupini S.; Orlandi F.; Francesca D.; Lorenzini G.; Barellini L.; Falcone A.; Cosimi A.; Bocci G. (2022). A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients. NPJ BREAST CANCER, vol. 8, pp. 0-0, ISSN:2374-4677 DOI

Francolini G.; Detti B.; Di Cataldo V.; Garlatti P.; Aquilano M.; Allegra A.; Lucidi S.; Cerbai C.; Ciccone L.P.; Salvestrini V.; Stocchi G.; Guerrieri B.; Visani L.; Loi M.; Desideri I.; Mangoni M.; Meattini I.; Livi L. (2022). Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719). LA RADIOLOGIA MEDICA, vol. 127, pp. 912-918, ISSN:0033-8362 DOI

Marta G.N.; Riera R.; Pacheco R.L.; Cabrera Martimbianco A.L.; Meattini I.; Kaidar-Person O.; Poortmans P. (2022). Moderately hypofractionated post-operative radiation therapy for breast cancer: Systematic review and meta-analysis of randomized clinical trials. THE BREAST, vol. 62, pp. 84-92, ISSN:0960-9776 DOI

Meattini I.; Palumbo I.; Becherini C.; Borghesi S.; Cucciarelli F.; Dicuonzo S.; Fiorentino A.; Spoto R.; Poortmans P.; Aristei C.; Livi L. (2022). The Italian Association for Radiotherapy and Clinical Oncology (AIRO) position statements for postoperative breast cancer radiation therapy volume, dose, and fractionation. LA RADIOLOGIA MEDICA, pp. 0-0, ISSN:1826-6983 DOI

Meattini I.; Salvestrini V.; Becherini C. (2022). Radiation therapy on the axilla after neoadjuvant chemotherapy. CURRENT OPINION IN ONCOLOGY, vol. 34, pp. 647-652, ISSN:1531-703X DOI

Andratschke, Nicolaus; Willmann, Jonas; Appelt, Ane L; Alyamani, Najlaa; Balermpas, Panagiotis; Baumert, Brigitta G; Hurkmans, Coen; Høyer, Morten; Langendijk, Johannes A; Kaidar-Person, Orit; van der Linden, Yvette; Meattini, Icro; Niyazi, Maximilian; Reynaert, Nick; De Ruysscher, Dirk; Tanadini-Lang, Stephanie; Hoskin, Peter; Poortmans, Philip; Nieder, Carsten (2022). European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. THE LANCET ONCOLOGY, vol. 23, pp. 469-478, ISSN:1474-5488 DOI

Francolini, Giulio; Di Cataldo, Vanessa; Detti, Beatrice; Simontacchi, Gabriele; Loi, Mauro; Valzano, Marianna; Desideri, Isacco; Meattini, Icro; Mangoni, Monica; Livi, Lorenzo (2022). Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer. CLINICAL & EXPERIMENTAL METASTASIS, pp. 0-0, ISSN:0262-0898 DOI

Fastner G.; Krug D.; Meattini I.; Gruber G.; Poortmans P. (2022). Expert Discussion: Hypofractionated Radiation Therapy - Standard for All Indications?. BREAST CARE, vol. 17, pp. 224-231, ISSN:1661-3791 DOI

Miglietta F.; Visani L.; Marini S.; Griguolo G.; Vernaci G.M.; Bottosso M.; Dieci M.V.; Meattini I.; Guarneri V. (2022). Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability?. CANCER TREATMENT REVIEWS, vol. 110, pp. 0-0, ISSN:0305-7372 DOI

Marrazzo L.; Redapi L.; Zani M.; Calusi S.; Meattini I.; Arilli C.; Casati M.; Compagnucci A.; Talamonti C.; Raspanti D.; Pertutti S.; Di Cataldo V.; Livi L.; Pallotta S. (2022). A semi-automatic planning technique for whole breast irradiation with tangential IMRT fields. PHYSICA MEDICA, vol. 98, pp. 122-130, ISSN:1120-1797 DOI

La Verde, Nicla; Damia, Giovanna; Garrone, Ornella; Santini, Daniele; Fabi, Alessandra; Ciccarese, Mariangela; Generali, Daniele Giulio; Nunzi, Martina; Poletto, Elena; Ferraris, Elisa; Cretella, Elisabetta; Scandurra, Giuseppa; Meattini, Icro; Bertolini, Alessandro Stefano; Cavanna, Luigi; Collovà, Elena; Romagnoli, Emanuela; Rulli, Eliana; Legramandi, Lorenzo; Guffanti, Federica; Bramati, Annalisa; Moretti, Anna; Cassano, Alessandra; Vici, Patrizia; Torri, Valter; Farina, Gabriella (2022). Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study. BREAST CANCER RESEARCH, vol. 24, pp. 0-0, ISSN:1465-542X DOI

Poortmans, Philip; Kaidar-Person, Orit; Meattini, Icro (2022). The Global Community Stands With American Society for Radiation Oncology's Experts in Protecting Women's Rights. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, pp. 0-0, ISSN:0360-3016 DOI

Francolini, Giulio; Frosini, Giulio; Di Cataldo, Vanessa; Detti, Beatrice; Carnevale, Maria Grazia; Banini, Marco; Peruzzi, Anna; Salvestrini, Viola; Visani, Luca; Olmetto, Emanuela; Becherini, Carlotta; Allegra, Andrea; Burchini, Luca; Scotti, Vieri; Mangoni, Monica; Meattini, Icro; Desideri, Isacco; Livi, Lorenzo (2022). Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy. JOURNAL OF GERIATRIC ONCOLOGY, pp. 0-0, ISSN:1879-4068 DOI

Visani, Luca; Livi, Lorenzo; Ratosa, Ivica; Orazem, Miha; Ribnikar, Domen; Saieva, Calogero; Becherini, Carlotta; Salvestrini, Viola; Scoccimarro, Erika; Valzano, Marianna; Cerbai, Cecilia; Desideri, Isacco; Bernini, Marco; Orzalesi, Lorenzo; Nori, Jacopo; Bianchi, Simonetta; Morandi, Andrea; Meattini, Icro (2022). Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer. RADIOTHERAPY AND ONCOLOGY, vol. 177, pp. 40-45, ISSN:0167-8140 DOI

Francolini G.; Campi R.; Di Cataldo V.; Detti B.; Loi M.; Triggiani L.; La Mattina S.; Borghetti P.; Magrini S.M.; Nicosia L.; Alongi F.; Ghirardelli P.; Vavassori V.; Allegra A.G.; Aquilano M.; Scoccimarro E.; Peruzzi A.; Pastina P.; Visani L.; Desideri I.; Serni S.; Meattini I.; Livi L. (2022). Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience. CLINICAL & TRANSLATIONAL ONCOLOGY, vol. 24, pp. 2039-2043, ISSN:1699-048X DOI

Desideri I.; Lucidi S.; Francolini G.; Meattini I.; Ciccone L.P.; Salvestrini V.; Valzano M.; Morelli I.; Angelini L.; Scotti V.; Bonomo P.; Greto D.; Terziani F.; Becherini C.; Visani L.; Livi L. (2022). Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833). MEDICAL ONCOLOGY, vol. 39, pp. 0-0, ISSN:1357-0560 DOI

Ciabattoni A.; Gregucci F.; De Rose F.; Falivene S.; Fozza A.; Daidone A.; Morra A.; Smaniotto D.; Barbara R.; Lozza L.; Vidali C.; Borghesi S.; Palumbo I.; Huscher A.; Perrucci E.; Baldissera A.; Tolento G.; Rovea P.; Franco P.; De Santis M.C.; Grazia A.D.; Marino L.; Meduri B.; Cucciarelli F.; Aristei C.; Bertoni F.; Guenzi M.; Leonardi M.C.; Livi L.; Nardone L.; De Felice F.; Rosetto M.E.; Mazzuoli L.; Anselmo P.; Arcidiacono F.; Barbarino R.; Martinetti M.; Pasinetti N.; Desideri I.; Marazzi F.; Ivaldi G.; Bonzano E.; Cavallari M.; Cerreta V.; Fusco V.; Sarno L.; Bonanni A.; Mangiacotti M.G.; Prisco A.; Buonfrate G.; Andrulli D.; Fontana A.; Bagnoli R.; Marinelli L.; Reverberi C.; Scalabrino G.; Corazzi F.; Doino D.; Di Genesio-Pagliuca M.; Lazzari M.; Mascioni F.; Pace M.P.; Mazza M.; Vitucci P.; Spera A.; Macchia G.; Boccardi M.; Evangelista G.; Sola B.; La Porta M.R.; Fiorentino A.; Levra N.G.; Ippolito E.; Silipigni S.; Osti M.F.; Mignogna M.; Alessandro M.; Ursini L.A.; Nuzzo M.; Meattini I.; D'Ermo G. (2022). AIRO Breast Cancer Group Best Clinical Practice 2022 Update. TUMORI, vol. 108, pp. 1-144, ISSN:2038-2529 DOI

Del Re M.; Crucitta S.; Omarini C.; Bargagna I.; Mongillo M.; Palleschi M.; Stucci S.; Meattini I.; D'Onofrio R.; Lorenzini G.; Biondani P.; De Giorgi U.; Porta C.; Livi L.; Natalizio S.; Fontana A.; Giontella E.; Angelini L.; Fogli S.; Danesi R. (2022). Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib. THE BREAST, vol. 66, pp. 157-161, ISSN:0960-9776 DOI

Meattini I.; Francolini G.; Di Cataldo V.; Visani L.; Becherini C.; Scoccimarro E.; Salvestrini V.; Bellini C.; Masi L.; Doro R.; Di Naro F.; Loi M.; Salvatore G.; Simontacchi G.; Greto D.; Bernini M.; Nori J.; Orzalesi L.; Bianchi S.; Mangoni M.; Livi L. (2022). Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894). CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, vol. 37, pp. 94-100, ISSN:2405-6308 DOI

Giulio Francolini, Mauro Loi, Lucia Pia Ciccone, Beatrice Detti, Vanessa Di Cataldo, Pamela Pinzani, Francesca Salvianti, Giulia Salvatore, Mariangela Sottili, Costanza Santini, Giulio Frosini, Luca Visani, Luca Burchini, Chiara Mattioli, Andrea Gaetano Allegra, Marianna Valzano, Cecilia Cerbai, Michele Aquilano, Viola Salvestrini, Isacco Desideri, Monica Mangoni, Icro Meattini, Lorenzo Livi (2022). Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275). MEDICAL ONCOLOGY, vol. 39, pp. 119-127, ISSN:1357-0560 DOI Accesso ONLINE all'editore

Meattini, Icro; Livi, Lorenzo; Lorito, Nicla; Becherini, Carlotta; Bacci, Marina; Visani, Luca; Fozza, Alessandra; Belgioia, Liliana; Loi, Mauro; Mangoni, Monica; Lambertini, Matteo; Morandi, Andrea (2022). Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside. CANCER TREATMENT REVIEWS, vol. 108, pp. 0-0, ISSN:0305-7372 DOI

Aristei C.; Bolukbasi Y.; Kaidar-Person O.; Pfeffer R.; Arenas M.; Boersma L.J.; Ciabattoni A.; Coles C.E.; Franco P.; Krengli M.; Leonardi M.C.; Marazzi F.; Masiello V.; Meattini I.; Montero A.; Offersen B.; Trigo M.L.; Bourgier C.; Genovesi D.; Kouloulias V.; Morganti A.G.; Meduri B.; Pasinetti N.; Pedretti S.; Perrucci E.; Rivera S.; Tombolini V.; Vidali C.; Valentini V.; Poortmans P. (2022). Ways to improve breast cancer patients' management and clinical outcome: The 2020 Assisi Think Tank Meeting. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 177, pp. 0-0, ISSN:1040-8428 DOI

Ciabattoni A.; Gregucci F.; D'Ermo G.; Dolfi A.; Cucciarelli F.; Palumbo I.; Borghesi S.; Gava A.; Cesaro G.M.; Baldissera A.; Giammarino D.; Daidone A.; Maurizi F.; Mignogna M.; Mazzuoli L.; Ravo V.; Falivene S.; Pedretti S.; Ippolito E.; Barbarino R.; di Cristino D.; Fiorentino A.; Aristei C.; Ramella S.; D'Angelillo R.M.; Meattini I.; Iotti C.; Donato V.; Formenti S.C. (2022). Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study. CANCERS, vol. 14, pp. 0-0, ISSN:2072-6694 DOI

Leonardi M.C.; Pepa M.; Luraschi R.; Vigorito S.; Dicuonzo S.; Isaksson L.J.; La Porta M.R.; Marino L.; Ippolito E.; Huscher A.; Argenone A.; De Rose F.; Cucciarelli F.; De Santis M.C.; Rossi F.; Prisco A.; Guarnaccia R.; Tabarelli de Fatis P.; Palumbo I.; Colangione S.P.; Mormile M.; Ravo V.; Fozza A.; Aristei C.; Orecchia R.; Cattani F.; Jereczek-Fossa B.A.; Leonardi C.; Gugliandolo S.G.; Morra A.; Gerardi M.A.; Zerella M.A.; Rosa La Porta M.; Cante D.; Petrucci E.; Borzi G.; Marrocco M.; Chieregato M.; Iadanza L.; Lobefalo F.; Valenti M.; Carmen De Santis M.; Cavallo A.; Russo S.; Guernieri M.; Malatesta T.; Meaglia I.; Liotta M.; Marcantonini M.; Pia Colangione S.; Mezzenga E.; Falivene S.; Arrichiello C.; Barbero M.P.; Ivaldi G.B.; Catalano G.; Vidali C.; Giannittb C.; Ciardo D.; Ciabattoni A.; Meattini I. (2022). The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study. RADIOTHERAPY AND ONCOLOGY, vol. 168, pp. 113-120, ISSN:0167-8140 DOI

Loi, M; Salvatore, G; Sottili, M; Calosi, L; Desideri, I; Becherini, C; Salvestrini, V; Ciccone, L P; Stocchi, G; Meattini, I; Francolini, G; Mangoni, M; Livi, L (2022). Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer. CLINICAL & TRANSLATIONAL ONCOLOGY, pp. 0-0, ISSN:1699-048X DOI

Desideri I.; Francolini G.; Ciccone L.P.; Stocchi G.; Salvestrini V.; Aquilano M.; Greto D.; Bonomo P.; Meattini I.; Scotti V.; Scoccianti S.; Simontacchi G.; Livi L. (2022). Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3). SUPPORTIVE CARE IN CANCER, vol. 30, pp. 1891-1892, ISSN:0941-4355 DOI

Meattini I.; Becherini C.; Boersma L.; Kaidar-Person O.; Marta G.N.; Montero A.; Offersen B.V.; Aznar M.C.; Belka C.; Brunt A.M.; Dicuonzo S.; Franco P.; Krause M.; MacKenzie M.; Marinko T.; Marrazzo L.; Ratosa I.; Scholten A.; Senkus E.; Stobart H.; Poortmans P.; Coles C.E. (2022). European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. THE LANCET ONCOLOGY, vol. 23, pp. 0-0, ISSN:1470-2045 DOI

Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.; Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R. (2022). Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients. ESMO OPEN, vol. 7, pp. 0-0, ISSN:2059-7029 DOI

Jereczek-Fossa B.A.; Pepa M.; Zaffaroni M.; Marvaso G.; Bruni A.; Buglione di Monale e Bastia M.; Catalano G.; Filippi A.R.; Franco P.; Gambacorta M.A.; Genovesi D.; Iati G.; Magli A.; Marafioti L.; Meattini I.; Merlotti A.; Mignogna M.; Musio D.; Pacelli R.; Pergolizzi S.; Tombolini V.; Trovo M.; Leonardi M.C.; Ricardi U.; Magrini S.M.; Corvo R.; Donato V. (2021). COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2. RADIOTHERAPY AND ONCOLOGY, vol. 155, pp. 120-122, ISSN:0167-8140 DOI

Salvestrini V.; Mariotti M.; Banini M.; Becherini C.; Visani L.; Scotti V.; Desideri I.; Livi L.; Meattini I. (2021). Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population. EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, vol. 6, pp. 157-160, ISSN:2380-8993 DOI

Marta G.N.; Meattini I. (2021). Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial. THE LANCET ONCOLOGY, vol. 22, pp. 0-0, ISSN:1470-2045 DOI

Meattini I.; Becherini C.; Bernini M.; Bonzano E.; Criscitiello C.; De Rose F.; De Santis M.C.; Fontana A.; Franco P.; Gentilini O.D.; Livi L.; Meduri B.; Parisi S.; Pasinetti N.; Prisco A.; Rocco N. (2021). Breast reconstruction and radiation therapy: An Italian expert Delphi consensus statements and critical review. CANCER TREATMENT REVIEWS, vol. 99, pp. 0-0, ISSN:0305-7372 DOI

Bernini M.; Meattini I.; Saieva C.; Becherini C.; Salvestrini V.; Visani L.; Stocchi G.; Bellini C.; Lorenzetti V.; Sordi S.; Nori J.; De Benedetto D.; Desideri I.; Bianchi S.; Livi L.; Orzalesi L. (2021). Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy. BREAST CANCER, pp. 1-12, ISSN:1340-6868 DOI

Livi L.; Barletta G.; Martella F.; Saieva C.; Desideri I.; Bacci C.; Del Bene M.R.; Airoldi M.; Amoroso D.; Coltelli L.; Scotti V.; Becherini C.; Visani L.; Salvestrini V.; Mariotti M.; Pedani F.; Bernini M.; Sanchez L.; Orzalesi L.; Nori J.; Bianchi S.; Olivotto I.; Meattini I. (2021). Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial. JAMA ONCOLOGY, vol. 7, pp. 1544-1549, ISSN:2374-2437 DOI

Marta G.N.; Ramiah D.; Kaidar-Person O.; Kirby A.; Coles C.; Jagsi R.; Hijal T.; Sancho G.; Zissiadis Y.; Pignol J.-P.; Ho A.Y.; Cheng S.H.-C.; Offersen B.V.; Meattini I.; Poortmans P. (2021). The Financial Impact on Reimbursement of Moderately Hypofractionated Postoperative Radiation Therapy for Breast Cancer: An International Consortium Report. CLINICAL ONCOLOGY, vol. 33, pp. 322-330, ISSN:0936-6555 DOI

Dubsky P.; Pinker K.; Cardoso F.; Montagna G.; Ritter M.; Denkert C.; Rubio I.T.; de Azambuja E.; Curigliano G.; Gentilini O.; Gnant M.; Gunthert A.; Hauser N.; Heil J.; Knauer M.; Knotek-Roggenbauerc M.; Knox S.; Kovacs T.; Kuerer H.M.; Loibl S.; Mannhart M.; Meattini I.; Penault-Llorca F.; Radosevic-Robin N.; Sager P.; Spanic T.; Steyerova P.; Tausch C.; Peeters M.-J.T.F.D.V.; Weber W.P.; Cardoso M.J.; Poortmans P. (2021). Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox. THE LANCET ONCOLOGY, vol. 22, pp. 18-28, ISSN:1470-2045 DOI

Marino L.; Lancellotta V.; Franco P.; Meattini I.; Meduri B.; Bernini M.; Fabi A.; Corvo R.; Magrini S.M.; Pappagallo G.L.; Arcangeli S.; D'Angelillo R.M. (2021). Loco-regional adjuvant radiation therapy in breast cancer patients with positive axillary lymph-nodes at diagnosis (CN2) undergoing preoperative chemotherapy and with complete pathological lymph-nodes response. Development of GRADE (Grades of recommendation, assessment, Development and Evaluation) recommendation by the Italian Association of radiation therapy and Clinical Oncology (AIRO). THE BREAST, vol. 55, pp. 119-127, ISSN:0960-9776 DOI

Francolini G.; Desideri I.; Stocchi G.; Ciccone L.P.; Salvestrini V.; Garlatti P.; Aquilano M.; Greto D.; Bonomo P.; Meattini I.; Scotti V.; Scoccianti S.; Simontacchi G.; Livi L. (2021). Impact of COVID-19 on workload burden of a complex radiotherapy facility. LA RADIOLOGIA MEDICA, vol. 126, pp. 717-721, ISSN:0033-8362 DOI

De Rose F.; De Santis M.C.; Meduri B.; Franzese C.; Franceschini D.; Franco P.; Pasinetti N.; Lancellotta V.; Giacobazzi P.; La Rocca E.; D'Angelo E.; Lozza L.; Livi L.; Meattini I.; Scorsetti M. (2021). Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study). JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol. 147, pp. 2069-2077, ISSN:0171-5216 DOI

Francolini G.; Loi M.; Detti B.; Desideri I.; Mangoni M.; Simontacchi G.; Meattini I.; Livi L. (2021). Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literature. CLINICAL & EXPERIMENTAL METASTASIS, vol. 38, pp. 227-230, ISSN:0262-0898 DOI

Senkus E.; Cardoso M.J.; Kaidar-Person O.; Lacko A.; Meattini I.; Poortmans P. (2021). De-escalation of axillary irradiation for early breast cancer – Has the time come?. CANCER TREATMENT REVIEWS, vol. 101, pp. 0-0, ISSN:0305-7372 DOI

Pizzuti L.; Krasniqi E.; Sperduti I.; Barba M.; Gamucci T.; Mauri M.; Veltri E.M.; Meattini I.; Berardi R.; Di Lisa F.S.; Natoli C.; Pistelli M.; Iezzi L.; Risi E.; D'Ostilio N.; Tomao S.; Ficorella C.; Cannita K.; Riccardi F.; Cassano A.; Bria E.; Fabbri M.A.; Mazzotta M.; Barchiesi G.; Botticelli A.; D'Auria G.; Ceribelli A.; Michelotti A.; Russo A.; Salimbeni B.T.; Sarobba G.; Giotta F.; Paris I.; Saltarelli R.; Marinelli D.; Corsi D.; Capomolla E.M.; Sini V.; Moscetti L.; Mentuccia L.; Tonini G.; Raffaele M.; Marchetti L.; Minelli M.; Ruggeri E.M.; Scavina P.; Bacciu O.; Salesi N.; Livi L.; Tinari N.; Grassadonia A.; Fedele Scinto A.; Rossi R.; Valerio M.R.; Landucci E.; Stani S.; Fratini B.; Maugeri-Sacca M.; De Tursi M.; Maione A.; Santini D.; Orlandi A.; Lorusso V.; Cortesi E.; Sanguineti G.; Pinnaro P.; Cappuzzo F.; Landi L.; Botti C.; Tomao F.; Cappelli S.; Bon G.; Pelle F.; Cavicchi F.; Fiorio E.; Foglietta J.; Scagnoli S.; Marchetti P.; Ciliberto G.; Vici P. (2021). PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, vol. 13, pp. 1-18, ISSN:1758-8340 DOI

Dahn H.M.; Boersma L.J.; de Ruysscher D.; Meattini I.; Offersen B.V.; Pignol J.-P.; Aristei C.; Belkacemi Y.; Benjamin D.; Bese N.; Coles C.E.; Franco P.; Ho A.; Hol S.; Jagsi R.; Kirby A.M.; Marrazzo L.; Marta G.N.; Moran M.S.; Nichol A.M.; Nissen H.D.; Strnad V.; Zissiadis Y.E.; Poortmans P.; Kaidar-Person O. (2021). The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 163, pp. 0-0, ISSN:1040-8428 DOI

Krasniqi E.; Pizzuti L.; Valerio M.R.; Capomolla E.; Botti C.; Sanguineti G.; Marchetti P.; Anselmi E.; Tomao S.; Giordano A.; Ficorella C.; Cannita K.; Livi L.; Meattini I.; Mauri M.; Greco F.; Veltri E.M.; Michelotti A.; Moscetti L.; Giotta F.; Lorusso V.; Paris I.; Tomao F.; Santini D.; Tonini G.; Villa A.; Gebbia V.; Gamucci T.; Ciliberto G.; Sperduti I.; Mazzotta M.; Barba M.; Vici P. (2021). Second-line eribulin in triple negative metastatic breast cancer patients. Multicentre retrospective study: The tetris trial. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, vol. 18, pp. 2245-2250, ISSN:1449-1907 DOI

Kaidar-Person O.; Offersen B.V.; Boersma L.; Meattini I.; Dodwell D.; Wyld L.; Aznar M.; Major T.; Kuehn T.; Strnad V.; Palmu M.; Hol S.; Poortmans P. (2021). Tricks and tips for target volume definition and delineation in breast cancer: Lessons learned from ESTRO breast courses. RADIOTHERAPY AND ONCOLOGY, vol. 162, pp. 185-194, ISSN:0167-8140 DOI

Leonardi M.C.; Pepa M.; Gugliandolo S.G.; Luraschi R.; Vigorito S.; Rojas D.P.; la Porta M.R.; Cante D.; Petrucci E.; Marino L.; Borzi G.; Ippolito E.; Marrocco M.; Huscher A.; Chieregato M.; Argenone A.; Iadanza L.; de Rose F.; Lobefalo F.; Cucciarelli F.; Valenti M.; de Santis M.C.; Cavallo A.; Rossi F.; Russo S.; Prisco A.; Guernieri M.; Guarnaccia R.; Malatesta T.; Meaglia I.; Liotta M.; de Fatis P.T.; Palumbo I.; Marcantonini M.; Colangione S.P.; Mezzenga E.; Falivene S.; Mormile M.; Ravo V.; Arrichiello C.; Fozza A.; Barbero M.P.; Ivaldi G.B.; Catalano G.; Vidali C.; Aristei C.; Giannitto C.; Miglietta E.; Ciabattoni A.; Meattini I.; Orecchia R.; Cattani F.; Jereczek-Fossa B.A. (2021). Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional study. BRITISH JOURNAL OF RADIOLOGY, vol. 94, pp. 0-0, ISSN:0007-1285 DOI

Meattini I.; Poortmans P.M.; Aznar M.C.; Becherini C.; Bonzano E.; Cardinale D.; Lenihan D.J.; Marrazzo L.; Curigliano G.; Livi L. (2021). Association of Breast Cancer Irradiation with Cardiac Toxic Effects: A Narrative Review. JAMA ONCOLOGY, vol. 7, pp. 924-932, ISSN:2374-2437 DOI

Francolini G.; Loi M.; Salvestrini V.; Mangoni M.; Detti B.; Di Cataldo V.; Aquilano M.; Pinzani P.; Salvianti F.; Desideri I.; Mariotti M.; Garlatti P.; Stocchi G.; Ciccone L.P.; Lucidi S.; Salvatore G.; Sottili M.; Meattini I.; Livi L. (2021). Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275). CLINICAL & EXPERIMENTAL METASTASIS, pp. 0-0, ISSN:0262-0898 DOI

Pizzuti L.; Barba M.; Mazzotta M.; Krasniqi E.; Maugeri-Sacca M.; Gamucci T.; Berardi R.; Livi L.; Ficorella C.; Natoli C.; Cortesi E.; Generali D.; La Verde N.; Cassano A.; Bria E.; Moscetti L.; Michelotti A.; Adamo V.; Zamagni C.; Tonini G.; Sergi D.; Marinelli D.; Paoletti G.; Tomao S.; Botticelli A.; Marchetti P.; Tinari N.; Grassadonia A.; Valerio M.R.; Mirabelli R.; Fabbri M.A.; D'Ostilio N.; Veltri E.; Corsi D.; Garrone O.; Paris I.; Sarobba G.; Meattini I.; Pistelli M.; Giotta F.; Lorusso V.; Garufi C.; Russo A.; Cazzaniga M.; Del Medico P.; Roselli M.; Vaccaro A.; Perracchio L.; di Benedetto A.; Daralioti T.; Sperduti I.; De Maria R.; Di Leo A.; Sanguineti G.; Ciliberto G.; Vici P. (2021). The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial. SCIENTIFIC REPORTS, vol. 11, pp. 0-0, ISSN:2045-2322 DOI

Francolini, Giulio; Ciccone, Lucia Pia; Di Cataldo, Vanessa; Detti, Beatrice; Simontacchi, Gabriele; Loi, Mauro; Mangoni, Monica; Desideri, Isacco; Meattini, Icro; Livi, Lorenzo (2021). May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk?. JOURNAL OF CLINICAL ONCOLOGY, pp. 0-0, ISSN:0732-183X DOI

Bernini M.; Sordi S.; Bembi N.; Meattini I.; De Benedetto D.; Cucchiari J.N.; Livi L.; Orzalesi L. (2021). Selective Denervation of Pectoralis Major Muscle Improves Cosmetic Outcome and Quality of Life in Retro-Pectoral Implant Based Breast Reconstruction. CLINICAL BREAST CANCER, pp. 0-0, ISSN:1526-8209 DOI

Kaidar-Person, Orit; Dahn, Hanna M; Nichol, Alan M; Boersma, Liesbeth J; de Ruysscher, Dirk; Meattini, Icro; Pignol, Jean-Philippe; Aristei, Cynthia; Belkacemi, Yazid; Benjamin, Dori; Bese, Nuran; Coles, Charlotte E; Franco, Pierfrancesco; Ho, Alice Y; Hol, Sandra; Jagsi, Reshma; Kirby, Anna M; Marrazzo, Livia; Marta, Gustavo N; Moran, Meena S; Nissen, Henrik D; Strnad, Vratislav; Zissiadis, Yvonne E; Poortmans, Philip M; Offersen, Birgitte V (2021). A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer. RADIOTHERAPY AND ONCOLOGY, pp. 0-0, ISSN:0167-8140 DOI

Gentile P.; Bernini M.; Orzalesi L.; Sordi S.; Meattini I.; Lessi F.; Kothari A.; Calabrese C. (2021). Titanium-coated polypropylene mesh as innovative bioactive material in conservatives mastectomies and pre-pectoral breast reconstruction. BIOACTIVE MATERIALS, vol. 6, pp. 4640-4653, ISSN:2452-199X DOI

Del Re, M; Omarini, C; Diodati, L; Palleschi, M; Meattini, I; Crucitta, S; Lorenzini, G; Isca, C; Fontana, A; Livi, L; Piacentini, F; Fogli, S; De Giorgi, U; Danesi, R (2021). Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients. ESMO OPEN, vol. 6, pp. 0-0, ISSN:2059-7029 DOI

Desideri I.; Becherini C.; Visani L.; Stocchi G.; Scoccimarro E.; Mariotti M.; Salvestrini V.; Scoccianti S.; Greto D.; Bonomo P.; Pecchioli G.; Bordi L.; Della Puppa A.; Francolini G.; Meattini I.; Livi L. (2020). Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases. JOURNAL OF GERIATRIC ONCOLOGY, pp. 31650-31659, ISSN:1879-4068 DOI

Benstead, Kim; Lara, Pedro C; Eller, Yannick; Engell-Noerregaard, Lotte; Eriksen, Jesper G; Gaye, Papa Macoumba; Jaal, Jana; Juretic, Antonio; Kase, Marju; Kouloulias, Vassilis; Kozma, Elvisa; Lagerlund, Magnus; Lumsden, Graeme; Meattini, Icro; Mjaaland, Ingvil; Pfeffer, Raphael (2020). Clinical oncology module for the ESTRO core curriculum. RADIOTHERAPY AND ONCOLOGY, vol. 156, pp. 19-22, ISSN:0167-8140 DOI

Desideri I.; Francolini G.; Ciccone L.P.; Stocchi G.; Salvestrini V.; Aquilano M.; Greto D.; Bonomo P.; Meattini I.; Scotti V.; Scoccianti S.; Simontacchi G.; Livi L. (2020). Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility. SUPPORTIVE CARE IN CANCER, pp. 1-7, ISSN:0941-4355 DOI

Meattini I.; Poortmans P.M.P.; Marrazzo L.; Desideri I.; Brain E.; Hamaker M.; Lambertini M.; Miccinesi G.; Russell N.; Saieva C.; Strnad V.; Visani L.; Kaidar-Person O.; Livi L. (2020). Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures. JOURNAL OF GERIATRIC ONCOLOGY, pp. 0-0, ISSN:1879-4068 DOI

Loi M.; Caini S.; Scoccianti S.; Bonomo P.; De Vries K.; Francolini G.; Simontacchi G.; Greto D.; Desideri I.; Meattini I.; Nuyttens J.; Livi L. (2020). Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 153, pp. 0-0, ISSN:1040-8428 DOI

De Santis M.C.; La Rocca E.; Vitullo A.; Meattini I.; Livi L. (2020). Comment on “Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant Breast Cancer: Feasibility, Safety, and Toxicity”. CLINICAL BREAST CANCER, vol. 20, pp. 0-0, ISSN:1526-8209 DOI

Ratosa I.; Orazem M.; Scoccimarro E.; Steinacher M.; Dominici L.; Aquilano M.; Cerbai C.; Desideri I.; Ribnikar D.; Marinko T.; Livi L.; Meattini I. (2020). Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer. CLINICAL BREAST CANCER, pp. 0-0, ISSN:1526-8209 DOI

Kaidar-Person O.; Meattini I.; Zippel D.; Poortmans P. (2020). Apples and oranges: comparing partial breast irradiation techniques. REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, vol. 25, pp. 780-782, ISSN:1507-1367 DOI

Lambertini, Matteo; Toss, Angela; Passaro, Antonio; Criscitiello, Carmen; Cremolini, Chiara; Cardone, Claudia; Loupakis, Fotios; Viscardi, Giuseppe; Meattini, Icro; Dieci, Maria Vittoria; Ferrara, Roberto; Giusti, Raffaele; Maio, Massimo Di (2020). Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective. ESMO OPEN, vol. 5, pp. 0-0, ISSN:2059-7029 DOI

Arenas, Meritxell; Selek, Ugur; Kaidar-Person, Orit; Perrucci, Elisabetta; Montero Luis, Angel; Boersma, Liesbeth; Coles, Charlotte; Offersen, Birgitte; Meattini, Icro; Bölükbaşı, Yasemin; Leonardi, Maria Cristina; Pfeffer, Raphael; Cutuli, Bruno; Vidali, Cristiana; Franco, Pierfrancesco; Kouloulias, Vassilis; Masiello, Valeria; Rivera, Sofia; Bourgier, Céline; Ciabattoni, Antonella; Lancellotta, Valentina; Trigo, Lurdes; Valentini, Vincenzo; Poortmans, Philip; Aristei, Cynthia (2020). The 2018 assisi think tank meeting on breast cancer: International expert panel white paper. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 151, pp. 0-0, ISSN:1040-8428 DOI

Jereczek-Fossa, Barbara Alicja; Pepa, Matteo; Marvaso, Giulia; Bruni, Alessio; Buglione di Monale E Bastia, Michela; Catalano, Gianpiero; Filippi, Andrea Riccardo; Franco, Pierfrancesco; Gambacorta, Maria Antonietta; Genovesi, Domenico; Iatì, Giuseppe; Magli, Alessandro; Marafioti, Luigi; Meattini, Icro; Merlotti, Anna; Mignogna, Marcello; Musio, Daniela; Pacelli, Roberto; Pergolizzi, Stefano; Tombolini, Vincenzo; Trovò, Marco; Ricardi, Umberto; Magrini, Stefano Maria; Corvò, Renzo; Donato, Vittorio (2020). COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO). RADIOTHERAPY AND ONCOLOGY, vol. 149, pp. 89-93, ISSN:0167-8140 DOI

Loi, Mauro; Desideri, Isacco; Dominici, Luca; Francolini, Giulio; Garlatti, Pietro; Ciccone, Lucia Pia; Stocchi, Giulia; Salvestrini, Viola; Meattini, Icro; Livi, Lorenzo (2020). Thermal Ablation versus SBRT in liver tumours: pros and cons. MEDICAL ONCOLOGY, vol. 37, pp. 0-0, ISSN:1357-0560 DOI

Meattini, Icro; Franco, Pierfrancesco; Belgioia, Liliana; Boldrini, Luca; Botticella, Angela; De Santis, Maria Carmen; Marvaso, Giulia; Montesi, Giampaolo; Parisi, Silvana; Triggiani, Luca; Lambertini, Matteo; Livi, Lorenzo (2020). Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists. ESMO OPEN, vol. 5, pp. 0-0, ISSN:2059-7029 DOI

Coles, C E; Aristei, C; Bliss, J; Boersma, L; Brunt, A M; Chatterjee, S; Hanna, G; Jagsi, R; Kaidar Person, O; Kirby, A; Mjaaland, I; Meattini, I; Luis, A M; Marta, G N; Offersen, B; Poortmans, P; Rivera, S (2020). International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic. CLINICAL ONCOLOGY, vol. 32, pp. 279-281, ISSN:0936-6555 DOI

Meattini, I; Andratschke, N; Kirby, A M; Sviri, G; Offersen, B V; Poortmans, P; Kaidar Person, O (2020). Challenges in the treatment of breast cancer brain metastases: evidence, unresolved questions, and a practical algorithm. CLINICAL & TRANSLATIONAL ONCOLOGY, pp. 0-0, ISSN:1699-048X DOI

Franco, Pierfrancesco; De Rose, Fiorenza; De Santis, Maria Carmen; Pasinetti, Nadia; Lancellotta, Valentina; Meduri, Bruno; Meattini, Icro (2020). Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, vol. 21, pp. 112-119, ISSN:2405-6308 DOI

Krasniqi, Eriseld; Pizzuti, Laura; Barchiesi, Giacomo; Sergi, Domenico; Carpano, Silvia; Botti, Claudio; Kayal, Ramy; Sanguineti, Giuseppe; Marchetti, Paolo; Botticelli, Andrea; Marinelli, Daniele; Gamucci, Teresa; Natoli, Clara; Grassadonia, Antonino; Tinari, Nicola; Tomao, Silverio; Tonini, Giuseppe; Santini, Daniele; Michelotti, Aandrea; Mentuccia, Lucia; Vaccaro, Aangela; Magnolfi, Emanuela; Gelibter, Alain; Magri, Valentina; Cortesi, Enrico; D'Onofrio, Loretta; Cassano, Alessandra; Cazzaniga, Marina; Moscetti, Luca; Fabbri, Agnese; Scinto, Angelo Fedele; Corsi, Domenico; Carbognin, Luisa; Bria, Emilio; La Verde, Nicla; Garufi, Carlo; Di Stefano, Pia; Mirabelli, Rossana; Veltri, Enzo; Paris, Ida; Giotta, Francesco; Lorusso, Vito; Landucci, Elisa; Ficorella, Corrado; Roselli, Mario; Adamo, Vincenzo; Ricciardi, Giuseppina; Russo, Antonio; Valerio, Maria Rosaria; Berardi, Rossana; Pistelli, Mirco; Cannita, Katia; Zamagni, Claudio; Garrone, Ornella; Baldini, Editta; Livi, Lorenzo; Meattini, Icro; Del Medico, Pietro; Generali, Daniele; De Maria, Ruggero; Risi, Emanuela; Ciliberto, Gennaro; Villa, Alice; Sperduti, Isabella; Mazzotta, Marco; Barba, Maddalena; Giordano, Antonio; Vici, Patrizia (2020). Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence. JOURNAL OF CELLULAR PHYSIOLOGY, pp. 0-0, ISSN:0021-9541 DOI

Poortmans, Philip M P; Takanen, Silvia; Marta, Gustavo Nader; Meattini, Icro; Kaidar-Person, Orit (2020). Winter is over: The use of Artificial Intelligence to individualise radiation therapy for breast cancer. THE BREAST, vol. 49, pp. 194-200, ISSN:0960-9776 DOI

Guckenberger, Matthias; Lievens, Yolande; Bouma, Angelique B; Collette, Laurence; Dekker, Andre; deSouza, Nandita M; Dingemans, Anne-Marie C; Fournier, Beatrice; Hurkmans, Coen; Lecouvet, Frédéric E; Meattini, Icro; Romero, Alejandra Méndez; Ricardi, Umberto; Russell, Nicola S; Schanne, Daniel H; Scorsetti, Marta; Tombal, Bertrand; Verellen, Dirk; Verfaillie, Christine; Ost, Piet (2020). Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. THE LANCET ONCOLOGY, vol. 21, pp. 0-0, ISSN:1470-2045 DOI

Meattini, Icro; Poortmans, Philip; Kirova, Youlia; Saieva, Calogero; Visani, Luca; Salvestrini, Viola; Kim, Jiyoung; Jung, Wonguen; Olmetto, Emanuela; Mariotti, Matteo; Desideri, Isacco; Fourquet, Alain; Livi, Lorenzo; Kim, Kyubo (2020). Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study. ACTA ONCOLOGICA, vol. 59, pp. 188-195, ISSN:0284-186X DOI

Sardaro A.; McDonald F.; Bardoscia L.; Lavrenkov K.; Singh S.; Ashley S.; Traish D.; Ferrari C.; Meattini I.; Asabella A.N.; Brada M. (2020). Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study. FRONTIERS IN ONCOLOGY, vol. 10, pp. 0-0, ISSN:2234-943X DOI

Kaidar-Person O.; Poortmans P.; Offersen B.V.; Siesling S.; Sklair-Levy M.; Meattini I.; de Ruysscher D.; Kuhn T.; Boersma L.J. (2020). Spatial location of local recurrences after mastectomy: a systematic review. BREAST CANCER RESEARCH AND TREATMENT, vol. 183, pp. 263-273, ISSN:0167-6806 DOI

Nuzzo, Marianna; Ursini, Lucia Anna; Patani, Fabiola; Rosa, Consuelo; Trignani, Marianna; DI Tommaso, Monica; Meattini, Icro; Gregucci, Fabiana; Ciabattoni, Antonella; Genovesi, Domenico; Caravatta, Luciana (2020). Using the Bolus in Post-mastectomy Radiation Therapy (PMRT): A National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Breast Cancer Group. ANTICANCER RESEARCH, vol. 40, pp. 6505-6511, ISSN:0250-7005 DOI

Gregucci F.; Fozza A.; Falivene S.; Smaniotto D.; Morra A.; Daidone A.; Barbara R.; Ciabattoni A.; Andrulli D.; Arcidiacono F.; Baiocchi C.; Baldissera A.; Barbarino R.; Bartoncini S.; Bono M.; Buffoli A.; Campanella B.; Campoccia S.; Catalano G.; Cavallari M.; Cerreta V.; Ciabattoni A.; Daidone A.; Deantonio L.; De Rose F.; Del Bufalo S.; Digennaro D.; Doino D.; Evangelista G.; Falivene S.; Fedele F.; Fiorentino A.; Fodor A.; Fontana A.; Fozza A.; Fusco V.; Gatti M.; Gerardi M.; Giannini M.; Girlando A.; Guenzi M.; Guida C.; Huscher A.; Iannone T.; Iorio V.; Ippolito E.; Ivaldi G.; La Porta M.; Lazzari G.; Lioce M.; Lora O.; Macchia G.; Mangiacotti M.G.; Marafioti L.; Marino L.; Marmiroli L.; Maucieri A.; Maurizi F.; Mazzuoli L.; Meattini I.; Meduri B.; Montesi G.; Morra A.; Munoz F.; Nuzzo M.; Orru S.; Parisi S.; Pasinetti N.; Pedretti S.; Perrucci E.; Piva D.; Prisco A.; Ravo V.; Santacaterina A.; Scolaro T.; Serafini F.; Spigone B.; Tolento G.; Vidali C.; Vitucci P.; Zini G. (2020). Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group. LA RADIOLOGIA MEDICA, vol. 125, pp. 674-682, ISSN:0033-8362 DOI

Marta G.N.; Coles C.; Kaidar-Person O.; Meattini I.; Hijal T.; Zissiadis Y.; Pignol J.-P.; Ramiah D.; Ho A.Y.; Cheng S.H.-C.; Sancho G.; Offersen B.V.; Poortmans P. (2020). The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 156, pp. 0-0, ISSN:1040-8428 DOI

Meattini, Icro; Marrazzo, Livia; Saieva, Calogero; Desideri, Isacco; Scotti, Vieri; Simontacchi, Gabriele; Bonomo, Pierluigi; Greto, Daniela; Mangoni, Monica; Scoccianti, Silvia; Lucidi, Sara; Paoletti, Lisa; Fambrini, Massimiliano; Bernini, Marco; Sanchez, Luis; Orzalesi, Lorenzo; Nori, Jacopo; Bianchi, Simonetta; Pallotta, Stefania; Livi, Lorenzo (2020). Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial. JOURNAL OF CLINICAL ONCOLOGY, pp. 0-0, ISSN:0732-183X DOI

Corradini S.; Krug D.; Meattini I.; Fastner G.; Matuschek C.; Cutuli B. (2019). Challenges in Radiotherapy. BREAST CARE, vol. 14, pp. 152-158, ISSN:1661-3791 DOI Accesso ONLINE all'editore

Barni S.; Livraghi L.; Gravina A.; Martella F.; D'Onofrio L.; Morritti M.; Michelotti A.; Vici P.; Mentuccia L.; Porcu L.; Orditura M.; Puglisi F.; Poletti P.; Caremoli E.R.; Ghilardi L.; Maiello E.; Pizzuti L.; Angelis C.D.; Landucci E.; Cinieri S.; Orlando L.; Fedele P.; Ciccarese M.; Forcignano R.; Leo S.; Musolino A.; Boggiani D.; Zamagni C.; Rubino D.; Garrone O.; Vandone A.M.; Fioretto L.; Fontanella C.; Berardi R.; Pistelli M.; Mastro L.D.; D'Alonzo A.; Natoli C.; Grassadonia A.; Zoratto F.; Santini D.; Giotta F.; Latorre A.; Vita L.; Antonella U.; Airoldi M.; Pedani F.; Livi L.; Meattini I.; La Verde N.; Dazzani C.; Tuccia F.; Bucci E.; Molteni L.P.; Andreis D.; Cecconetto L.; Marra D.; D'Amico M.; Petrelli F.; Cretella E.; Ferrari A.; Fabi A.; Gori S.; Menatti E.; Gambi V.; Gambaro A.R.; Saracchini S.; Frascaroli M.; Donati S.; Cocciolone V.; Falco I.; Oliani C.; Riccardi F.; Mocerino C.; Febbraro A. (2019). Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study. JOURNAL OF GERIATRIC ONCOLOGY, vol. 10, pp. 990-993, ISSN:1879-4068 DOI

De Rose F.; Cozzi L.; Meattini I.; Fogliata A.; Franceschini D.; Franzese C.; Tomatis S.; Becherini C.; Livi L.; Scorsetti M. (2019). The Potential Role of Intensity-modulated Proton Therapy in the Regional Nodal Irradiation of Breast Cancer: A Treatment Planning Study. CLINICAL ONCOLOGY, pp. 0-0, ISSN:0936-6555 DOI Accesso ONLINE all'editore

Pizzuti L.; Krasniqi E.; Barchiesi G.; Della Giulia M.; Izzo F.; Sanguineti G.; Marchetti P.; Mazzotta M.; Giusti R.; Botticelli A.; Gamucci T.; Natoli C.; Grassadonia A.; Tinari N.; Iezzi L.; Tomao S.; Tomao F.; Tonini G.; Santini D.; Astone A.; Michelotti A.; De Angelis C.; Mentuccia L.; Vaccaro A.; Magnolfi E.; Gelibter A.; Magri V.; Cortesi E.; D'Onofrio L.; Cassano A.; Rossi E.; Cazzaniga M.; Moscetti L.; Omarini C.; Piacentini F.; Fabbri M.A.; Scinto A.F.; Corsi D.; Carbognin L.; Bria E.; La Verde N.; Samaritani R.; Garufi C.; Barni S.; Mirabelli R.; Sarmiento R.; Veltri E.M.; D'Auria G.; Paris I.; Giotta F.; Lorusso V.; Cardillo F.; Landucci E.; Mauri M.; Ficorella C.; Roselli M.; Adamo V.; Ricciardi G.R.R.; Russo A.; Berardi R.; Pistelli M.; Fiorio E.; Cannita K.; Sini V.; D'Ostilio N.; Foglietta J.; Greco F.; Zamagni C.; Garrone O.; Di Cocco B.; Baldini E.; Livi L.; Desideri I.; Meattini I.; Sarobba G.; Del Medico P.; De Tursi M.; Generali D.; De Maria R.; Risi E.; Ciliberto G.; Sperduti I.; Villa A.; Barba M.; Di Leo A.; Vici P. (2019). Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting. INTERNATIONAL JOURNAL OF CANCER, pp. 0-0, ISSN:0020-7136 DOI Accesso ONLINE all'editore

Montero-Luis A.; Aristei C.; Meattini I.; Arenas M.; Boersma L.; Bourgier C.; Coles C.; Cutuli B.; Falcinelli L.; Kaidar-Person O.; Leonardi M.C.; Offersen B.; Marazzi F.; Rivera S.; Tagliaferri L.; Tombolini V.; Vidali C.; Valentini V.; Poortmans P. (2019). The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 138, pp. 207-213, ISSN:1040-8428 DOI Accesso ONLINE all'editore

Desideri I.; Francolini G.; Scotti V.; Pezzulla D.; Becherini C.; Terziani F.; Delli Paoli C.; Olmetto E.; Visani L.; Meattini I.; Greto D.; Bonomo P.; Loi M.; Detti B.; Livi L. (2019). Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer. CLINICAL & TRANSLATIONAL ONCOLOGY, vol. 21, pp. 933-938, ISSN:1699-048X DOI Accesso ONLINE all'editore

Meattini I.; Lambertini M.; Desideri I.; De Caluwe A.; Kaidar-Person O.; Livi L. (2019). Radiation therapy for young women with early breast cancer: Current state of the art. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 137, pp. 143-153, ISSN:1040-8428 DOI Accesso ONLINE all'editore

Taffurelli M.; Pellegrini A.; Meattini I.; Orzalesi L.; Tinterri C.; Roncella M.; Terribile D.; Caruso F.; Tazzioli G.; Pollini G.; Friedman D.; Mariotti C.; Cianchetti E.; Cabula C.; Thomas R.; Cedolini C.; Rovera F.; Grassi M.; Lucani G.; Cappella A.; Bortul M.; Stacul G.; Scarabeo F.; Procaccini E.; Galimberti V. (2019). Secondary breast angiosarcoma: A multicentre retrospective survey by the national Italian association of Breast Surgeons (ANISC). THE BREAST, vol. 45, pp. 56-60, ISSN:0960-9776 DOI Accesso ONLINE all'editore

Belkacemi Y.; Majdoul S.; Tsoutsou P.P.; Abouegylah M.; Kaidar-Person O.; Meattini I.; Poortmans P.M.P.; Taghian A. (2019). Is Postoperative Breast Radiation Therapy Safe in Patients With Scleroderma?. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 104, pp. 10-11, ISSN:0360-3016 DOI Accesso ONLINE all'editore

Kaidar-Person O.; Vrou Offersen B.; Hol S.; Arenas M.; Aristei C.; Bourgier C.; Joao Cardoso M.; Chua B.; Coles C.E.; Engberg Damsgaard T.; Gabrys D.; Jagsi R.; Jimenez R.; Kirby A.M.; Kirkove C.; Kirova Y.; Kouloulias V.; Marinko T.; Meattini I.; Mjaaland I.; Nader Marta G.; Witt Nystrom P.; Senkus E.; Skytta T.; Tvedskov T.F.; Verhoeven K.; Poortmans P. (2019). ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer.. RADIOTHERAPY AND ONCOLOGY, vol. 137, pp. 159-166, ISSN:0167-8140 DOI Accesso ONLINE all'editore

Arcangeli S.; Jereczek-Fossa B.A.; Alongi F.; Aristei C.; Becherini C.; Belgioia L.; Buglione M.; Caravatta L.; D'Angelillo R.M.; Filippi A.R.; Fiore M.; Genovesi D.; Greco C.; Livi L.; Magrini S.M.; Marvaso G.; Mazzola R.; Meattini I.; Merlotti A.; Palumbo I.; Pergolizzi S.; Ramella S.; Ricardi U.; Russi E.; Trovo M.; Sindoni A.; Valentini V.; Corvo R. (2019). Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 134, pp. 104-119, ISSN:1040-8428 DOI Accesso ONLINE all'editore

Arcangeli S.; Jereczek-Fossa B.A.; Alongi F.; Aristei C.; Becherini C.; Belgioia L.; Buglione M.; Caravatta L.; D'Angelillo R.M.; Filippi A.R.; Fiore M.; Genovesi D.; Greco C.; Livi L.; Magrini S.M.; Marvaso G.; Mazzola R.; Meattini I.; Merlotti A.; Palumbo I.; Pergolizzi S.; Ramella S.; Ricardi U.; Russi E.; Trovo M.; Sindoni A.; Valentini V.; Corvo R. (2019). Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 134, pp. 87-103, ISSN:1040-8428 DOI Accesso ONLINE all'editore

Kaidar-Person O.; Meattini I.; Poortmans P.M.P. (2019). “Between Uncertainties and Overtreatment”. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 104, pp. 15-16, ISSN:0360-3016 DOI Accesso ONLINE all'editore

Mangoni, Monica; Sottili, Mariangela; Salvatore, Giulia; Campanacci, Domenico; Scoccianti, Guido; Beltrami, Giovanni; Paoli, Camilla Delli; Dominici, Luca; Maragna, Virginia; Olmetto, Emanuela; Meattini, Icro; Desideri, Isacco; Bonomo, Pierluigi; Greto, Daniela; Livi, Lorenzo (2019). Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors?. LA RADIOLOGIA MEDICA, vol. 124, pp. 282-289, ISSN:0033-8362 DOI

Meattini, I; De Santis, M C; De Rose, F; Desideri, I; Franco, P; Kaidar-Person, O; Meduri, B; Pasinetti, N; Lancellotta, V (2019). Local Treatment of the Axilla in Early Breast Cancer: So Many Questions, Still Few Answers. CLINICAL ONCOLOGY, pp. 0-0, ISSN:0936-6555 DOI

Desideri, Isacco*; Francolini, Giulio; Carta, Giulio Alberto; Di Cataldo, Vanessa; Masi, Laura; Meattini, Icro; Bonomo, Pierluigi; Loi, Mauro; Greto, Daniela; Visani, Luca; Lo Russo, Monica; Grassi, Roberta; Teriaca, Maria Ausilia; Garlatti, Pietro; Nardi, Cosimo; Livi, Lorenzo (2019). Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, vol. 18, pp. 1533033818818561-1533033818818566, ISSN:1533-0346 DOI Accesso ONLINE all'editore

Marrazzo, Livia*; Meattini, Icro; Arilli, Chiara; Calusi, Silvia; Casati, Marta; Talamonti, Cinzia; Livi, Lorenzo; Pallotta, Stefania (2019). Auto-planning for VMAT accelerated partial breast irradiation. RADIOTHERAPY AND ONCOLOGY, vol. 132, pp. 85-92, ISSN:0167-8140, ELSEVIER IRELAND LTD: DOI Accesso ONLINE all'editore

Becherini, Carlotta; Meattini, Icro; Livi, Lorenzo; Garlatti, Pietro; Desideri, Isacco; Scotti, Vieri; Orzalesi, Lorenzo; Sanchez, Luis Jose; Bernini, Marco; Casella, Donato; Nesi, Silvia; Nori, Jacopo; Bianchi, Simonetta; Pallotta, Stefania; Marrazzo, Livia (2019). External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial. TUMORI, vol. 105, pp. 205-209, ISSN:0300-8916 DOI

Tanini S, Fisher AD, Meattini I, Bianchi S, Ristori J, Maggi M, Lo Russo G (2019). Testosterone and Breast Cancer in Transmen: Case Reports, Review of the Literature, and Clinical Observation. CLINICAL BREAST CANCER, vol. 19 (2), pp. E271-E275, ISSN:1526-8209, CIG MEDIA GROUP, LP: DOI Accesso ONLINE all'editore

Livi, Lorenzo; Scotti, Vieri; Desideri, Isacco; Saieva, Calogero; Cecchini, Sara; Francolini, Giulio; Becherini, Carlotta; Delli Paoli, Camilla; Visani, Luca; Salvestrini, Viola; De Feo, Maria Laura; Nori, Jacopo; Bernini, Marco; Sanchez, Luis; Orzalesi, Lorenzo; Bianchi, Simonetta; Meattini, Icro (2019). Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial. EUROPEAN JOURNAL OF CANCER, vol. 108, pp. 100-110, ISSN:0959-8049, ELSEVIER SCI LTD: DOI Accesso ONLINE all'editore

Corradini S.; Krug D.; Meattini I.; Matuschek C.; Bolke E.; Francolini G.; Baumann R.; Figlia V.; Pazos M.; Tonetto F.; Trovo M.; Mazzola R.; Alongi F. (2019). Preoperative radiotherapy: A paradigm shift in the treatment of breast cancer? A review of literature. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 141, pp. 102-111, ISSN:1040-8428 DOI Accesso ONLINE all'editore

Lastraioli E, Iorio J, Meattini I, Bernini M, Dominici L, Maragna V, Vezzosi V, Casella D, Nori J, Orzalesi L, Bianchi S, Livi L , Arcangeli A (2018). hERG1 channel expression in breast cancer: association with molecular parameters, pathological features and survival. EUROPEAN JOURNAL OF CANCER, vol. 92, pp. 140-141, ISSN:0959-8049

Selvi V; Nori J; Meattini I; Francolini G; Morelli N; De Benedetto D; Bicchierai G; Di Naro F; Gill MK; Orzalesi L; Sanchez L; Susini T; Bianchi S; Livi L; Miele V (2018). Corrigendum to "Role of Magnetic Resonance Imaging in the Preoperative Staging and Work-Up of Patients Affected by Invasive Lobular Carcinoma or Invasive Ductolobular Carcinoma". BIOMED RESEARCH INTERNATIONAL, pp. 9056239-, ISSN:2314-6141 DOI

Selvi, Valeria; Nori, Jacopo; Meattini, Icro; Francolini, Giulio; Morelli, Noemi; Di Benedetto, Diego; Bicchierai, Giulia*; Di Naro, Federica; Gill, Maninderpal Kaur; Orzalesi, Lorenzo; Sanchez, Luis; Susini, Tommaso; Bianchi, Simonetta; Livi, Lorenzo; Miele, Vittorio (2018). Role of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinoma. BIOMED RESEARCH INTERNATIONAL, vol. 2018, pp. 0-0, ISSN:2314-6133 DOI Accesso ONLINE all'editore

Francolini, Giulio; Desideri, Isacco*; Meattini, Icro; Becherini, Carlotta; Terziani, Francesca; Olmetto, Emanuela; Delli Paoli, Camilla; Pezzulla, Donato; Loi, Mauro; Bonomo, Pierluigi; Greto, Daniela; Calusi, Silvia; Casati, Marta; Pallotta, Stefania; Livi, Lorenzo (2018). Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014). STRAHLENTHERAPIE UND ONKOLOGIE, pp. 0-0, ISSN:0179-7158 DOI Accesso ONLINE all'editore

Loi, Mauro*; Desideri, Isacco; Olmetto, Emanuela; Francolini, Giulio; Greto, Daniela; Bonomo, Pierluigi; Simontacchi, Gabriele; Di Brina, Lucia; Meattini, Icro; Livi, Lorenzo (2018). BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management. THE BREAST JOURNAL, pp. 1-5, ISSN:1075-122X DOI Accesso ONLINE all'editore

Nori, Jacopo; Gill, Maninderpal Kaur; Meattini, Icro; Delli Paoli, Camilla; Abdulcadir, Dalmar; Vanzi, Ermanno; Boeri, Cecilia; Gabbrielli, Silvia; Giannotti, Elisabetta; Lucci, Francesco; Vezzosi, Vania; De Benedetto, Diego; Bicchierai, Giulia*; Bianchi, Simonetta; Sanchez, Luis; Orzalesi, Lorenzo; Carmelo, Guido; Miele, Vittorio; Livi, Lorenzo; Casella, Donato (2018). The Evolving Role of Ultrasound Guided Percutaneous Laser Ablation in Elderly Unresectable Breast Cancer Patients: A Feasibility Pilot Study. BIOMED RESEARCH INTERNATIONAL, vol. 2018, pp. 0-0, ISSN:2314-6133 DOI Accesso ONLINE all'editore

Meattini, Icro*; Poortmans, Philip; Livi, Lorenzo; Kaidar Person, Orit; Pallotta, Stefania; Becherini, Carlotta; Marrazzo, Livia (2018). Partial breast irradiation for ductal carcinoma in situ: The Goldilocks principle?. THE BREAST JOURNAL, pp. 0-0, ISSN:1075-122X DOI Accesso ONLINE all'editore

Meattini, Icro; Pasinetti, Nadia; Meduri, Bruno; De Rose, Fiorenza; De Santis, Maria Carmen; Franco, Pierfrancesco; Lancellotta, Valentina; Rossi, Francesca; Saieva, Calogero; Desideri, Isacco; Delli Paoli, Camilla; D'Angelo, Elisa; Triggiani, Luca; Bastiani, Paolo; Alongi, Filippo; Lozza, Laura; Aristei, Cynthia; Ricardi, Umberto; Scorsetti, Marta; Livi, Lorenzo (2018). A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study). RADIOTHERAPY AND ONCOLOGY, pp. 1-7, ISSN:0167-8140 DOI Accesso ONLINE all'editore

Meattini, Icro; Pezzulla, Donato; Saieva, Calogero; Bernini, Marco; Orzalesi, Lorenzo; Sanchez, Luis Jose; Desideri, Isacco; Francolini, Giulio; Bonomo, Pierluigi; Greto, Daniela; Loi, Mauro; Mangoni, Monica; Bruni, Alessio; Nori, Jacopo; Vezzosi, Vania; Bianchi, Simonetta; Livi, Lorenzo (2018). Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study. CLINICAL BREAST CANCER, vol. 18, pp. 773-780, ISSN:1526-8209 DOI

Meattini, Icro; Desideri, Isacco; Scotti, Vieri; Simontacchi, Gabriele; Livi, Lorenzo (2018). Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer. THE BREAST, vol. 42, pp. 1-2-2, ISSN:0960-9776 DOI

Greto, Daniela; Loi, Mauro; Saieva, Calogero; Muntoni, Cristina; Delli Paoli, Camilla; Becherini, Carlotta; Ciabatti, Cinzia; Perna, Marco; Campanacci, Domenico; Terziani, Francesca; Beltrami, Giovanni; Scoccianti, Guido; Bonomo, Pierluigi; Meattini, Icro; Desideri, Isacco; Simontacchi, Gabriele; Mangoni, Monica; Livi, Lorenzo (2018). Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma. TUMORI, pp. 1-8, ISSN:0300-8916 DOI Accesso ONLINE all'editore

Loi, Mauro; Incrocci, Luca; Desideri, Isacco; Bonomo, Pierluigi; Detti, Beatrice; Simontacchi, Gabriele; Greto, Daniela; Olmetto, Emanuela; Francolini, Giulio; Meattini, Icro; Livi, Lorenzo (2018). Prognostic impact of nodal relapse in definitive prostate-only irradiation. LA RADIOLOGIA MEDICA, vol. 123, pp. 631-637, ISSN:0033-8362 DOI Accesso ONLINE all'editore

Jessica Iorio, Icro Meattini, Simonetta Bianchi, Marco Bernini, Virginia Maragna, Luca Dominici,Donato Casella, Vania Vezzosi, Lorenzo Orzalesi, Jacopo Nori, Lorenzo Livi, Annarosa Arcangeli, Elena Lastraioli (2018). hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer.. CANCER CELL INTERNATIONAL, vol. 18, pp. 93-100, ISSN:1475-2867 DOI

Greto D.; Loi M.; Saieva C.; Muntoni C.; Paoli C.D.; Becherini C.; Ciabatti C.; Perna M.; Campanacci D.; Terziani F.; Beltrami G.; Scoccianti G.; Bonomo P.; Meattini I.; Desideri I.; Simontacchi G.; Mangoni M.; Livi L. (2018). Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma. TUMORI, vol. 104, pp. 322-329, ISSN:0300-8916 DOI

Kaidar-Person, Orit; Meattini, Icro; Poortmans, Philip (2018). Radiation therapy after breast conserving surgery increases long-term breast conservation for DCIS patients. THE BREAST, vol. 37, pp. 179-180, ISSN:0960-9776 DOI

Kaidar-Person, O.; Meattini, I.; Jain, P.; Bult, P.; Simone, N.; Kindts, I.; Steffens, R.; Weltens, C.; Navarria, P.; Belkacemi, Y.; Lopez-Guerra, J.; Livi, L.; Baumert, B. G.; Vieites, B.; Limon, D.; Kurman, N.; Ko, K.; Yu, J. B.; Chiang, V.; Poortmans, P.; Zagar, T. (2018). Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study. BREAST CANCER RESEARCH AND TREATMENT, vol. 167, pp. 479-483, ISSN:0167-6806 DOI Accesso ONLINE all'editore

Meattini, Icro; Livi, Lorenzo; Pallotta, Stefania; Marrazzo, Livia (2018). Partial breast irradiation: The time is there!. THE BREAST, vol. 38, pp. 98-100, ISSN:0960-9776 DOI Accesso ONLINE all'editore

Mangoni, Monica; Sottili, Mariangela; Salvatore, Giulia; Meattini, Icro; Desideri, Isacco; Greto, Daniela; Loi, Mauro; Becherini, Carlotta; Garlatti, Pietro; Paoli, Camilla Delli; Dominici, Luca; Gerini, Chiara; Scoccianti, Silvia; Bonomo, Pierluigi; Silvano, Angela; Beltrami, Giovanni; Campanacci, Domenico; Livi, Lorenzo (2018). Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors. RADIATION RESEARCH, vol. 190, pp. 464-472, ISSN:0033-7587 DOI Accesso ONLINE all'editore

Mangoni, Monica; Sottili, Mariangela; Gerini, Chiara; Desideri, Isacco; Bastida, Cinzia; Pallotta, Stefania; Castiglione, Francesca; Bonomo, Pierluigi; Meattini, Icro; Greto, Daniela; Olmetto, Emanuela; Terziani, Francesca; Becherini, Carlotta; Delli Paoli, Camilla; Trombetta, Laura; Loi, Mauro; Biti, Giampaolo; Livi, Lorenzo (2017). A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model. ORAL ONCOLOGY, vol. 64, pp. 52-58, ISSN:1368-8375 DOI Accesso ONLINE all'editore

Desideri, Isacco; Francolini, Giulio; Becherini, Carlotta; Terziani, Francesca; Delli Paoli, Camilla; Olmetto, Emanuela; Loi, Mauro; Perna, Marco; Meattini, Icro; Scotti, Vieri; Greto, Daniela; Bonomo, Pierluigi; Sulprizio, Susanna; Livi, Lorenzo (2017). Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study. MEDICAL ONCOLOGY, vol. 34, pp. 0-0, ISSN:1357-0560 DOI Accesso ONLINE all'editore

Loi, Mauro; Desideri, Isacco; Greto, Daniela; Mangoni, Monica; Sottili, Mariangela; Meattini, Icro; Becherini, Carlotta; Terziani, Francesca; Paoli, Camilla Delli; Olmetto, Emanuela; Bonomo, Pierluigi; Livi, Lorenzo (2017). Radiotherapy in the age of cancer immunology: Current concepts and future developments. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 112, pp. 1-10, ISSN:1040-8428 DOI

Bonomo, Pierluigi; Loi, Mauro; Desideri, Isacco; Olmetto, Emanuela; Delli Paoli, Camilla; Terziani, Francesca; Greto, Daniela; Mangoni, Monica; Scoccianti, Silvia; Simontacchi, Gabriele; Francolini, Giulio; Meattini, Icro; Caini, Saverio; Livi, Lorenzo (2017). Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 120, pp. 98-110, ISSN:1040-8428 DOI Accesso ONLINE all'editore

Bicchierai, G; Nori, J; Livi, L; De Benedetto, D; Vanzi, E; Boeri, C; Bianchi, S; Becherini, C; Meattini, I (2017). Core needle biopsy for the assessment of unilateral male breast lesions. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, pp. 680-682, ISSN:0748-7983 DOI

Meattini, Icro; Desideri, Isacco; Francolini, Giulio; Vannini, Agnese; Perna, Marco; Garlatti, Pietro; Grassi, Roberta; Livi, Lorenzo (2017). Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature. MEDICAL ONCOLOGY, vol. 34, pp. 0-0, ISSN:1357-0560 DOI

Meattini, Icro; Curigliano, Giuseppe; Terziani, Francesca; Becherini, Carlotta; Airoldi, Mario; Allegrini, Giacomo; Amoroso, Domenico; Barni, Sandro; Bengala, Carmelo; Guarneri, Valentina; Marchetti, Paolo; Martella, Francesca; Piovano, Pierluigi; Vannini, Agnese; Desideri, Isacco; Tarquini, Roberto; Galanti, Giorgio; Barletta, Giuseppe; Livi, Lorenzo (2017). SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab. MEDICAL ONCOLOGY, vol. 34, pp. 0-0, ISSN:1357-0560 DOI

Ruggirello, Irene; Nori, Jacopo; Desideri, Isacco; Saieva, Calogero; Giannotti, Elisabetta; Bicchierai, Giulia; De Benedetto, Diego; Francolini, Giulio; Bianchi, Simonetta; Vezzosi, Vania; Sanchez, Luis; Susini, Tommaso; Orzalesi, Lorenzo; Meattini, Icro; Livi, Lorenzo; Miele, Vittorio (2017). Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, vol. 43, pp. 2257-2260, ISSN:0748-7983 DOI Accesso ONLINE all'editore

Kaidar-Person, Orit; Meattini, Icro; Deal, Allison M.; Francolini, Giulio; Carta, Giulio; Terzo, Lauren; Camporeale, Jayne; Muss, Hyman; Marks, Lawrence B.; Livi, Lorenzo; Mayer, Deborah K.; Zagar, Timothy M. (2017). The use of psychological supportive care services and psychotropic drugs in patients with early-stage breast cancer: a comparison between two institutions on two continents. MEDICAL ONCOLOGY, vol. 34, pp. 0-0, ISSN:1357-0560 DOI Accesso ONLINE all'editore

Meattini, Icro; Saieva, Calogero; Bastiani, Paolo; Martella, Francesca; Francolini, Giulio; lo Russo, Monica; Paoletti, Lisa; Doria, Morena; Desideri, Isacco; Terziani, Francesca; De Luca Cardillo, Carla; Bendinelli, Benedetta; Ciabatti, Cinzia; Muntoni, Cristina; Tinacci, Galliano; Nori, Jacopo; Smith, Herd; Brancato, Beniamino; Galli, Lorenzo; Sanchez, Luis Jose; Casella, Donato; Bernini, Marco; Orzalesi, Lorenzo; Carta, Giulio Alberto; Bianchi, Simonetta; Rossi, Francesca; Livi, Lorenzo (2017). Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series. THE BREAST, vol. 33, pp. 139-144, ISSN:0960-9776 DOI Accesso ONLINE all'editore

Bicchierai, Giulia; Rigacci, Luigi; Miele, Vittorio; Meattini, Icro; De Benedetto, Diego; Selvi, Valeria; Bianchi, Simonetta; Livi, Lorenzo; Nori, Jacopo (2017). Role of core needle biopsy in primary breast lymphoma. LA RADIOLOGIA MEDICA, vol. 122, pp. 651-655, ISSN:0033-8362 DOI Accesso ONLINE all'editore

Aznar, M. C.; Meattini, I.; Poortmans, P.; Steyerova, P.; Wyld, L. (2017). "To clip or not to clip. That is no question!". EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, vol. 43, pp. 1145-1147, ISSN:0748-7983 DOI Accesso ONLINE all'editore

Sottili, Mariangela; Mangoni, Monica; Gerini, Chiara; Salvatore, Giulia; Castiglione, Francesca; Desideri, Isacco; Bonomo, Pierluigi; Meattini, Icro; Greto, Daniela; Loi, Mauro; Francolini, Giulio; Perna, Marco; Grassi, Roberta; Biti, Giampaolo; Livi, Lorenzo (2017). Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice. HEAD & NECK, vol. 40, pp. 577-583, ISSN:1043-3074 DOI Accesso ONLINE all'editore

Bonomo, Pierluigi; Desideri, Isacco; Loi, Mauro; Lo Russo, Monica; Olmetto, Emanuela; Maragna, Virginia; Francolini, Giulio; Delli Paoli, Camilla; Grassi, Roberta; Pezzulla, Donato; Greto, Daniela; Meattini, Icro; Livi, Lorenzo (2017). Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?. ORAL ONCOLOGY, vol. 74, pp. 142-147, ISSN:1368-8375 DOI Accesso ONLINE all'editore

Meattini, I; Francolini, G.; Livi, L.; Nori, J. (2017). In reply to: Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, pp. 0-0, ISSN:0748-7983 DOI Accesso ONLINE all'editore

Meattini, Icro; Saieva, Calogero; Miccinesi, Guido; Desideri, Isacco; Francolini, Giulio; Scotti, Vieri; Marrazzo, Livia; Pallotta, Stefania; Meacci, Fiammetta; Muntoni, Cristina; Bendinelli, Benedetta; Sanchez, Luis Jose; Bernini, Marco; Orzalesi, Lorenzo; Nori, Jacopo; Bianchi, Simonetta; Livi, Lorenzo (2017). Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial. EUROPEAN JOURNAL OF CANCER, vol. 76, pp. 17-26, ISSN:0959-8049 DOI Accesso ONLINE all'editore

Mangoni, M; Sottili, M; Gerini, C; Desideri, I; Bastida, C; Pallotta, S; Castiglione, F; Bonomo, P; Meattini, I; Greto, D; Cappelli, S; Di Brina, L; Loi, M; Biti, G; Livi, L. (2017). A PPAR-gamma agonist protects from radiation-induced intestinal toxicity. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, vol. 5, pp. 218-226, ISSN:2050-6406 DOI Accesso ONLINE all'editore

Greto, D; Scoccianti, S; Compagnucci, A; Arilli, C; Casati, M; Francolini, G; Cecchini, S; Loi, M; Desideri, I; Bordi, L; Bono, P; Bonomo, P; Meattini, I; Detti, B; Livi, L (2016). Gamma Knife Radiosurgery in the management of single and multiple brain metastases. CLINICAL NEUROLOGY AND NEUROSURGERY, vol. 141, pp. 43-47, ISSN:0303-8467 DOI

Detti, B; Bonomo, P.; Masi, L.; Doro, R.; Cipressi, S.; Iermano, C.; Bonucci, I.; Franceschini, D.; Di Brina, L.; Baki, M.; Simontacchi, G.; Meattini, I.; Carini, M.; Serni, S.; Nicita, G.; Livi, L. (2016). CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed. WORLD JOURNAL OF UROLOGY, vol. 34, pp. 311-317, ISSN:0724-4983 DOI Accesso ONLINE all'editore

Franco, Pierfrancesco; Fiorentino, Alba; Dionisi, Francesco; Fiore, Michele; Chiesa, Silvia; Vagge, Stefano; Cellini, Francesco; Caravatta, Luciana; Tombolini, Mario; De Rose, Fiorenza; Meattini, Icro; Mortellaro, Gianluca; Apicella, Giuseppina; Marino, Lorenza; Greto, Daniela (2016). Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting. TUMORI, vol. 102, pp. 459-471, ISSN:0300-8916 DOI

Meattini, Icro; Francolini, Giulio; Livi, Lorenzo (2016). Radiosensitivity in the breast cancer management scenario: Another step forward?. JOURNAL OF THORACIC DISEASE, vol. 8, pp. 0-0, ISSN:2072-1439 DOI Accesso ONLINE all'editore

Meattini, I.; Saieva, C.; Desideri, I.; Simontacchi, G.; Marrazzo, L.; Scoccianti, S.; De Luca Cardillo, C.; Scotti, V.; Bonomo, P.; Mangoni, M.; Rossi, F.; Nori, J.; Casella, D.; Bernini, M.; Sanchez, L.; Orzalesi, L.; Pallotta, S.; Bianchi, S.; Livi, L. (2016). PV-0512: Accelerated partial breast irradiation for Luminal-A breast cancer: analysis from a phase 3 trial. RADIOTHERAPY AND ONCOLOGY, vol. 119, pp. 242-242, ISSN:0167-8140 DOI

Talamonti, C.; Marrazzo, L.; Arilli, C.; Galeotti, C.; Casati, M.; Calusi, S.; Domizi, C.; Fidanzio, A.; Meattini, I.; Scoccianti, S.; Bonomo, P.; Piermattei, A.; Pallotta, S. (2016). Beam delivery check and in-vivo dosimetry during breast radiotherapy treatment. PHYSICA MEDICA, vol. 32, pp. 66-66, ISSN:1120-1797 DOI

Orzalesi, Lorenzo; Casella, Donato; Criscenti, Valentina; Gjondedaj, Ulpiana; Bianchi, Simonetta; Vezzosi, Vania; Nori, Jacopo; Cecconi, Lorenzo; Meattini, Icro; Livi, Lorenzo; Bernini, Marco (2016). Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series. BREAST CANCER, vol. 23, pp. 640-648, ISSN:1340-6868 DOI

Meattini, Icro; Guenzi, Marina; Fozza, Alessandra; Vidali, Cristiana; Rovea, Paolo; Meacci, Fiammetta; Livi, Lorenzo (2016). Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer. BREAST CANCER, pp. 0-0, ISSN:1340-6868 DOI

Meattini, Icro; Saieva, Calogero; Meacci, Fiammetta; Scotti, Vieri; De Luca Cardillo, Carla; Desideri, Isacco; Baldazzi, Valentina; Mangoni, Monica; Scoccianti, Silvia; Detti, Beatrice; Simontacchi, Gabriele; Nori, Jacopo; Orzalesi, Lorenzo; Sanchez, Luis; Casella, Donato; Bernini, Marco; Fambrini, Massimiliano; Bianchi, Simonetta; Livi, Lorenzo (2016). Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin. FUTURE ONCOLOGY, vol. 12, pp. 625-635, ISSN:1479-6694 DOI Accesso ONLINE all'editore

Livi, Lorenzo; Meattini, Icro; Kaidar-Person, Orit; Poortmans, Philip M (2016). Elective Nodal Irradiation in Breast Cancer: Time for Trials on the Basis of Tumor Biology. JOURNAL OF CLINICAL ONCOLOGY, vol. 34, pp. 2672-2673, ISSN:0732-183X DOI

Casella, Donato; Calabrese, Claudio; Bianchi, Simonetta; Meattini, Icro; Bernini, Marco (2016). Subcutaneous Tissue Expander Placement with Synthetic Titanium-Coated Mesh in Breast Reconstruction: Long-term Results. PLASTIC AND RECONSTRUCTIVE SURGERY – GLOBAL OPEN, vol. 3, pp. 0-0, ISSN:2169-7574 DOI Accesso ONLINE all'editore

Alongi, Filippo; Meattini, Icro; Mazzola, Rosario; Giaj Levra, Niccolò; Fiorentino, Alba; Livi, Lorenzo (2016). In regard to Boero et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 95, pp. 855-856, ISSN:0360-3016 DOI Accesso ONLINE all'editore

Meattini, I.; Bicchierai, G.; Saieva, C.; De Benedetto, D.; Desideri, I.; Becherini, C.; Abdulcadir, D.; Vanzi, E.; Boeri, C.; Gabbrielli, S.; Lucci, F.; Sanchez, L.; Casella, D.; Bernini, M.; Orzalesi, L.; Vezzosi, V.; Greto, D.; Mangoni, M.; Bianchi, S.; Livi, L.; Nori, J. (2016). Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: single-institution experience and review of published literature. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, pp. 0-0, ISSN:0748-7983 DOI

Meattini, Icro; Desideri, Isacco; Di Cataldo, Vanessa; Francolini, Giulio; De Luca Cardillo, Carla; Scotti, Vieri; Loi, Mauro; Detti, Beatrice; Mangoni, Monica; Agresti, Benedetta; Baldazzi, Valentina; Greto, Daniela; Casella, Donato; Bernini, Marco; Sanchez, Luis Jose; Orzalesi, Lorenzo; Nori, Jacopo; Fambrini, Massimiliano; Bianchi, Simonetta; Livi, Lorenzo (2016). Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience. FUTURE ONCOLOGY, vol. 12, pp. 1117-1124, ISSN:1479-6694 DOI

Detti, Beatrice; Francolini, Giulio; Becherini, Carlotta; Olmetto, Emanuela; Giacomelli, Irene; Scartoni, Daniele; Greto, Daniela; Baldazzi, Valentina; Simontacchi, Gabriele; Meattini, Icro; Livi, Lorenzo (2016). Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature. JOURNAL OF CHEMOTHERAPY, vol. 28, pp. 432-434, ISSN:1120-009X DOI

Bernini, Marco; Meattini, Icro; Casella, Donato (2016). Two-stage implant based breast reconstruction: should we always exchange the tissue expander for an implant right away?. GLAND SURGERY, vol. 5, pp. 369-371, ISSN:2227-684X DOI

Talamonti, C.; Arilli, C.; Marrazzo, L.; Calusi, S.; Galeotti, C.; Wandel, Y.; Meattini, I.; Scoccianti, S.; Pallotta, S. (2016). A new approach in patient QA: Beam delivery check and in-vivo dosimetry during radiotherapy treatment. PHYSICA MEDICA, vol. 32, pp. 237-238, ISSN:1120-1797 DOI

Franceschini, Davide; Paiar, Fabiola; Saieva, Calogero; Bonomo, Pierluigi; Agresti, Benedetta; Meattini, Icro; Greto, Daniela; Mangoni, Monica; Meacci, Fiammetta; Loi, Mauro; Zei, Giacomo; Livi, Lorenzo; Biti, Giampaolo (2016). Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy. LA RADIOLOGIA MEDICA, vol. 121, pp. 229-237, ISSN:0033-8362 DOI

Casella, Donato; Calabrese, Claudio; Orzalesi, Lorenzo; Gaggelli, Ilaria; Cecconi, Lorenzo; Santi, Caterina; Murgo, Roberto; Rinaldi, Stefano; Regolo, Lea; Amanti, Claudio; Roncella, Manuela; Serra, Margherita; Meneghini, Graziano; Bortolini, Massimiliano; Altomare, Vittorio; Cabula, Carlo; Catalano, Francesca; Cirilli, Alfredo; Caruso, Francesco; Lazzaretti, Maria Grazia; Meattini, Icro; Livi, Lorenzo; Cataliotti, Luigi; Bernini, Marco (2016). Current trends and outcomes of breast reconstruction following nipple-sparing mastectomy: results from a national multicentric registry with 1006 cases over a 6-year period. BREAST CANCER, pp. 0-0, ISSN:1340-6868 DOI

Detti, B; Bonomo, P.; Masi, L.; Doro, R.; Cipressi, S.; Iermano, C.; Bonucci, I.; Franceschini, D.; Di Cataldo, V.; Di Brina, L.; Baki, M.; Simontacchi, G.; Meattini, I.; Carini, M.; Serni, S.; Nicita, G.; Livi, L. (2015). Cyberknife treatment for low and intermediate risk prostate cancer. CANCER INVESTIGATION, vol. 33, pp. 188-192, ISSN:0735-7907 DOI

Livi, L; Meattini, I; Marrazzo, L; Simontacchi, G; Pallotta, S; Saieva, C; Paiar, F; Scotti, V; De Luca Cardillo, C; Bastiani, P; Orzalesi, L; Casella, D; Sanchez, L; Nori, J; Fambrini, M; Bianchi, S. (2015). Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. EUROPEAN JOURNAL OF CANCER, vol. 51, pp. 451-463, ISSN:0959-8049 DOI Accesso ONLINE all'editore

Bonomo, Pierluigi; Cipressi, Samantha; Desideri, Isacco; Masi, Laura; Doro, Raffaela; Iermano, Carmine; Greto, Daniela; Simontacchi, Gabriele; Mangoni, Monica; Paiar, Fabiola; Meattini, Icro; Scoccianti, Silvia; Santoro, Gennaro; Valente, Serafina; Gensini, Gian Franco; Livi, Lorenzo (2015). Stereotactic body radiotherapy with CyberKnife for cardiac malignancies. TUMORI, vol. 101, pp. 294-297, ISSN:0300-8916 DOI Accesso ONLINE all'editore

Meattini, I.; Marrazzo, L.; Saieva, C.; Pallotta, S.; Simontacchi, G.; Scotti, V.; Furfaro, I.; Meacci, F.; Orzalesi, L.; Livi, L. (2015). PD-0042: APBI versus whole breast irradiation in women age 70 years or older: a subgroup analysis of a phase 3 randomised trial. RADIOTHERAPY AND ONCOLOGY, vol. 115, pp. 20-20, ISSN:0167-8140 DOI

Mangoni, Monica; Sottili, Mariangela; Loi, Mauro; Gerini, Chiara; Meattini, Icro; Livi, Lorenzo (2015). Cancer stem cells: biology and potential therapeutic applications. In: Nima Razei. Cancer Immunology, pp. 1-485, heidelberg: springer, ISBN:978-3-662-44945-5. DOI

Monica, Mangoni; Mariangela, Sottili; Chiara, Gerini; Pierluigi, Bonomo; Anna, Bottoncetti; Francesca, Castiglione; Ciro, Franzese; Sara, Cassani; Daniela, Greto; Tatiana, Masoni; Icro, Meattini; Stefania, Pallotta; Alessandro, Passeri; Alberto, Pupi; Eleonora, Vanzi; Giampaolo, Biti; Lorenzo, Livi (2015). A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model. LUNG CANCER, vol. 90, pp. 405-409, ISSN:0169-5002 DOI

Detti, B; Bonomo, P; Masi, L; Doro, R; Cipressi, S; Iermano, C; Bonucci, I; Franceschini, D; Di Brina, L; Bakhi, M; Simontacchi, G; Meattini, I; Livi, L. (2015). Stereotactic radiotherapy for isolated nodal recurrence of prostate cancer.. WORLD JOURNAL OF UROLOGY, vol. 33, pp. 1197-1203, ISSN:0724-4983 DOI Accesso ONLINE all'editore

Meattini, Icro; Marrazzo, Livia; Zani, Margherita; Paiar, Fabiola; Pallotta, Stefania; Simontacchi, Gabriele; Bucciolini, Marta; Livi, Lorenzo (2015). Four-dimensional computed tomography in accelerated partial breast irradiation planning: single series from a phase III trial. LA RADIOLOGIA MEDICA, vol. 120, pp. 1078-1082, ISSN:0033-8362 DOI Accesso ONLINE all'editore

Scoccianti S.; Detti B.; Gadda D.; Greto D.; Furfaro I.; Meacci F.; Simontacchi G.; Di Brina L.; Bonomo P.; Giacomelli I.; Meattini I.; Mangoni M.; Cappelli S.; Cassani S.; Talamonti C.; Bordi L.; Livi L. (2015). Organs at risk in the brain and their dose-constraints in adults and in children: A radiation oncologist's guide for delineation in everyday practice.. RADIOTHERAPY AND ONCOLOGY, vol. 114, pp. 230-238, ISSN:0167-8140 DOI

Meattini, Icro; Saieva, Calogero; Marrazzo, Livia; Di Brina, Lucia; Pallotta, Stefania; Mangoni, Monica; Meacci, Fiammetta; Bendinelli, Benedetta; Francolini, Giulio; Desideri, Isacco; De Luca Cardillo, Carla; Scotti, Vieri; Furfaro, Ilaria Francesca; Rossi, Francesca; Greto, Daniela; Bonomo, Pierluigi; Casella, Donato; Bernini, Marco; Sanchez, Luis; Orzalesi, Lorenzo; Simoncini, Roberta; Nori, Jacopo; Bianchi, Simonetta; Livi, Lorenzo (2015). Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial. BREAST CANCER RESEARCH AND TREATMENT, vol. 153, pp. 539-547, ISSN:0167-6806 DOI Accesso ONLINE all'editore

Meattini, Icro; Boersma, Liesbeth; Livi, Lorenzo; Kirkove, Carine; Gabryś, Dorota; Somaiah, Navita; Remouchamps, Vincent; Elkhuizen, Paula H M; Kirova, Youlia; Rivera, Sofia (2015). In Regard to Vaidya et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 92, pp. 960-961, ISSN:0360-3016 DOI

Meattini, Icro; Francolini, Giulio; Scotti, Vieri; De Luca Cardillo, Carla; Cappelli, Sabrina; Meacci, Fiammetta; Furfaro, Ilaria Francesca; Muntoni, Cristina; Scoccianti, Silvia; Detti, Beatrice; Mangoni, Monica; Nori, Jacopo; Orzalesi, Lorenzo; Fambrini, Massimiliano; Bianchi, Simonetta; Livi, Lorenzo (2015). Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer. MEDICAL ONCOLOGY, vol. 32, pp. o-o, ISSN:1357-0560 DOI Accesso ONLINE all'editore

Meattini, Icro; Saieva, Calogero; Livi, Lorenzo (2015). Authors reply. EUROPEAN JOURNAL OF CANCER, vol. 51, pp. 1478-1479, ISSN:0959-8049 DOI Accesso ONLINE all'editore

De Bari, B; Vallati, M; Gatta, R; Simeone, C; Girelli, G; Ricardi, U; Meattini, I; Gabriele, P; Bellavita, R; Krengli, M; Cafaro, I; Cagna, E; Bunkheila, F; Borghesi, S; Signor, M; Di Marco, A; Bertoni, F; Stefanacci, M; Pasinetti, N; Buglione, M; Magrini, Sm. (2015). Could machine learning improve the prediction of pelvic nodal status of prostate cancer patients? Preliminary results of a pilot study.. CANCER INVESTIGATION, vol. 33, pp. 232-240, ISSN:0735-7907 DOI Accesso ONLINE all'editore

Meattini, Icro; Saieva, Calogero; Bertocci, Silvia; Francolini, Giulio; Zei, Giacomo; De Luca Cardillo, Carla; Scotti, Vieri; Greto, Daniela; Bonomo, Pierluigi; Orzalesi, Lorenzo; Bianchi, Simonetta; Livi, Lorenzo (2015). Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node. TUMORI, vol. 101, pp. 78-83, ISSN:0300-8916 DOI Accesso ONLINE all'editore

Mangoni, Monica; Sottili, Mariangela; Gerini, Chiara; Fucci, Rossella; Pini, Alessandro; Calosi, Laura; Bonomo, Pierluigi; Detti, Beatrice; Greto, Daniela; Meattini, Icro; Simontacchi, Gabriele; Loi, Mauro; Scartoni, Daniele; Furfaro, Ilaria; Pallotta, Stefania; Livi, Lorenzo (2015). Protective Effect of Leuprorelin on Radiation-induced Intestinal Toxicity. ANTICANCER RESEARCH, vol. 35, pp. 3875-3884, ISSN:0250-7005 Accesso ONLINE all'editore

Livi, Lorenzo; Meattini, Icro (2015). Radiotherapy or surgery for the axilla in node-positive breast cancer?. THE LANCET ONCOLOGY, vol. 16, pp. 0-0, ISSN:1470-2045 DOI Accesso ONLINE all'editore

Detti, Beatrice; Franceschini, Davide; Saieva, Calogero; Di Brina, Lucia; Baki, Mohammed; Meattini, Icro; Di Cataldo, Vanessa; Pasquetti, Eleonora Monteleone; Furfaro, Ilaria; Mancuso, Anna; Simontacchi, Gabriele; Livi, Lorenzo (2015). Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience. CANCER INVESTIGATION, vol. 32, pp. 445-450, ISSN:0735-7907 DOI

Greto D; Livi L; Saieva C; Bonomo P; Meattini I; Loi M; Di Brina L; Beltrami G; Campanacci D; Scoccianti G; Capanna R; Mangoni M; Paiar F; Franchi A; Biti G (2014). Neoadjuvant treatment of soft tissue sarcoma.. LA RADIOLOGIA MEDICA, vol. 119, pp. 195-200, ISSN:0033-8362 DOI

Greto D; Livi L; Bonomo P; Masi L; Detti B; Meattini I; Mangoni M; Doro R; Favuzza V; Cipressi S; Iermano C; Bonucci I; Loi M; Biti G. (2014). Cyberknife stereotactic radiosurgery for the re-irradiation of brain lesions: a single-centre experience.. LA RADIOLOGIA MEDICA, pp. 721-726, ISSN:1826-6983 DOI

Scotti V;Meattini I;Franzese C;Saieva C;Bertocci S;Meacci F;Furfaro I;Scartoni D;Cecchini S;Desideri I;Ferrari K;Bruni A;De Luca Cardillo C;Bastiani P;Agresti B;Mangoni M;Livi L;Biti G (2014). Radiotherapy timing in the treatment of limited-stage small cell lung cancer: the impact of thoracic and brain irradiation on survival.. TUMORI, vol. 100, pp. 289-295, ISSN:0300-8916 DOI

Bonomo P;Cipressi S;Iermano C;Bonucci I;Masi L;Doro R;Favuzza V;Paiar F;Simontacchi G;Meattini I;Greto D;Agresti B;Livi L;Biti G (2014). Salvage stereotactic re-irradiation with CyberKnife for locally recurrent head and neck cancer: a single center experience.. TUMORI, vol. 100, pp. 278-283, ISSN:0300-8916 DOI

Mangoni, M; Desideri, I; Detti, B; Bonomo, P; Greto, D; Paiar, F; Simontacchi, G; Meattini, I; Scoccianti, S; Masoni, T; Ciabatti, C; Turkaj, A; Serni, S; Minervini, A; Gacci, M; Carini, M; Livi, L. (2014). Hypofractionation in prostate cancer: radiobiological basis and clinical appliance.. BIOMED RESEARCH INTERNATIONAL, vol. 2014, pp. 1-8, ISSN:2314-6133 DOI

Simontacchi G; Meattini I ; Marrazzo L ; Pallotta S ; Talamonti C ; Turkaj A; Topulli J, Monteleone E ; Cappelli S ; Masoni T ; Bucciolini M ; Livi L (2014). Comparison of Static Fields IMRT and Helical IMRT for Accelerated Partial Breast Irradiation. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, pp. S260-S260, ISSN:0360-3016 DOI

Meattini I;Desideri I;Saieva C;Francolini G;Scotti V;Bonomo P;Greto D;Mangoni M;Nori J;Orzalesi L;Fambrini M;Bianchi S;Livi L (2014). Impact of sentinel node tumor burden on outcome of invasive breast cancer patients.. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, vol. 40, pp. 1195-1202, ISSN:0748-7983 DOI

Nori J;Meattini I;Giannotti E;Abdulcadir D;Mariscotti G;Calabrese M;Angelino F;Chiesa F;Saieva C;Vanzi E;Boeri C;Bianchi S;Sanchez L;Orzalesi L;Casella D;Susini T;Livi L (2014). Role of preoperative breast MRI in ductal carcinoma in situ for prediction of the presence and assessment of the extent of occult invasive component.. THE BREAST JOURNAL, vol. 20, pp. 243-248, ISSN:1075-122X DOI

Abdulcadir D;Nori J;Meattini I;Giannotti E;Boeri C;Vanzi E;Vezzosi V;Bianchi S (2014). Phyllodes tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: Analysis of 51 cases from a single institution and review of the literature.. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, pp. 859-864, ISSN:0748-7983 DOI

Meattini I;Santi R;Scartoni D;Giacomelli I;De Luca Cardillo C;Scotti V;Casella D;Simoncini R;Orzalesi L;Nori J;Paglierani M;Livi L (2014). Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature.. CASE REPORTS IN ONCOLOGICAL MEDICINE, vol. 2014, pp. 0-0, ISSN:2090-6706 DOI

D. Greto; S. Pallotta; L. Masi; C. Talamonti; R. Doro; S. Scoccianti; L. Marrazzo; I. Meattini; P. Bonomo; L. Livi (2014). Dosimetric comparison between Tomotherapy and Cyberknife for radiosurgery of single brain metastasis. RADIOTHERAPY AND ONCOLOGY, pp. 397-397, ISSN:0167-8140

Pegurri L;Buglione M;Girelli G;Guarnieri A;Meattini I;Ricardi U;Mangoni M;Gabriele P;Bellavita R;Krengli M;Bonetta A;Cagna E;Bunkheila F;Borghesi S;Signor M;Di Marco A;Bertoni F;Stefanacci M;Gatta R;De Bari B;Magrini SM (2014). Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society.. TUMORI, vol. 100, pp. 31-37, ISSN:0300-8916 DOI

Greto, D.; Pallotta, S.; Masi, L.; Talamonti, C.; Doro, R.; Scoccianti, S.; Marrazzo, L.; Meattini, I.; Bonomo, P.; Livi, L. (2014). PO-0982: Dosimetric comparison between Tomotherapy and Cyberknife for radiosurgery of single brain metastasis. RADIOTHERAPY AND ONCOLOGY, vol. 111, pp. 138-139, ISSN:0167-8140 DOI

Meattini, I; Cecchini, S; Di Cataldo, V; Saieva, C; Francolini, G; Scotti, V; Bonomo, P; Mangoni, M; Greto, D; Nori, J; Orzalesi, L; Casella, D; Simoncini, R; Fambrini, M; Bianchi, S; Livi, L. (2014). Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy.. BIOMED RESEARCH INTERNATIONAL, vol. 2014, pp. 0-0, ISSN:2314-6133 DOI

Meattini I;Giannotti E;Abdulcadir D;Saieva C;Guerrieri AM;Vanzi E;Scartoni D;Cecchini S;Sanchez LJ;Orzalesi L;Casella D;Bianchi S;Livi L;Nori J (2014). The impact of method of biopsy on the incidence of breast cancer sentinel lymph node metastases.. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, vol. 40, pp. 277-281, ISSN:0748-7983 DOI

Meattini I;Cecchini S;Muntoni C;Scotti V;De Luca Cardillo C;Mangoni M;Bonomo P;Nori J;Casella D;Simoncini R;Orzalesi L;Bianchi S;Livi L (2014). Cutaneous and cardiac toxicity of concurrent trastuzumab and adjuvant breast radiotherapy: a single institution series.. MEDICAL ONCOLOGY, vol. 31, pp. 0-0, ISSN:1357-0560 DOI

Scotti, V; Marrazzo, L; Saieva, C; Agresti, B; Meattini, I; Desideri, I; Cecchini, S; Bertocci, S; Franzese, C; De Luca Cardillo, C; Zei, G; Loi, M; Greto, D; Mangoni, M; Bonomo, P; Livi, L; Biti, Gp (2014). Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University.. LA RADIOLOGIA MEDICA, vol. 119, pp. 13-19, ISSN:0033-8362 DOI

Bonomo, P; Cipressi, S; Saieva, C; Greto, D; Masi, L; Paiar, F; Di Cataldo, V; Meattini, I; Cecchini, S; Mangoni, M; Doro, R; Iermano, C; Bonucci, I; Livi, L; Biti, G (2013). Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases.. TUMORI, vol. 99, pp. 611-616, ISSN:0300-8916 DOI

Scotti, V; Saieva, C; Di Cataldo, V; Bruni, A; Desideri, I; Bertocci, S; Meattini, I; Livi, L; Simontacchi, G; De Luca Cardillo, C; Bendinelli, B; Bastiani, P; Mangoni, M; Agresti, B; Biti, G (2013). Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer.. TUMORI, vol. 98, pp. 464-470, ISSN:0300-8916 DOI

Davide Franceschini;Fabiola Paiar;Icro Meattini;Benedetta Agresti;Eleonora Monteleone Pasquetti;Daniela Greto;Pierluigi Bonomo;Livia Marrazzo;Marta Casati;Lorenzo Livi;Giampaolo Biti (2013). Simultaneous integrated boost-intensity-modulated radiotherapy in head and neck cancer. LARYNGOSCOPE, vol. 123, pp. 97-103, ISSN:0023-852X DOI

Franceschini, D.; Scotti, V.; Simontacchi, G.; Meattini, I.; Paiar, F.; Greto, D.; Bonomo, P.; Franzese, C.; Di Cataldo, V.; Pallotta, S.; Biti, G. (2013). Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report. TUMORI, pp. 233-236, ISSN:2038-2529 DOI

Scotti, V; Desideri, I; Meattini, I; Cataldo, Vd; Cecchini, S; Petrucci, A; Franzese, C; Greto, D; Livi, L; Bonomo, P; Biti, G (2013). Management of inflammatory breast cancer: Focus on radiotherapy with an evidence-based approach.. CANCER TREATMENT REVIEWS, vol. 39, pp. 119-124, ISSN:0305-7372 DOI

Meattini I;Livi L;Saieva C;Franceschini D;Scotti V;Mangoni M;Loi M;Di Brina L;Zei G;Bonomo P;Greto D;Gelain E;Nori J;Sanchez LJ;Orzalesi L;Bianchi S;Biti G (2013). Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen.. CLINICAL BREAST CANCER, vol. 13, pp. 247-253, ISSN:1526-8209 DOI

Lorenzo Livi;Pierluigi Bonomo;Icro Meattini;Gabriele Simontacchi;Daniela Greto;Isacco Desideri;Fiammetta Meacci;Vieri Scotti;Sara Cecchini;Jacopo Nori;Luis Jose Sanchez;Lorenzo Orzalesi;Fabiola Paiar;Gianpaolo Biti (2013). Paclitaxel and bevacizumab in first-line treatment for HER2-negative metastatic breast cancer: single-center experience. MEDICAL ONCOLOGY, vol. 30, pp. 0-0, ISSN:1357-0560 DOI

I. Meattini;L. Livi;D. Franceschini;C. Saieva;F. Meacci;L. Marrazzo;B. Bendinelli;V. Scotti;C. De Luca Cardillo;J. Nori;L. Sanchez;L. Orzalesi;P. Bonomo;D. Greto;M. Bucciolini;S. Bianchi;G. Biti (2013). Role of radiotherapy boost in women with ductal carcinoma in situ: A single-center experience in a series of 389 patients. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, vol. 39, pp. 613-618, ISSN:0748-7983 DOI

Bonomo P;Livi L;Rampini A;Meattini I;Agresti B;Simontacchi G;Paiar F;Mangoni M;Bonucci I;Greto D;Masi L;Doro R;Marrazzo L;Biti G (2013). Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience.. LA RADIOLOGIA MEDICA, vol. 118, pp. 1055-1065, ISSN:0033-8362 DOI

Monica Mangoni; Sara Cecchini; Icro Meattini; Gabriele Simontacch (2013). Il carcinoma midollare. In: Carlo Gobitti, Renzo Mazzarotto, Luca Tagliaferri. La radioterapia dei tumori differenziati della tiroide. Indicazioni e criteri guida., pp. 13.1-13.6 Gruppo di Studio di Radioterapia Metabolica dell’Associazione Italiana, ISBN:9788897305040.

Lorenzo Livi;Icro Meattini;Davide Franceschini;Calogero Saieva;Fiammetta Meacci;Livia Marrazzo;Elena Gerlain;Isacco Desideri;Vieri Scotti;Jacopo Nori;Luis Jose Sanchez;Lorenzo Orzalesi;Pierluigi Bonomo;Daniela Greto;Simonetta Bianchi;Giampaolo Biti (2013). Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 Patients treated with a prospective margin-directed policy. RADIOTHERAPY AND ONCOLOGY, vol. 108, pp. 273-278, ISSN:0167-8140 DOI

Casamassima, F; Livi, L; Masciullo, S; Menichelli, C; Masi, L; Meattini, I; Bonucci, I; Agresti, B; Simontacchi, G; Doro, R. (2012). Stereotactic radiotherapy for adrenal gland metastases: university of Florence experience.. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 82, pp. 919-923, ISSN:0360-3016 DOI

Scotti, V; Di Cataldo, V; Falchini, M; Meattini, I; Livi, L; Ugolini, D; Comin, Ce; Mazza, E; Franzese, C; Biti, G (2012). Isolated chest wall implantation of non-small cell lung cancer after fine-needle aspiration: a case report and review of the literature.. TUMORI, vol. 98, pp. 0-0, ISSN:0300-8916 DOI

Livi, L; Meattini, I; Saieva, C; Franzese, C; Di Cataldo, V; Greto, D; Franceschini, D; Scotti, V; Bonomo, P; Nori, J; Sanchez, L; Vezzosi, V; Bianchi, S; Cataliotti, L; Biti, G (2012). Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer.. CANCER, vol. 118, pp. 3236-3243, ISSN:0008-543X DOI

Fabiola, Paiar; Vanessa, Di Cataldo; Giacomo, Zei; Eleonora, Monteleone Pasquetti; Sara, Cecchini; Icro, Meattini; Monica, Mangoni; Benedetta, Agresti; Carmine, Iermano; Pierluigi, Bonomo; Giampaolo, Biti (2012). Role of chemotherapy in nasopharyngeal carcinoma. ONCOLOGY REVIEWS, vol. 6, pp. 1-6, ISSN:1970-5565 DOI

Icro Meattini;Lorenzo Livi;Calogero Saieva;Davide Franceschini;Livia Marrazzo;Daniela Greto;Vieri Scotti;Silvia Scoccianti;Fabiola Paiar;Lorenzo Bordi;Jacopo Nori;Luis Sanchez;Lorenzo Orzalesi;Simonetta Bianchi;Giampaolo Biti (2012). Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: a single center experience. JOURNAL OF CHEMOTHERAPY, vol. 24, pp. 279-284, ISSN:1120-009X DOI

I. Meattini;L. Marrazzo;L. Livi;S. Pallotta;G. Simontacchi;F. Paiar;C. Franzese;D. Franceschini;F. Meacci;G. Biti (2012). 4-DIMENSIONAL COMPUTED TOMOGRAPHY IN ACCELERATED PARTIAL BREAST IRRADIATION PLANNING. RADIOTHERAPY AND ONCOLOGY, vol. 103, pp. 305-305, ISSN:0167-8140

Meattini I;Livi L;Franceschini D;Saieva C;Scotti V;Casella D;Criscenti V;Zanna I;Meacci F;Gerlain E;Agresti B;Mangoni M;Paiar F;Simontacchi G;Greto D;Nori J;Bianchi S;Cataliotti L;Biti G (2012). Treatment of invasive male breast cancer: a 40-year single-institution experience.. LA RADIOLOGIA MEDICA, pp. 476-486, ISSN:0033-8362 DOI

Magrini, Sm; Tonoli, S; Costa, L; Pasinetti, N; Paiar, F; Livi, L; Simontacchi, G; Meattini, I; Pegurri, L; Borghetti, P; Frata, P; Ponticelli, P; Buglione, M; Biti, G. (2012). A benchmark study on 883 nasopharyngeal cancer patients treated in two ItalianCentres from 1977 to 2000. Part II: evolving technical choices and toxicitypatterns.. LA RADIOLOGIA MEDICA, vol. 117, pp. 715-724, ISSN:1826-6983 DOI

Scotti, V; Meattini, I; Saieva, C; Rampini, A; De Luca Cardillo, C; Bastiani, P; Mangoni, M; Agresti, B; Santomaggio, C; Di Cataldo, V; Franzese, C; Livi, L; Magrini, Sm; Biti, G. (2012). Limited-stage small-cell lung cancer treated with early chemo-radiotherapy: the impact of effective chemotherapy.. TUMORI, vol. 98, pp. 53-59, ISSN:0300-8916 DOI

Livi, L; Meattini, I; Scotti, V; De Luca Cardillo, C; Galardi, A; Iermano, C; Sanchez, L; Nori, J; Mangoni, M; Franzese, C; Orzalesi, L; Bertocci, S; Agresti, B; Masoni, T; Bianchi, S; Cataliotti, L; Biti, G. (2011). Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclines.. JOURNAL OF CHEMOTHERAPY, vol. 23, pp. 158-162, ISSN:1973-9478 DOI

Livi, L; Meattini, I; Scotti, V; Saieva, C; Simontacchi, G; Marrazzo, L; Franzese, C; Cassani, S; Paiar, F; Di Cataldo, V; Nori, J; Jose Sanchez, L; Bianchi, S; Cataliotti, L; Biti, G. (2011). Concomitant adjuvant chemo-radiation therapy with anthracycline-based regimens in breast cancer: a single centre experience.. LA RADIOLOGIA MEDICA, vol. 116, pp. 1050-1058, ISSN:0033-8362 DOI

V. Scotti;I. Meattini;B. Agresti;L. Marrazzo;C. De Luca Cardillo;M. Mangoni;G. Biti (2011). 76P THE IMPACT OF A BREATHING-CONTROL SYSTEM ON TARGET MARGINS AND NORMAL TISSUE SPARING IN THE TREATMENT OF LUNG CANCER: ANALYSIS OF 12 CASES AT RADIOTHERAPY UNIT OF FLORENCE UNIVERSITY. LUNG CANCER, vol. 71, pp. S39-S39, ISSN:0169-5002 DOI

Livi, L; Meattini, I; de Luca Cardillo, C; Scotti, V; Agresti, B; Franzese, C; Sanchez, L; Nori, J; Bertocci, S; Cassani, S; Bianchi, S; Cataliotti, L; Biti, G. (2011). Use ofdoxorubicin plus cyclophosphamide followed by docetaxel as adjuvant chemotherapy for breast cancer.. JOURNAL OF CHEMOTHERAPY, vol. 23, pp. 36-39, ISSN:1973-9478 DOI

Sandro, Tonoli; Paola, Vitali; Vieri, Scotti; Filippo, Bertoni; Luigi, Spiazzi; Barbara, Ghedi; Fabrizio, Banci Buonamici; Livia, Marrazzo; Gabriele, Guidi; Icro, Meattini; Paolo, Bastiani; Maurizio, Amichetti; Marco, Schwarz; Stefano, Maria Magrini (2011). Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series. RADIOTHERAPY AND ONCOLOGY, vol. 101, pp. 311-315, ISSN:0167-8140 DOI

Meattini, I; Bruni, A; Scotti, V; Livi, L; De Luca Cardillo, C; Galardi, A; Cipressi, S; Biti, G (2010). Oral ibandronate in metastatic bone breast cancer: the Florence University experience and a review of the literature.. JOURNAL OF CHEMOTHERAPY, vol. 22, pp. 58-62, ISSN:1973-9478 DOI

L.Livi; S.Borghesi; I.Meattini; C.Saieva; C De Luca Cardillo; V.Scotti; M.Mangoni; A.Galardi; L.Cataliotti; F.Paiar; S.Bianchi; G.Biti (2010). Adjuvant trastuzumab in breast cancer: experience from the University of Florence.. JOURNAL OF CHEMOTHERAPY, vol. 22, pp. 115-118, ISSN:1973-9478 DOI

Di Mambro, A; Giuliani, C; Ammannati, F; Mannucci, E; Scoccianti, S; Detti, B; Meattini, I; Mennonna, P; Forti, G; Serio, M; Peri, A. (2010). A single-institution restrospective experience of brachytherapy in the treatment of pituitary tumors: transsphenoidal approach combined with (192)Ir-afterloading catheters.. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, vol. 33, pp. 455-460, ISSN:1720-8386 DOI Accesso ONLINE all'editore

Livi L; Scotti V; Saieva C; Meattini I; Detti B; Simontacchi G; Cardillo CD; Paiar F; Mangoni M; Marrazzo L; Agresti B; Cataliotti L; Bianchi S; Biti G. (2010). Outcome After Conservative Surgery and Breast Irradiation in 5,717 Patients with Breast Cancer: Implications for Supraclavicular Nodal Irradiation.. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 76, pp. 978-983, ISSN:0360-3016 DOI

Livi L; Meattini I; Saieva C; Borghesi S; Scotti V; Petrucci A; Rampini A; Marrazzo L; Di Cataldo V; Bianchi S; Cataliotti L; Biti G (2010). The impact of young age on breast cancer outcome. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, vol. 36, pp. 639-645, ISSN:0748-7983 DOI

Livi, L; Meattini, I; Di Cataldo, V; Cardillo Cde, L; Scotti, V; Sanchez, L; Nori, J; Agresti, B; Iermano, C; Pasquetti, Em; Bianchi, S; Cataliotti, L; Biti, G. (2010). Postmastectomy radiotherapy in breast cancer adjuvant treatment.. MINERVA CHIRURGICA, vol. 65, pp. 527-536, ISSN:0026-4733

Scotti, V; Borghesi, S; Meattini, I; Saieva, C; Rossi, F; Petrucci, A; Galardi, A; Livi, L; Agresti, B; Fambrini, M; Marchionni, M; Biti, G. (2010). Postoperative radiotherapyin stage I/II endometrial cancer: retrospective analysis of 883 patients treated at the University of Florence.. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol. 20, pp. 1540-1548, ISSN:1048-891X DOI

Meattini I; Livi L; Saieva C; Marrazzo L; Rampini A; Iermano C; Papi MG; Detti B; Scoccianti S; Biti G (2010). Breast cancer following Hodgkin's Disease: theexperience of the University of Florence.. THE BREAST JOURNAL, vol. 16, pp. 290-296, ISSN:1075-122X DOI

Scotti V; Meattini I; Saieva C; Agresti B; de Luca Cardillo C; Bastiani P; Livi L; Mangoni M; Di Cataldo V; Marrazzo L; Rampini A; Cipressi S; Bruni A; Santini P; Biti G (2010). Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients.. RADIOTHERAPY AND ONCOLOGY, vol. 96, pp. 84-88, ISSN:0167-8140 DOI

Meattini I; Scotti V; Pescini F; Livi L; Sulprizio S; Palumbo V; Sarti C; Biti G. (2010). Ischemic stroke during cisplatin-based chemotherapy for testicular germ celltumor: case report and review of the literature.. JOURNAL OF CHEMOTHERAPY, vol. 22, pp. 134-136, ISSN:1973-9478 DOI

Lorenzo Livi; Simona Borghesi; Calogero Saieva; Icro Meattini; Andrea Rampini; Alessia Petrucci; Beatrice Detti; Alessio Bruni; Fabiola Paiar; Monica Mangoni; Livia Marrazzo; Benedetta Agresti; Luigi Cataliotti; Simonetta Bianchi; Giampaolo Biti (2009). Radiotherapy Timing in 4,820 patients with Breast Cancer: University of Florence Experience.. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 73, pp. 365-369, ISSN:0360-3016 DOI

Detti B; Livi L; Scoccianti S; Gacci M; Lapini A; Cai T; Meattini I; Mileo AM; Iannalfi A; Bruni A; Biti G (2009). Management of Stage II testicular seminoma over a period of 40 years.. UROLOGIC ONCOLOGY, vol. 27, pp. 534-538, ISSN:1078-1439 DOI

Livi L; Meattini I; Cardillo Cde L; Mangoni M; Greto D; Petrucci A; Rampini A; Bruni A; Galardi A; Cataliotti L; Biti G. (2009). Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy inmetastatic breast cancer: a retrospective analysis.. TUMORI, vol. 95, pp. 422-426, ISSN:0300-8916

Scoccianti S; Detti B; Meattini I; Iannalfi A; Sardaro A; Leonulli BG; Martinelli F; Bordi L; Pellicanò G; Biti G (2008). Symptomatic leptomeningeal andintramedullary metastases from intracranial glioblastoma multiforme: a casereport.. TUMORI, vol. 94, pp. 877-881, ISSN:0300-8916

Silvia Scoccianti; Beatrice Detti; Angela Sardaro; Alberto Iannalfi; Icro Meattini; Barbara Grilli Leonulli; Simona Borghesi; Francesco Martinelli; Lorenzo Bordi; Franco Ammannati; Giampaolo Biti (2008). Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience.. ANTI-CANCER DRUGS, vol. 19, pp. 613-620, ISSN:0959-4973 DOI

Livi L; Meattini I; Detti B; Biti G; Gacci M; Lapini A; Serni S; Carini M (2008). Ruolo della PET [18F]-Colina nella ripresa biochimica di malattia dopo prostatectomia radicale. .

Lorenzo, Livi; Calogero, Saieva; Simona, Borghesi; Lisa, Paoletti; Icro, Meattini; Andrea, Rampini; Alessia, Petrucci; Silvia, Scoccianti; Fabiola, Paiar; Luigi, Cataliotti; Barbara, Grilli Leonulli; Simonetta, Bianchi; Gian Paolo, Biti (2008). Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma.. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 71, pp. 705-709, ISSN:0360-3016 DOI

Detti B; Meattini I; Livi L; Biti G; Gacci M; Serni S; Lapini A; Carini M (2008). Recidive tardive nei tumori germinali del testicolo: esperienza ventennale. .

Mangoni M; Meattini I; Agresti B; Pallotta S; Marrazzo L; Nesi G; Lombardi A; Cantini G; Poli G; Gelmini S; Luconi M; Serio M; Bucciolini M; Mannelli M; Biti G (2008). Antitumor effect and interaction with ionizing radiation of PPAR_GAMMA on adrenocortical carcinoma. TUMORI, pp. S4-S5, ISSN:2038-2529

Borghesi S; Scoccianti S; Sardaro A; Detti B; Meattini I; Iannalfi A; Agresti B; Pallotta S; Martinelli F; Montanaro D; Pellicanò G; Biti G (2007). The value of functional MRI (perfusion MRI and spettroscopy MRI) for radiotherapy planning in high grade gliomas: a case report. TUMORI, pp. S139-S139, ISSN:2038-2529

Livi L; Detti B; Meattini I; Sánchez LJ; Biti GP. (2007). Organ-confined prostate cancer: treatment with high doses of radioterapy (intensity modulated radiotherapy). ACTAS UROLÓGICAS ESPAÑOLAS, vol. 31, pp. 611-616, ISSN:0210-4806

Detti B; Livi L; Scoccianti S; Meattini I; Gacci M; Lapini A; Biti G. (2007). Late relapse in testicular germ cell tumors.. TUMORI, vol. 93, pp. 428-431, ISSN:0300-8916

LIVI L; SAIEVA C; DETTI B; MEATTINI I; SUSINI T; PAIAR F; MILEO A; RAMPINI A; BRUNI A; PETRUCCI A; G. BITI (2007). Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy.. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, vol. 33, pp. 977-981, ISSN:0748-7983 DOI

Icro MEATTINI

Biography

Personal

Background

Experience

2018 – 2024 National Scientific Qualification I-level as Full Professor for Radiation Oncology (Scientific Disciplinary Sector SSD MED/36).

2011 – 2018 Consultant Clinical/Radiation Oncologist at Radiation Oncology Unit, Oncology Department. AOU Careggi Hospital, University of Florence, Florence, Italy.

2010 – 2011 Post-training Research Fellowship at Radiation Oncology Unit, Oncology Department. AOU Careggi Hospital, University of Florence, Florence, Italy.

Education and Qualifications

2017 – 2019 EORTC Early Career Investigators (ECI) Leadership Program for the management of Clinical Research in Oncology. Brussels, Belgium.

2016 – 2018 Master’s degree in Oncologic Drugs and Radiotherapy. University of Brescia, Brescia, Italy

2005 – 2009 Resident in Training, MD Program, University of Florence, Florence, Italy.

2008 – 2009 Resident in Training Fellowship, Royal Marsden Hospital, London, UK.

1999 – 2005 MD degree, University of Florence, Florence, Italy

H-index: 27, Publications: original peer-reviewed: 221 (available at https://pubmed.ncbi.nlm.nih.gov/?term=Meattini+I&sort=date&size=200), Book Editor: 1, Book Chapter Contributor: 5.

Icro MEATTINI

Curriculum

work experience

2024 – present

2018 – present

2018 – 2029

2011 – 2018

2010 – 2011

Head, Breast Unit, Azienda Ospedaliero Universitaria Careggi (AOUC), Florence University Hospital, Florence, Italy

Chair, Breast Cancer Multi-Disciplinary Team (MDT), AOUC, Florence University Hospital, Florence, Italy

Associate Professor, Radiation Oncology, Department of Experimental and Clinical Biomedical Sciences “M. Serio” – University of Florence, Florence, Italy

Consultant, Radiation and Clinical Oncologist, Radiation Oncology Unit, AOUC, Florence University Hospital, Florence, Italy

Chair, Breast Cancer MDT for Radiation Oncology (2012 – present)

Head, Clinical Research Unit, Radiation Oncology Department (2017 – present)

National Scientific Qualification I level, Full Professor for Radiation Oncology (Scientific Disciplinary Sector [SSD] MED/36)

Consultant, Radiation/Clinical Oncologist

AOUC Florence University Hospital, Florence, Italy

Radiation Oncology Unit, Oncology Department

Research Fellow on “Evaluation of genetic predisposition to induced radio toxicity” at Radiation Oncology Unit, Oncology Department, AOUC Florence University Hospital, University of Florence, Florence, Italy

education and training

2017 – 2019

2016 – 2018

2005 – 2009

2008 – 2009

2005 – 2006

1999 – 2005

1994 – 1999

European Organisation for Research and Treatment of Cancer (EORTC)

Early Career Investigators (ECI) Leadership Program for the management of Clinical Research in Oncology

University of Brescia, Brescia, Italy

II Degree Master on “Oncologic Drugs and Radiotherapy”. Dissertation thesis “Hypofractionation in young breast cancer patients”. Supervisor: Prof. Stefano M. Magrini

University of Florence, Florence, Italy

Postgraduate Degree in Radiation Oncology. Dissertation topic “Breast cancer in patients treated for Hodgkin lymphoma: University of Florence experience”. Supervisor: Prof. Giampaolo Biti. 70/70 cum Laude

Royal Marsden Hospital, London, UK

Fellowship at Royal Marsden Hospital, London (UK). Supervisor: Prof. Michael Brada.

University of Florence, Florence, Italy

Research fellow at Department of Clinical Physiopathology

Topic: "Risk-assessment in Radiotherapy". [European project LSHC-CT-2004-503564 of 6^th program MAESTRO (Advanced Methods and Equipment for Simulation and Treatment in Oncology Radiology)].

University of Florence, Florence, Italy

Medical Degree. Dissertation topic “Localized prostate cancer treated with intensity-modulated radiation therapy (IMRT)” Supervisor: Prof. Giampaolo Biti. 110/110 cum Laude.

High School “N. Rodolico”, Florence, Italy

Scientific High school degree. 100/100.

personal skills

Mother tongue

Italian

Foreign languages

English

UNDERSTANDING

Reading

Listening

SPEAKING

Spoken interaction

Spoken production

WRITING

Spanish

UNDERSTANDING

Reading

Listening

SPEAKING

Spoken interaction

Spoken production

WRITING

Scientific Publications

Scientific and Educational Activities

Author of more than 300 peer-reviewed scientific publications in international journals, available at: https://www.ncbi.nlm.nih.gov/pubmed/?term=meattini+i

h-index: 36 (Mar 21, 2025)

306 documents, 6361 citations by 5283 documents

available at: https://www.scopus.com/authid/detail.uri?authorId=23027824500

Organization and participation as a speaker at national and international scientific conferences.

- Local Organizing Committee of the XVII National Congress of the Italian Association of Radiotherapy Oncology (AIRO) 2007, Florence, Italy.

- Invited speaker. XXII AIRO National Congress. Rome. Topic: "Radiotherapy after neoadjuvant system therapy: irradiation of the lymph node chains? cons ". 17-20/11/2012.

- Invited speaker. Workshop topic: "Advanced Breast Cancer: Evidence and Future Perspectives". Montecatini Terme, Italy. 24/05/2013.

- Invited speaker. 17th ECCO - 38th ESMO - 32nd ESTRO. European Cancer Congress: Reinforcing Multidisciplinary. Amsterdam, Netherlands.

- Invited speaker in the Roundtable Session on "How to Improve Career Opportunities for Young Oncologists Across Europe". 27/09/2013-01/10/2013.

- Invited speaker. XXIII AIRO National Congress. Taormina, Italy. "Toxicity in associations with systemic therapies". 26-29/10/2013.

- Report. ESTRO 33, Vienna, Austria. Selected oral communication in the session Clinical. Topic: “Breast cancer. Toxicity of APBI using IMRT versus whole breast irradiation: 3-year follow-up of a Phase III randomized trial with first (presenting author) I. Meattini. 4-8 / 04/2014.

- Invited speaker. Workshop topic: "Aggressive disease and indolent disease in advanced stage breast cancer". Pontedera, Italy. 06/19/2014.

- Invited speaker. Workshop topic: "Metastatic breast cancer therapy: role of anthracyclines", Pisa, Italy. 08/10/2014.

- Invited speaker. Workshop topic: "Building the best therapeutic program for the BC+ HR+/HER2- patient", Montecatini, Italy. 31/10/2014.

- Invited speaker. XXIV AIRO National Congress. Padua, Italy. "Wide Angle in Oncological Radiotherapy 2014". 9-11/11/2014.

- Invited speaker. Topic: "Consensus on the new indication in the eribulin as second line therapy ", Reggio Emilia. 03/03/2015.

- Report. 3rd ESTRO Forum, Barcelona, Spain. Presentation as a poster discussion in the Clinical session. APBI versus whole breast irradiation in women age 70 years or older: a subgroup analysis of a phase 3 randomized trial with first (presenting author) I. Meattini. 24-28 / 04/2015.

- Consensus Conference speaker. Topic: from the practice of "follow up" to the culture of "survivorship care", organized by the Italian Association of Medical Oncology (AIOM). Rome, 10-11/09/2015.

- Invited speaker. XXV AIRO National Congress. Rimini, Italy. Symposium "Breast reconstruction and radiotherapy implications". 7-10/11/2015.

- Invited speaker. V AIRO ZOOM Journal Club 2015, Bologna, Italy. 19/02/2016.

- Invited speaker. Workshop Topic: "HER2 determination" amplification methods. AOUC Florence, Italy. 26/02/2016.

- Invited speaker. Workshop topic: "The Breast Unit as a model of care for gender medicine in the AOU Careggi", AOUC Florence, Italy. 08/03/2016.

- Invited speaker. "HER2 positive breast carcinoma: Highlights and perspectives". AOU Careggi Florence, Italy. 13/04/2016.

- Invited speaker. "We Breast". Workshop topic: “Treatment of HR +/HER2 metastatic breast cancer in postmenopausal patients: from literature to clinical practice. Chemotherapy and hormone therapy”. Prato, Italy 14/06/2016.

- Invited speaker. Advisory Board. Topic: "Treatment of patients with ER + HER2 metastatic breast cancer with Everolimus plus Exemestane: sharing of clinical and practical aspects to optimize treatment and management of patients". Antignano (Livorno), Italy. 27/06/2016.

- Invited speaker. Sustainability forum and opportunities in the health sector. Roundtable "The new frontiers in oncology". Stazione Leopolda, Florence, Italy. 23/09/2016.

- Invited speaker. Workshop Topic: "The Government of Pharmaceutical Innovation: Models of Sustainable Management of Innovative and High Cost Oncology Drugs". Istituto Toscano Tumori, Florence, Italy. 27/09/2016.

- Scientific Commission of the XXVII and XXVIII National Congress of the Italian Association of Radiotherapy Oncology (AIRO). Rimini, Italy 2017-2018.

- Invited speaker. XXVI AIRO National Congress. Symposium: "Innovative drugs in breast cancer". Rimini, Italy. 30/09/2016 - 02/10/2016.

- Invited speaker. Conference "Primary therapy in breast cancer". Oncological Tuesdays of AIOM Toscana. Pisa, Italy. 04/10/2016.

- Invited speaker. Senological diagnostics seminary with interactive presentation. Topic: "Disease recovery: diagnosis and biological meaning. Utilities and limits of follow-up ". Florence, Italy. 17-20/10/2016.

- Invited speaker. Itinerary section AIRO "Consensus for the irradiation of the mammary lymph node stations", Ospedale dell'Angelo di Venezia Mestre, Italy. 21/10/2016.

- Invited speaker. Brescia Meetings in Radiation Oncology. "International Research projects in cardio-oncology: focus on breast cancer". Brescia, Italy. 17-18 /11/2016.

- Report. ECCO 2017. Amsterdam, Netherlands. Proffered Paper Session: "Breast Cancer". Oral Presentation in a Proffered Paper Session. IMRT-Florence phase 3 trial: "Health-related quality of life analysis from the accelerated partial breast irradiation". 29/01/2017.

- Invited speaker. "Advanced Breast Cancer HR +: HER2- versus HER2 +. Open questions. BreastINg Work: aBC HR + / HER2 - an evolving panorama ". Camogli, Italy 31/03/2017 - 01/04/2017.

- Invited speaker. Topic: “Lecture on External beam partial irradiation”. ESTRO 36, Vienna, Austria. 5-9 /05/2017.

- Invited speaker. Topic: “Management of the patient with metastatic breast cancer”. Pisa, Italy 11 May 2017.

- Consensus conference. Topic: "In situ carcinoma of the breast". Catania, Italy. 18-20/05/2017.

- Invited speaker. Topic: "Update Course in Cardio-Oncology". Pietrasanta, Italy. 15/09/2017.

- Invited speaker. Topic: "Metastatic breast carcinoma with positive hormone receptors. Which clinical entity? ". Bergamo, Italy. 22-23/09/2017.

- Invited speaker. European Society for Radiation Oncology (ESTRO) and European Organization for the Research and Treatment of Cancer (EORTC). Speaker at the Annual Meeting of the Korean Society for Radiation Oncology (KOSRO). Seoul, Korea. 13/10/2017.

- Executive Committee of the IX edition of the Congress in Senology (AIS). Florence, Italy. 8-10/11/2017.

- Invited speaker. Topic: "Highlights in Radiotherapy. What news from the 2017 International Congresses”? "Il Cardello" Radiological Research Center. Rome, Italy. 25/01/2018.

- Executive Committee and Expert Board of the "2nd Think Tank meeting on research challenges in breast cancer", endorsed by ESTRO Assisi, Italy 1-3/03/2018.

- Local Organizer of the Spring Meeting of the Oncology Radiotherapy Group (ROG) of the European Organization for Cancer Research and Treatment (EORTC). Florence, Italy 11-13/03/2018.

- Invited speaker. Panel of Experts. 11th European Breast Cancer Conference (EBCC). Multidisciplinary Team in the Real-World session on "Young HER2 Negative Patients with Breast Cancer". Barcelona (Spain). 21-23/03/2018.

- ESTRO Conference 37, selected Oral Communication on: "DCIS treated with breast conservative surgery and radiotherapy: a national multicentre experience". Barcelona (Spain). 20-24/04/2018.

- Invited speaker. meeting “I se ed i ma del trattamento del carcinoma mammario metastatico ER+/HER2-“. Ferrara, 11-12 May 2018.

- Invited Speaker. Brescia Meetings in Radiation Oncology “Immunity, drugs, radiation: from biology to contemporary clinical oncology”. Brescia, 20-21 September 2018.

- Advisory Board coordinator. Corso ECM “Help Desk in aBC. Share the clinical experience”. Firenze, 5 October 2018.

- Advisory Board. Breast Cancer Expert Meeting. Pisa, 13 November 2018.

- Invited Speaker. Annual Meeting Swedish Breast Medical Oncologist, Brostonkologisk Forening (BOF). Hesselby Slott, Vallingby, Stockholm (Sweden). 23-25 January 2019.

- Panel of Experts. Breast Surgery Toolbox – Hirslanden Klinik St. Anna Brustzentrum (ESTRO representative). “A consensus and toolbox to improve breast conservation rates and to guide axillary management after preoperative systemic therapy (PST)”. Luzern (Switzerland). 8 February 2019.

- Invited Speaker. Meeting “Focus sulla chirurgia oncologica e ricostruttiva della mammella”. Pisa, 11-12 April 2019.

- Invited Speaker. ESTRO 38 Annual Meeting. SP-0463 Towards less radiotherapy in breast cancer treatment. Milan, 27-30 April 2019.

- Executive Committee and Invited Speaker. XI Edition Biannual Meeting “Attualità in Senologia (AIS)”. Firenze, 6-8 November 2019.

- Invited Speaker. VIII Breast Surgery Workshop. “Ductal carcinoma in situ of the breast”. Aarhus, 21-23 May 2019.

- Panel of Experts. III Skagen meeting. Skagen, 4-6 June 2019.

- Advisory Board. “HR+ 2020, Il carcinoma mammario avanzato in alta risoluzione”. Firenze, 21 June 2019.

- Invited Speaker. 29th Residential Course “Modern Radiotherapy, time issues and new drugs”. Roma, 21-23 October 2019.

- Invited Speaker. XXI Congress of the Brazilian Society of Radiotherapy. Rio de Janeiro (Brasil), 23-27 October 2019.

- Invited Speaker. ESMO Breast Cancer Virtual Meeting. “Is cardiac damage still relevant? And how can be avoided?”. Virtual, 23-24 May 2020.

- Invited Speaker. Biannual Meeting 12th European Breast Cancer Conference (EBCC-12) (virtual). European SocieTy for Radiotherapy & Oncology (ESTRO) - State of the Art in Radiation Oncology 2020. The best treatment in breast cancer radiotherapy 3D vs. IMRT. Virtual, 2-3 October 2020.

- Invited Speaker. Breast Turkish International Meeting Breastambul (hybrid/virtual). Istanbul, virtual, 17-18 October 2020.

- Invited Speaker. ESTRO40 Annual Meeting (virtual). 28 Nov – 1 Dec 2020.

- Invited Speaker. World Congress of Brachytherapy 2020 (virtual). Debate: Partial Breast Irradiation with 1-3 fractions. Virtual, 6-8 May 2021.

- Invited Speaker. Highlights St. Gallen Breast Cancer Conference 2021. Webinar, 28 May 2021.

- Invited Speaker. MORE TIME MORE LIFE. “Advanced Breast Cancer HR+ HER2-, dagli studi alla pratica clinica: gli inibitori CDK4/6 sono davvero tutti uguali?“. Webinar, 2 July 2021.

- Invited Speaker. Senoforum Accademia di Senologia Umberto Veronesi. 15-16 July 2021.

- Invited Speaker. ESTRO41 Annual Meeting. Session: New endpoints for early breast cancer - Less is more? Presentation title: Health-related quality of life - Primary or surrogate endpoint? Madrid, 27-31 August 2021.

- Faculty member and Speaker. ESMO Virtual Preceptorship on Cancer Care in Elderly Patients. Radiotherapy in older patients. 2-3 September 2021.

- Faculty. Focus Group CNAO: Patologie mammarie. Webinar, 21 September 2021.

- Invited Speaker. Webinar ECM FAD "Il meraviglioso mondo dei PARP inibitori: dalla biologia molecolare alla pratica clinica". Webinar, 23 September 2021.

- Faculty member and Invited Speaker. Breastics24h Breast Oncoplastic. Oncoplastic Multidisciplinary Board Meeting. Webinar, 25 September 2021.

- Invited Speaker and Faculty. ESSO Advanced Course on Breast Cancer Surgery. Live Virtual Course, 24 November 2021.

- Panel of Experts. Assisi ATTM. Assisi, 21-23 February 2022.

- Invited Speaker and Faculty. ESTRO APBI multidisciplinary Course. Virtual, 28-30 March 2022.

- Invited Speaker and Session Chair. Omission of radiation therapy. GBCC Annual Meeting. Seoul, Korea, April 2022.

- Invited Speaker, Chair, and selected proffered paper. ESTRO42 Annual Meeting. Copenhagen, 6-10 May 2022.

- Faculty and Invited Speaker.2° Congresso Rete Senologica Toscana. Cortona, 13-14 May 2022.

- Invited Speaker and Faculty. ESMO Preceptorship programme on breast cancer. Live Virtual Course, 14-15 June 2022.

- Panel of Experts. IV Skagen meeting. Skagen, 21-23 June 2022.

- Faculty and Invited Speaker. 13^th European Breast Cancer Conference (EBCC). Barcelona, Spain, 16-18 November 2022.

- Faculty and Invited Speaker. 18^th St. Gallen International Breast Cancer Conference (SGBCC). Vienna, Austria, 15-18 March 2023.

- Invited Speaker. ESTRO 2023 Clinical Pre-meeting palliative care course. Vienna, Austria, 12 May 2023.

- Invited Speaker. ESTRO 2023 Annual Meeting. Vienna, Austria, 12-16 May 2022.

- Faculty. ESSO Advanced Course on Breast Cancer Surgery. Madrid (SP), 28-30 September 2023.

- Invited Speaker. 42nd Congress of the European Society of Surgical Oncology. Florence, Italy, 25-27 October 2023.

- Faculty. ESMO Preceptorship on Breast Cancer. Lugano, Switzerland, 6-7 October 2023.

- Invited Speaker. XXXIII AIRO National Congress. Rimini, Italy, 27-29 October 2023.

- Invited Speaker. Educational Program at 2023 San Antonio Breast Cancer Symposium. San Antonio, Texas (USA), 4-9 December 2023.

- Invited Speaker, Chair. 14^th European Breast Cancer Conference (EBCC). Milan, Italy, 20-22 March 2024.

- Invited Speaker. ESMO Breast Cancer 2024. Berlin, Germany, 15-17 May 2024.

- Faculty. 24^th Workshop on Methods in Clinical Cancer Research (MCCR). Sint Michielsgestel, Netherlands, 15-21 June 2024.

- Invited Speaker.17^th Annual Meeting of the Korean Society of Medical Oncology & 2024 International Conference (KSMO 2024). Seoul, South Korea, 26-27 September 2024.

- Invited Speaker and Faculty. Breastambul Conference 2024. Istanbul, Turkey, 10-12 October 2024.

- Invited Speaker. San Antonio Breast Cancer Symposium 2024. San Antonio, Texas (USA), 9-12 December 2024.

- Invited Speaker. Breast Cancer at the Limits meeting. London, UK, 10 January, 2025.

- Invited Speaker, Char & Faculty roles. 2025 ESTRO Annual meeting. Vienna, Austria, 2-5 May, 2025.

- Invited Speaker. ESMO Breast Cancer 2025. Munich, Germany, 15-17 May, 2025.

- Invited Speaker. Educational Session. 2025 ASCO Annual meeting. Chicago, USA, May 30 – June 3, 2025.

- Invited Speaker. San Antonio Breast Cancer Symposium 2025. San Antonio, Texas (USA), 9-12 December 2025.

Management, organization, and participation in the activities of national and international research groups.

- Co-Chair of the Inter-regional Section Tosco-Umbra of the Italian Association of Radiotherapy Oncology (GTUOR). Biennium 2013-2015.

- Co-Chair of the Breast Cancer Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Biennium 2014-2016.

- Radiation Oncology Group (ROG) and the Breast Cancer Group (BCG) of the European Organization for Cancer Research and Treatment (EORTC). 2014-today.

- Co-Chair of the Breast Working party (BWP) of the ROG of the EORTC. 2013-2018.

- Selected for the program promoted by the European Organization for Cancer Research and Treatment (EORTC): Early Career Investigator (ECI) EORTC Program. 2017-2019.

- European Organization for Research and Treatment of Cancer (EORTC) - Radiation Oncology Group (ROG) -Disease Oriented Groups Junior Representative (jRDR) for Breast Cancer. March 2018-2020.

- Founding Partner and Chair of the National / International Multi-Center Study Group "Clinical Oncology Breast Cancer Group - Group of Clinical Oncology of Breast Cancer" (COBCG). March 2018-today.

- Member the Italian College of Senologists. 2016-2020.

- Member of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). 2006-today.

- Member of the Italian Association of Radiobiology (AIRB).

- Member of European Society for Radiation Oncology (ESTRO) since 2012

- Member of the European Organization for Research and Treatment of Cancer (EORTC) since 2014.

- Writing Committee of Breast Cancer AIRO Italian Guideline. 2017-2018.

- Reviewer Committee of Breast Cancer AIRO Italian Guideline. 2019-2020.

- Reviewer Committee of Breast Cancer Italian Guideline of the Medical Oncology Italian Association (AIOM). 2018-2020.

- Executive Committee of the Biannual Meeting “Attualità in Senologia”. Florence. 2019 and 2021.

- Scientific Committee of SenoNetwork. 2020-2022.

- Scientific Committee of the National Meeting AIRO. 2016-2022.

- Chair of the Breast Cancer Group of AIRO. 2020-2022.

- Board Member of the Radiation Oncology Scientific Council (ROSC) EORTC. 2020-present.

- Member of the ESTRO SAG for Clinical Radiotherapy SAG. ESTRO Meeting 2020 (virtual), ESTRO Meeting 2021 (Madrid), and ESTRO Meeting 2022 (Copenhagen).

- Board member of the ESTRO-ACROP guidelines breast cancer focus group. 2022-present.

- Scientific Committee of Tuscany Region Senologic Network on axillary management. Comitato Scientifico Regionale sul Trattamento dell'Ascella. Rete Senologica Toscana. 2021-2022.

- Faculty member of the College of the European School of Oncology (ESO). 2022-present.

- Task force member of Accelerated Partial Breast Irradiation (APBI) Replacement: An ASTRO Evidence-Based Clinical Practice Guideline. March, 2022.

- Faculty member of 13^th European Breast Cancer Conference (EBCC). Barcelona, Spain, 16-18 November 2022.

- Faculty member of 18^th St. Gallen International Breast Cancer Conference (SGBCC). Vienna, Austria, 15-18 March 2023.

- Faculty member of 13^th European Breast Cancer Conference (EBCC). Milan, Italy, March 2024.

- ESTRO clinical Board Member. 2023 – 2026.

- ESTRO Educational Committee (EDC) Board Member. 2023 – present.

- ESTRO-Industry task force Chair. 2024 – present

- ESTRO Clinical Radiotherapy Scientific Advisory Group (SAG) Chair. ESTRO Meeting 2025 (Vienna, Austria).

- Organising Committee of 15^th EBCC. Barcelona, Spain, March, 2026.

- ESTRO Clinical Radiotherapy Scientific Advisory Group (SAG) member. ESTRO Meeting 2026 (Stockholm, Sweden).

Responsibility and coordination of scientific works and research

- Co-Principal Investigator. APBI-IMRT-Florence (NCT02104895) phase III trial. Accelerated Partial Breast Irradiation Using Intensity Modulated Radiotherapy Versus Whole Breast Irradiation. Institution: University of Florence, Italy.

- Sub-Investigator. PERTAIN Trial (Hoffmann-La Roche) A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Hormone Receptor-Positive, HER2-positive Metastatic Breast Cancer patients. NCT01491737.

- Sub-Investigator. SAFE HER trial (Hoffmann-La Roche). A Safety and Tolerability Study of Assisted- and Self-Administered Subcutaneous Herceptin (Trastuzumab) as Adjuvant Therapy in Patients with Early HER2-Positive Breast Cancer (SafeHer). NCT01566721.

- Sub-Investigator. BELLE3 trial (Novartis). Randomized, double-blind, placebo-controlled, Phase III trial with BKM120 in combination with fulvestrant in postmenopausal patients with HER2-negative hormone receptor positive, locally advanced or metastatic carcinoma treated with aromatase inhibitors and presented progression during or after therapy with a regimen containing an mTOR inhibitor.

- Sub-Investigator. SAFE phase III trial (NCT02236806). Role of ACE Inhibitors and Beta Blockers as Cardiotoxicity Prevention in Breast Cancer Patients Treated With (Neo) Adjuvant Anthracyclines and / or Trastuzumab: a Four Arm, Placebo Control, Randomized Trial. Institution: University of Florence, Italy.

- Sub-Investigator. GIM13 AMBRA (Oncotech Consortium). Longitudinal cohort study on the therapeutic choices of HER2-negative metastatic breast cancer in Italian clinical practice.

- Sub-Investigator. GIM10 CONSENT (IRCCS AOU San Martino-IST). Phase III clinical study comparing the concomitant and sequential administration of CT and AI as adjuvant treatment of postmenopausal patients with hormone-sensitive breast cancer.

- Sub-Investigator. SANDPIPER Trial (Hoffmann-La Roche). SANDPIPER Study: A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant In Patients With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy. NCT02340221.

- Sub-Investigator. BONADIUV phase II trial (NCT02616744). A Single - blind, Randomized, Placebo - controlled Phase II Study to Evaluate the Impact of Oral Bisphosphonate Treatment on Bone Mineral Density in Osteopenic Women Receiving Adjuvant Aromatase Inhibitors - BONADIUV Trial. Institution: University of Florence, Italy.

- Sub-Investigator. GIM16 FEVEX (Consorzio Oncotech). Fulvestrant followed by everolimus plus exemestane vs examestane and everolimus followed by fulvestrant in postmenopausal women with hormone receptor positive (HR +) ad human epidermal growth factor receptor type 2 negative (HER2-) locally advanced (LABC) or metastatic breast cancer (MBC) previously treated with non steroidal aromatase inhibitors (NSAI): a multicentre, phase III trial.

- Sub-Investigator. SINODAR ONE trial (Humanitas Research Foundation - Rozzano, Milan). T1-T2 mammary carcinoma: comparison of excision and preservation of axillary lymph nodes in the presence of metastases to the sentinel lymph node.

- Sub-Investigator. PAINTER trial (Medical Oncology of the Fatebenefratelli Hospital) .PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment. NCT02864030.

- Co-Investigator. LUCY Study: Lynparza Breast Cancer Real-World Utility, Clinical Effectiveness and Safety Study A Phase IIIb, Single-arm, Open-label Multicentre Study of Olaparib Monotherapy in the Treatment of HER2-ve Metastatic Breast Cancer Patients with Germline BRCA1 / 2 Mutations. Eudract Code: 2017-001054-34.

- Co-Investigator. Patients With Her2-Positive Unresectable Locally Advanced Or Metastatic Breast Cancer (F. Hoffmann-La Roche Ltd). Protocol Number MO39146.

- Co-Investigator. A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Atezolizumab In Combination With Chemotherapy For Patients With Early Relapsing Recurrent (Inoperable Locally Advanced Or Metastatic) Triple-Negative Breast Cancer "(F. Hoffmann -La Roche Ltd). Protocol Number MO39193. Eudract Number 2016-005119-42.

- Co-Investigator. A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of atezolizumab (Anti-PD-L1 antibody) In Combination With Paclitaxel compared With Placebo With Paclitaxel For Patients With Previously Untreated Inoperable Locally Advanced Or Metastatic Triple Negative Breast Cancer (F. Hoffmann-La Roche Ltd). Protocol Number MO39196 Eudract Number 2016-004024-29.

- Co-Investigator. Palbociclib Collaborative Adjuvant Study: A Randomized Phase III Trial Of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone For Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2) -Negative Early Breast Cancer (Pallas). Alliance Foundation Trials, Llc. Clinicaltrials.Gov Identifier: Nct02513394.

- Co-Investigator. Non-Interventional Study To Characterize The Real World Treatment Patterns And Outcomes Of Women With ER+, HER2- Advanced Or Metastatic Breast Cancer In Italy (Pfizer). Protocol Number A5481031.

- Co-Investigator. Compleement-1: “An open-label, multicenter, Phase IIIb study to assess the safety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre / postmenopausal women with hormone receptor-positive (HR +) HER2- negative (HER2) advanced breast cancer (BC) with no prior hormone therapy for advanced disease”. Eudract Code: 2016-003467-19.

- Principal Investigator. Phase III trial (EUROPA trial). ExclUsive endocRine therapy Or Partial breast irradiation for women aged ≥70 years with luminal A-like early stage breast cancer (EUROPA): a randomized phase 3 non-inferiority trial. ClinicalTrial.gov Identifier NCT04134598. Institution: University of Florence.

Scientific responsibility for national and international projects

- Professional Research Assign at the Department of Clinical Physiopathology of the University of Florence, Italy. Topic: "Risk-assessment in Radiotherapy". European project no. LSHC-CT-2004-503564 - VI Program MAESTRO (Methods and Advanced Equipment for Simulation and Treatment in Radio Oncology). 10/1/2005 - 01/03/2006.

- Research fellowship Topic “Evaluation of genetic predisposition to induced radio toxicity” (DAI Oncology, SODC Radiotherapy) of the Department of Clinical Pathophysiology of the University of Florence, Italy. (2009 Regional Health Research Grant). 01/07/2010 - 30/07/2011.

Participation in editorial committees of Journals and Editorial series

- Cancer and Clinical Oncology (ISSN: 1927-4858, Print; ISSN: 1927-4866, Online)

- Case Reports in Pathology (ISSN: 2090-6781)

- Translational Cancer Research (Translator Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803)

- Subject Editor (Radiation Therapy) Critical Review in Oncology/Hematology (ISSN 1040-8428), 2022-2024.

- Editorial Board, Radiotherapy and Oncology (ISSN 0167-8140). 2025-present.

- Editorial Board, European Journal of Surgical Oncology (EJSO). 2025-present.

Reviewer for Scientific Journals

- Cancer and Clinical Oncology (ISSN: 1927-4858, Print; ISSN: 1927-4866, Online).

- Case report in Pathology (ISSN: 2090-6781).

- BMC Cancer (ISSN: 1471-2407).

- Onkologie (ISSN: 1423-0240).

- Medical radiology (ISSN: 1826-6983).

- Tumor Biology (ISSN: 1010-4283).

- Clinical Breast Cancer (ISSN: 1526-8209).

- Urologic Oncology (ISSN: 1078-1439).

- The Breast (ISSN: 0960-9776).

- Future Oncology (ISSN 1479-6694).

- Radiotherapy and Oncology (ISSN 0167-8140)

- Critical Review in Oncology/Hematology (ISSN 1040-8428)

- The Lancet Oncology (ISSN 1470-2045)

- JAMA Oncology (ISSN 2374-2437, ISSN 2374-2445)

- Journal of Clinical Oncology (ISSN 0732-183X, ISSN 1527-7755)

Assignments in University teaching courses and research institutes

- Fellowship. Oncology Radiotherapy Unit - Radiation Oncology Unit, Royal Marsden Hospital, London (UK). Supervisor: Prof. Michael Brada from 01.10.2008 to 31.03.2009. Clinical activity at the "Royal Marsden Hospital" (RMH), London (UK) and research activity at The Institute of Cancer Research (ICR), London, Sutton (UK). Consulting at the Chelsea and Sutton institute of the RMH specialized in lung and brain cancer (Prof. Michael Brada). Outpatient clinical activity at the Sutton site of the specialized RMH in hematological malignancies (Prof. Alan Horwich). Discussion and participation in Multi-Diciplinary Team (MDT) of lung cancer (Sutton's RMH site) and cerebral cancer (St. George Hospital, Wimbledon, London).

- Frontal teaching and student tutor in Master's Degree course, Medical School and Three-year Degree Course in Medical Radiology Techniques.

- Frontal teaching and mentoring in specialized training Specialization school in Radiation Oncology AOUC Florence.

- Thesis co-supervisor (Supervisor Prof. Lorenzo Livi) Medical School, University of Florence, Italy.

- Local Speaker of the Advanced Course on Multidisciplinary Breast Cancer Treatment of the European Society of Radiotherapy Oncology (ESTRO), ESTRO Teaching Course on the Multidisciplinary Management of Breast Cancer 2015, ESTRO School of Radiation Oncology.

- Teacher of the ESTRO Teaching Course on Accelerated partial Breast Irradiation. 2020-present.

- Teacher Faculty. II Degree Master on “Oncologic Drugs and Radiotherapy”. University of Brescia, Brescia, Italy. 2023-present.

University of Florence academic teaching courses:

- Medical Radiology, Imaging Techniques, and Radiotherapy (2018-2020)

DIAGNOSTIC IMAGING TECHNIQUES II [B019930, B024640, B029359]

GENERAL RADIOLOGY DIAGNOSTIC TECHNIQUES - SENIOLOGY AND INTERVENTIONAL RADIOLOGY [B029341]

- Healthcare Assistance (2020-2021)

PREVENTIVE SCIENCES [B020074, B030150]

- Obstetrics (2021-present)

HEALTH AND SAFETY PROMOTION [B030999]

- Nursing (2018-present)

DIAGNOSTIC AND THERAPEUTIC PROCESSES [B030242]

- Medicine and Surgery (2018-present)

DIAGNOSTIC IMAGING (INTEGRATED COURSE) [0090435]

Clinical activity

Main clinical care responsibilities (Radiation Oncology Unit – AOUC Firenze, Prof. Lorenzo Livi):

- Clinical, diagnostic, therapeutic and follow-up settings; participation in MDT, concomitant therapies (radiotherapy, chemotherapy, molecular therapies), supportive and palliative care;

- Head of Breast Unit at AOUC Florence University Hospital and Head of Breast Cancer MDT;

- Day-Hospital activities: chemotherapies and molecular therapies in primary, adjuvant and metastatic settings of cancer patients; supportive therapy; management of revaluations under treatment; participation in internal, national and international clinical trials (sponsored and academics);

- Activities in the radiotherapy planning unit: management of early therapy and tolerance consulting; linear accelerators, tomotherapy, GammaKnife, CyberKnife; use of treatment plan systems for the contouring and planning of standard, conformational, stereotactic, IMRT, VMAT (XiO, Odyssey, Pinnacle, Monaco) treatments;

- Knowledge of record and verify systems; use of PACS systems for image management; use of patient positioning verification systems and immobilization systems.

All the information provided in this curriculum vitae is accurate and truthful. I authorize the processing of my personal data in accordance with EU Regulation 2016/679 on the protection of personal data (GDPR). Any unauthorized use or disclosure of this information is prohibited. I declare that I am aware that the personal data provided will be treated with the utmost confidentiality and used exclusively for the purposes of the current selection process.

Florence, Italy

21/03/2025

Icro MEATTINI

Icro MEATTINI

Icro MEATTINI

Icro MEATTINI

ORGANIZZAZIONE E PARTECIPAZIONE COME RELATORE A CONGRESSI SCIENTIFICI NAZIONALI E INTERNAZIONALI

GESTIONE, ORGANIZZAZIONE E PARTECIPAZIONE NELLE ATTIVITÀ DI GRUPPI DI RICERCA NAZIONALI E INTERNAZIONALI

RESPONSABILITÀ SCIENTIFICA DI PROGETTI NAZIONALI E INTERNAZIONALI

PARTECIPAZIONE IN COMITATI EDITORIALI DI RIVISTE E SERIE EDITORIALI

REVISORE PER RIVISTE SCIENTIFICHE

INCARICHI IN CORSI UNIVERSITARI E ISTITUTI DI RICERCA

ATTIVITÀ CLINICA

Icro MEATTINI

Icro MEATTINI

Icro MEATTINI

Icro MEATTINI

Icro MEATTINI